0001820721-23-000079 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover Page - USD ($)	12 Months Ended
Cover Page - USD ($)	Dec. 31, 2022	Mar. 20, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-39613
Entity Registrant Name	ARRAY TECHNOLOGIES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-2747826
Entity Address, Address Line One	3901 Midway Place NE
Entity Address, City or Town	Albuquerque
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	87109
City Area Code	(505)
Local Phone Number	881-7567
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	ARRY
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 1,552,485,022
Entity Common Stock Shares Outstanding		150,768,883
Documents Incorporated by Reference	Portions of the registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission (“SEC”) subsequent to the date hereof pursuant to Regulation 14A in connection with the registrant’s 2023 Annual Meeting of Stockholders, are incorporated by reference into Part III of this Annual Report on Form 10-K. We intend to file such proxy statement with the SEC not later than 120 days after the conclusion of the registrant’s fiscal year ended December 31, 2022.
Entity Central Index Key	0001820721
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2022
Auditor Information [Abstract]
Auditor name	BDO USA, LLP
Auditor location	Austin, Texas
Auditor firm ID	243

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 133,901	$ 62,778	$ 51,046	$ 49,491	$ 367,670
Accounts receivable, net	421,183	485,174	452,836	390,921	236,009
Inventories, net	233,159	269,775	329,951	299,010	205,653
Income tax receivables	3,532	12,765	16,217	31,079	9,052
Prepaid expenses and other	39,434	40,484	52,006	45,670	33,649
Total current assets	831,209	870,976	902,056	816,171	852,033
Property, plant and equipment, net	23,174	20,024	17,802	16,878	10,692
Goodwill	416,184	401,373	417,694	442,222	69,727
Other intangible assets, net	386,364	399,883	436,549	482,035	174,753
Deferred tax assets	16,466	18,785	18,521	0	9,345
Other assets	32,655	23,145	26,009	26,544	26,429
Total assets	1,706,052	1,734,186	1,818,631	1,783,850	1,142,979
Current liabilities
Accounts payable	170,430	199,358	231,798	187,466	92,002
Accrued expenses and other	54,895	91,102	51,072	54,837	38,494
Accrued warranty reserve	3,690	4,237	2,911	3,201	3,192
Income tax payable	6,881	10,587	419	6,452	60
Deferred revenue	178,922	154,692	167,556	121,624	99,575
Current portion of contingent consideration	1,200	0		0	1,773
Current portion of debt	38,691	47,686	51,494	48,180	4,300
Other current liabilities	10,553	4,981	6,949	10,886	5,909
Total current liabilities	465,262	513,121	512,677	433,124	245,305
Deferred tax liability	72,606	76,864	86,590	99,260	0
Contingent consideration, net of current portion	7,387	7,113	7,686	9,363	12,804
Other long-term liabilities	14,808	9,113	9,723	7,102	5,557
Long-term warranty	1,786	3,852	4,056	4,743	0
Long-term debt, net of current portion	720,352	725,109	793,557	778,248	711,056
Total liabilities	1,282,201	1,335,172	1,414,289	1,331,840	974,722
Commitments and contingencies (Note 15)
Series A Redeemable Perpetual Preferred Stock: $0.001 par value; 500,000 shares authorized; 406,000 and 350,000 issued, respectively; liquidation preference of $400.0 million and $350.0 million, respectively	299,570	287,561	293,974	281,792	237,462	$ 0
Stockholders’ equity (deficit)
Preferred stock $0.001 par value; 4,500,000 shares authorized; none issued	0	0	0	0	0
Common stock $0.001 par value; 1,000,000,000 shares authorized; 150,513,104 and 135,026,940 issued, respectively	150	150	150	150	135
Additional paid-in capital	383,176	392,862	401,614	411,232	202,562
Accumulated deficit	(267,470)	(262,219)	(302,863)	(297,839)	(271,902)
Accumulated other comprehensive income	8,425	(19,340)	11,467	56,675	0
Total stockholders’ equity (deficit)	124,281	111,453	110,368	170,218	(69,205)	$ (80,899)	$ 305,151
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity (deficit)	$ 1,706,052	$ 1,734,186	$ 1,818,631	$ 1,783,850	$ 1,142,979

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Temporary equity, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Temporary equity, shares authorized (in shares)	500,000	500,000	500,000	500,000	500,000
Temporary equity, shares issued (in shares)	406,000	400,000	412,606	400,000	350,000
Temporary equity, liquidation preference	$ 400,000,000	$ 400,000,000	$ 413,000,000	$ 400,000,000	$ 350,000,000.0
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000
Preferred stock, shares issued (in shares)	0	0	0	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	150,513,104	150,334,261	150,279,160	150,173,507	135,026,940

Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 14, 2020	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue		$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475	$ 1,637,546	$ 853,318	$ 872,662
Cost of revenue		434,801	379,919	273,999	653,918	1,088,719	1,410,270	770,459	669,861
Gross profit		80,223	39,946	26,587	66,533	146,756	227,276	82,859	202,801
Operating expenses
General and administrative		38,703	28,936	45,425	74,361	113,064	150,777	80,974	55,634
Contingent consideration		(572)	(1,678)	(3,731)	(5,409)	(5,981)	(4,507)	2,696	26,441
Depreciation and amortization		24,898	26,020	23,237	49,257	74,155	99,139	23,930	25,514
Total operating expenses		63,029	53,278	64,931	118,209	181,238	245,409	107,600	107,589
Income (loss) from operations		17,194	(13,332)	(38,344)	(51,676)	(34,482)	(18,133)	(24,741)	95,212
Other income (expense)
Other income (expense), net		(399)	(371)	743	372	(27)	2,789	(905)	(2,305)
Legal settlement		42,750				42,750	42,750	0	0
Foreign currency gain		(159)	(1,736)	3,863	2,127	1,968	1,155	0	0
Interest expense		(8,746)	(8,021)	(6,942)	(14,963)	(23,709)	(33,513)	(35,475)	(15,129)
Total other income (expense)		33,446	(10,128)	(2,336)	(12,464)	20,982	13,181	(36,380)	(17,434)
Income (loss) before income tax benefit		50,640	(23,460)	(40,680)	(64,140)	(13,500)	(4,952)	(61,121)	77,778
Income tax (benefit) expense		9,996	(18,436)	(14,743)	(33,179)	(23,183)	(9,384)	(10,718)	18,705
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	59,073
Preferred dividends and accretion		12,257	12,182	11,606	23,788	36,045	48,054	15,715	0
Net income (loss) to common shareholders		$ 28,387	$ (17,206)	$ (37,543)	$ (54,749)	$ (26,362)	$ (43,622)	$ (66,118)	$ 59,073
Income (loss) per common share
Basic (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49
Diluted (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49
Weighted average common shares outstanding
Basic (in shares)	119,994,467	150,322,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,467,000
Diluted (in shares)	119,994,467	151,382,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,514,000

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 40,644	$ (5,024)	$ (25,937)	$ (30,961)	$ 9,683	$ 4,432	$ (50,403)	$ 59,073
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Change in foreign currency translation adjustments	(30,807)	(45,208)	56,675	11,467	(19,340)	8,425	0	0
Comprehensive income (loss)	$ 9,837	$ (50,232)	$ 30,738	$ (19,494)	$ (9,657)	$ 12,857	$ (50,403)	$ 59,073

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Series A Preferred Stock	Member’s Equity	Common Stock	Common Stock Series A Preferred Stock	Additional Paid-In Capital	Additional Paid-In Capital Series A Preferred Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019			1
Beginning balance at Dec. 31, 2019			$ 305,151
Beginning balance (in shares) at Dec. 31, 2019				0
Beginning balance at Dec. 31, 2019	$ 305,151			$ 0		$ 0		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Special distribution	(589,000)		(589,000)
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)				7,000
Initial public offering of common stock, net of underwriting discounts and commissions	145,532			$ 7		145,525
Deferred offering costs	(6,464)					(6,464)
Stock compensation expense	4,809		3,397			1,412
Net income (loss)	59,073		$ 71,394					(12,321)
Corporate conversion and stock split (in shares)			(1)	119,994
Corporate conversion and stock split	0		$ 209,058	$ 120				(209,178)
Ending balance (in shares) at Dec. 31, 2020			0
Ending balance at Dec. 31, 2020			$ 0
Ending balance (in shares) at Dec. 31, 2020				126,994
Ending balance at Dec. 31, 2020	$ (80,899)			$ 127		140,473		(221,499)	$ 0
Ending balance (in shares) at Dec. 31, 2020	0
Ending balance at Dec. 31, 2020	$ 0
Beginning balance (in shares) at Dec. 31, 2019				0
Beginning balance at Dec. 31, 2019	305,151			$ 0		0		0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation	4,809		3,397			1,412
Issuance of stock, net (in shares)				7,000
Issuance of stock, net	145,532			$ 7		145,525
Net (loss)	59,073		$ 71,394					(12,321)
Ending balance (in shares) at Dec. 31, 2020				126,994
Ending balance at Dec. 31, 2020	(80,899)			$ 127		140,473		(221,499)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)				7,875
Initial public offering of common stock, net of underwriting discounts and commissions	104,764			$ 8		104,756
Stock compensation expense	13,562					13,562
Net income (loss)	(50,403)							(50,403)
Ending balance (in shares) at Dec. 31, 2021				135,027
Ending balance at Dec. 31, 2021	$ (69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Preferred, net of fees (in shares)	350
Issuance of Series A Preferred, net of fees	$ 229,799
Preferred cumulative dividends plus accretion	8,226
Payment of dividends	(8,052)
Preferred accretion	$ 7,489
Ending balance (in shares) at Dec. 31, 2021	350
Ending balance at Dec. 31, 2021	$ 237,462
Beginning balance (in shares) at Dec. 31, 2020				126,994
Beginning balance at Dec. 31, 2020	(80,899)			$ 127		140,473		(221,499)	0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation (in shares)				158
Equity-based compensation	13,562					13,562
Issuance of stock, net (in shares)				7,875
Issuance of stock, net	104,764			$ 8		104,756
Deferred tax impact of capped call	(40,514)					(40,514)
Preferred cumulative dividends plus accretion	(8,226)					(8,226)
Preferred accretion	(7,489)					(7,489)
Net (loss)	(50,403)							(50,403)
Ending balance (in shares) at Dec. 31, 2021				135,027
Ending balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)				15,147
Initial public offering of common stock, net of underwriting discounts and commissions		$ 215,878			$ 15		$ 215,863
Stock compensation expense	4,413					4,413
Net income (loss)	(25,937)							(25,937)
Ending balance (in shares) at Mar. 31, 2022				150,174
Ending balance at Mar. 31, 2022	$ 170,218			$ 150		411,232		(297,839)	56,675
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Preferred, net of fees (in shares)	50
Issuance of Series A Preferred, net of fees	$ 32,724
Preferred cumulative dividends plus accretion	$ 11,606
Ending balance (in shares) at Mar. 31, 2022	400
Ending balance at Mar. 31, 2022	$ 281,792
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation	4,413					4,413
Issuance of stock, net (in shares)				15,147
Issuance of stock, net		215,878			$ 15		215,863
Preferred cumulative dividends plus accretion	(11,606)					(11,606)
Net (loss)	(25,937)							(25,937)
Other comprehensive income	56,675								56,675
Ending balance (in shares) at Mar. 31, 2022				150,174
Ending balance at Mar. 31, 2022	170,218			$ 150		411,232		(297,839)	56,675
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)					15,252
Initial public offering of common stock, net of underwriting discounts and commissions		215,498			$ 15		215,483
Stock compensation expense	7,357					7,357
Net income (loss)	(30,961)							(30,961)
Ending balance (in shares) at Jun. 30, 2022				150,279
Ending balance at Jun. 30, 2022	$ 110,368			$ 150		401,614		(302,863)	11,467
Beginning balance (in shares) at Dec. 31, 2021	350
Beginning balance at Dec. 31, 2021	$ 237,462
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Preferred, net of fees (in shares)	50
Issuance of Series A Preferred, net of fees	$ 32,724
Preferred cumulative dividends plus accretion (in shares)	13
Preferred cumulative dividends plus accretion	$ 23,788
Ending balance (in shares) at Jun. 30, 2022	413
Ending balance at Jun. 30, 2022	$ 293,974
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation	7,357					7,357
Issuance of stock, net (in shares)					15,252
Issuance of stock, net		215,498			$ 15		215,483
Preferred cumulative dividends plus accretion	(23,788)					(23,788)
Net (loss)	(30,961)							(30,961)
Other comprehensive income	11,467								11,467
Ending balance (in shares) at Jun. 30, 2022				150,279
Ending balance at Jun. 30, 2022	110,368			$ 150		401,614		(302,863)	11,467
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)					15,146
Initial public offering of common stock, net of underwriting discounts and commissions		214,906			$ 15		214,891
Stock compensation expense	11,454					11,454
Net income (loss)	9,683							9,683
Ending balance (in shares) at Sep. 30, 2022				150,334
Ending balance at Sep. 30, 2022	$ 111,453			$ 150		392,862		(262,219)	(19,340)
Beginning balance (in shares) at Dec. 31, 2021	350
Beginning balance at Dec. 31, 2021	$ 237,462
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Preferred, net of fees (in shares)	50
Issuance of Series A Preferred, net of fees	$ 32,724
Preferred cumulative dividends plus accretion (in shares)	13
Preferred cumulative dividends plus accretion	$ 36,045
Dividends paid (in shares)	(13)
Dividends paid	$ (18,670)
Ending balance (in shares) at Sep. 30, 2022	400
Ending balance at Sep. 30, 2022	$ 287,561
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation (in shares)				161
Equity-based compensation	11,454					11,454
Issuance of stock, net (in shares)					15,146
Issuance of stock, net		214,906			$ 15		214,891
Preferred cumulative dividends plus accretion	(36,045)					(36,045)
Net (loss)	9,683							9,683
Other comprehensive income	(19,340)								(19,340)
Ending balance (in shares) at Sep. 30, 2022				150,334
Ending balance at Sep. 30, 2022	111,453			$ 150		392,862		(262,219)	(19,340)
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)				15,147
Initial public offering of common stock, net of underwriting discounts and commissions	216,078	(1,938)		$ 15		216,063	(1,938)
Stock compensation expense	14,543					14,543
Net income (loss)	4,432							4,432
Ending balance (in shares) at Dec. 31, 2022				150,513
Ending balance at Dec. 31, 2022	$ 124,281			$ 150		383,176		(267,470)	8,425
Beginning balance (in shares) at Dec. 31, 2021	350
Beginning balance at Dec. 31, 2021	$ 237,462
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Preferred, net of fees (in shares)	50
Issuance of Series A Preferred, net of fees	$ 32,724
Preferred cumulative dividends plus accretion (in shares)	19
Preferred cumulative dividends plus accretion	$ 48,054
Dividends paid (in shares)	(13)
Dividends paid	$ (18,670)
Ending balance (in shares) at Dec. 31, 2022	406
Ending balance at Dec. 31, 2022	$ 299,570
Beginning balance (in shares) at Dec. 31, 2021				135,027
Beginning balance at Dec. 31, 2021	(69,205)			$ 135		202,562		(271,902)	0
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation (in shares)				339
Equity-based compensation	14,543					14,543
Issuance of stock, net (in shares)				15,147
Issuance of stock, net	216,078	(1,938)		$ 15		216,063	(1,938)
Preferred cumulative dividends plus accretion	(48,054)					(48,054)
Net (loss)	4,432							4,432
Other comprehensive income	8,425								8,425
Ending balance (in shares) at Dec. 31, 2022				150,513
Ending balance at Dec. 31, 2022	124,281			$ 150		383,176		(267,470)	8,425
Beginning balance (in shares) at Mar. 31, 2022				150,174
Beginning balance at Mar. 31, 2022	170,218			$ 150		411,232		(297,839)	56,675
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions		(380)					(380)
Stock compensation expense	2,944					2,944
Net income (loss)	(5,024)							(5,024)
Ending balance (in shares) at Jun. 30, 2022				150,279
Ending balance at Jun. 30, 2022	$ 110,368			$ 150		401,614		(302,863)	11,467
Beginning balance (in shares) at Mar. 31, 2022	400
Beginning balance at Mar. 31, 2022	$ 281,792
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion (in shares)	13
Preferred cumulative dividends plus accretion	$ 12,182
Ending balance (in shares) at Jun. 30, 2022	413
Ending balance at Jun. 30, 2022	$ 293,974
Beginning balance (in shares) at Mar. 31, 2022				150,174
Beginning balance at Mar. 31, 2022	170,218			$ 150		411,232		(297,839)	56,675
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation (in shares)				105
Equity-based compensation	2,944					2,944
Issuance of stock, net		(380)					(380)
Preferred cumulative dividends plus accretion	(12,182)					(12,182)
Net (loss)	(5,024)							(5,024)
Other comprehensive income	(45,208)								(45,208)
Ending balance (in shares) at Jun. 30, 2022				150,279
Ending balance at Jun. 30, 2022	110,368			$ 150		401,614		(302,863)	11,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering of common stock, net of underwriting discounts and commissions		(592)					(592)
Stock compensation expense	4,097					4,097
Net income (loss)	40,644							40,644
Ending balance (in shares) at Sep. 30, 2022				150,334
Ending balance at Sep. 30, 2022	111,453			$ 150		392,862		(262,219)	(19,340)
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion	$ 12,257
Dividends paid (in shares)	(13)
Dividends paid	$ (18,670)
Ending balance (in shares) at Sep. 30, 2022	400
Ending balance at Sep. 30, 2022	$ 287,561
Beginning balance (in shares) at Jun. 30, 2022				150,279
Beginning balance at Jun. 30, 2022	110,368			$ 150		401,614		(302,863)	11,467
Increase (Decrease) in Permanent Equity [Roll Forward]
Equity-based compensation (in shares)				55
Equity-based compensation	4,097					4,097
Issuance of stock, net		$ (592)					$ (592)
Preferred cumulative dividends plus accretion	(12,257)					(12,257)
Net (loss)	40,644							40,644
Other comprehensive income	(30,807)								(30,807)
Ending balance (in shares) at Sep. 30, 2022				150,334
Ending balance at Sep. 30, 2022	$ 111,453			$ 150		$ 392,862		$ (262,219)	$ (19,340)

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income (loss)	$ 4,432	$ (50,403)	$ 59,073
Adjustments to net income (loss):
Provision for (recovery of) bad debts	2,599	(467)	595
Deferred tax benefit	(31,565)	(10,102)	(2,739)
Depreciation and amortization	101,059	25,946	27,474
Amortization of debt discount and issuance costs	6,857	15,036	3,366
Interest paid-in-kind	0	0	3,421
Equity-based compensation	14,982	13,757	4,809
Contingent consideration	(4,507)	2,696	26,441
Warranty provision	4,152	516	953
Provision for inventory obsolescence	(859)	990	1,225
Changes in operating assets and liabilities, net of acquisition
Accounts receivable	(76,984)	(116,848)	(23,038)
Inventories	20,870	(88,184)	28,340
Income tax receivables	5,611	8,106	(16,530)
Prepaid expenses and other	19,124	(21,226)	1,101
Accounts payable	12,667	7,015	(50,519)
Accrued expenses and other	1,024	9,133	10,913
Income tax payable	(755)	(8,754)	6,870
Lease liabilities	3,784	221	0
Contingent consideration	0	0	(25,000)
Deferred revenue	59,002	(50,619)	(178,960)
Net cash provided by (used in) operating activities	141,493	(263,187)	(122,205)
Investing activities:
Purchase of property, plant and equipment	(10,619)	(3,357)	(1,338)
Acquisition of STI, net of cash acquired	(373,818)	0	0
Investment in equity security	0	(11,975)	0
Net cash used in investing activities	(384,437)	(15,332)	(1,338)
Financing activities:
Proceeds from Series A issuance	33,098	224,987	0
Proceeds from common stock issuance	15,885	120,645	145,532
Series A equity issuance costs	(1,893)	(7,195)	0
Common stock issuance costs	(450)	(3,873)	0
Dividends paid on Series A Preferred	(18,670)	(8,051)	0
Payments on revolving credit facility	(116,000)	(126,033)	(70)
Proceeds from revolving credit facility	116,000	126,033	0
Proceeds from issuance of other debt	20,188	0	0
Proceeds from issuance of convertible notes	0	413,321	0
Premium paid on capped call	0	(52,870)	0
Fees paid on issuance of convertible notes	0	(1,591)	0
Principal payments on term loan facility	(14,300)	0	(57,702)
Proceeds from term loan facility	0	0	575,000
Principal payments on other debt	(23,935)	(133,225)	(115,000)
Payments on related party loans	0	0	(45,558)
Payment of special distribution	0	0	(589,000)
Contingent consideration	(1,483)	(7,810)	0
Deferred offering costs	0	0	(6,464)
Debt issuance costs	0	(6,590)	(36,011)
Net cash provided by (used in) financing activities	8,440	537,748	(129,273)
Effect of exchange rate changes on cash and cash equivalent balances	735	0	0
Net change in cash and cash equivalents	(233,769)	259,229	(252,816)
Cash and cash equivalents, beginning of period	367,670	108,441	361,257
Cash and cash equivalents, end of period	133,901	367,670	108,441
Supplemental Cash Flow Information
Cash paid for interest	23,118	24,306	6,935
Cash paid for income taxes	10,739	13,318	31,103
Non-cash Investing and Financing Activities
Dividends accrued on Series A Preferred	6,389	0	0
Stock consideration paid for acquisition of STI	$ 200,224	$ 0	$ 0

Organization and Business	12 Months Ended
Organization and Business	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business	Organization and Business Array Technologies, Inc. (the “Company”), formerly ATI Intermediate Holdings, LLC, is a Delaware corporation formed in December 2018 as a wholly owned subsidiary of ATI Investment Parent, LLC (“Former Parent”). On October 14, 2020, the Company converted from a Delaware limited liability company to a Delaware corporation and changed the Company’s name to Array Technologies, Inc. In connection with the corporate conversion, the Company converted all 1,000 of our outstanding member units into 100,000,000 shares of common stock and then completed a stock split of 1.19994-for-1. The corporate conversion and stock split representing 119,994,467 shares of common stock have been adjusted retroactively for the purposes of calculating basic and diluted earnings per share. On January 11, 2022 (the “Acquisition Date”), the Company acquired 100% of the share capital of Soluciones Técnicas Integrales Norland, S.L.U., a Spanish private limited liability Company, and its subsidiaries (collectively, “STI”) with cash and common stock of the Company (the “STI Acquisition”). The STI Acquisition was accounted for as a business combination. See Note 3 – Acquisition of STI. Headquartered in Albuquerque, New Mexico, the Company is a leading global manufacturer and supplier of utility-scale solar tracking systems and technologies.

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Accounting and Presentation The accompanying consolidated financial statements were prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation. Recent Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). ASU 2021-08 requires contract assets and contract liabilities obtained in a business combination to be recognized and measured in accordance with Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers (“ASC 606”). At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the recent update, such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company early adopted ASU 2021-08 as of January 1, 2022. See Note 3 – Acquisition of STI for further information and disclosures related to the STI Acquisition. The standard was applied to the acquisition accounting for STI. Principles of Consolidation The consolidated financial statements include the accounts of Array Technologies, Inc. and its Subsidiaries. All intercompany accounts and transactions have been eliminated upon consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Although management believes its estimates are reasonable, actual results could differ from those estimates. Impact of COVID-19 Pandemic We continue to closely monitor the ongoing impact of the COVID-19 pandemic in all the locations where we operate. At this time, the extent to which the pandemic may affect our business, operations and plans, including the resulting impact on our expenditures and capital needs, remains uncertain and is subject to change, but overall the pandemic appears to be having a lessening impact on our business and the markets in which we operate. On January 31, 2023, the Biden administration announced its plan to let the coronavirus public health emergency expire in May 2023. Impact of the Ongoing Conflict in Ukraine The ongoing conflict in Ukraine has reduced the availability of material that can be sourced in Europe and, as a result, increased logistics costs for the procurement of certain inputs and materials used in our products. We do not know ultimate severity or duration of the conflict in Ukraine, but we continue to monitor the situation and evaluate our procurement strategy and supply chain as to reduce any negative impact on our business, financial condition and results of operations. Inflation Inflationary pressures, while somewhat moderating recently, are expected to persist, at least in the near-term, and may continue to negatively impact our results of operation. To mitigate the inflationary pressures on our business, we have implemented selective price increases in certain markets, accelerated productivity initiatives and expanded our supplier base, while continuing to execute on overhead cost containment practices. Foreign Currency Translation For non-U.S. subsidiaries that operate in a local currency environment, assets and liabilities are translated into U.S. dollars at period end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the period. Translation adjustments for these subsidiaries are accumulated as a separate component of net parent investment. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired, and all other assets and liabilities are translated at period end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates, and all other income and expense items are translated at average exchange rates prevailing during the period. Gains and losses which result from remeasurement are included in earnings. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. We regularly maintain cash balances that exceed insured amounts, but we have experienced no losses associated with these amounts to date. At December 31, 2022 all cash balances were deposited with banks, and we had no cash equivalents. Accounts Receivable The Company’s accounts receivable are due primarily from solar contractors across the U.S. and internationally. Credit is extended in the normal course of business based on evaluation of a customer’s financial condition and, generally, collateral is not required. Trade receivables consist of uncollateralized customer obligations due under normal trade terms requiring payment within 30-60 days of the invoice date. Management regularly reviews outstanding accounts receivable and provides for estimated credit losses through an estimate of expected credit losses valuation account. The Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses, (“ASU 2016-13”) on January 1, 2021 which revised the methodology for measuring credit losses on financial instruments including trade accounts receivable and the timing of when such losses are recorded. The Company adopted ASU 2016-13 using a modified retrospective approach with a cumulative effect adjustment to the opening balance of retained earnings, which had no impact on the consolidated financial statements. The allowance for credit losses is a valuation account that is deducted from a financial asset’s amortized cost to present the net amount we expect to collect from the asset. We estimate allowances for credit losses using relevant available information from both internal and external sources. We monitor the estimated credit losses associated with our trade accounts receivable and unbilled accounts receivable based primarily on our collection history and the delinquency status of amounts owed to us, which we determine based on the aging of such receivables. In evaluating the level of established reserves, management makes judgments regarding the customers’ ability to make required payments, economic events, and other factors. As the financial conditions of these customers change, circumstances develop, or additional information becomes available, adjustments to the valuation account may be required. When deemed uncollectible, the receivable is charged against the valuation account for credit losses or directly written off. Unbilled receivables represent temporary timing differences between shipments made and billing milestones achieved and are recorded in the accounts receivable balances. Such amounts have not been billed due to pending commercial criteria such as billing on a specified date of the month or upon completion of mega-watt deliveries. Unbilled receivables are invoiced once the underlying commercial criteria have been met and we expect payment within 30 to 60 days. Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost or estimated net realizable value using primarily the weighted average method and some valued using the FIFO method. Provisions are made to reduce excess or obsolete inventories to their estimated net realizable values. Property, Plant and Equipment Property, plant and equipment are recorded at cost, net of accumulated depreciation and amortization. Improvements, betterments and replacements which extend the life of an asset are capitalized. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are expensed as incurred. A gain or loss on the sale of property, plant and equipment is calculated as the difference between the cost of the asset disposed of, net of depreciation, and the sales proceeds received. A gain or loss on an asset disposal is recognized in the period that the sale occurs. Leases Operating lease arrangements are comprised primarily of real estate and equipment agreements. The Company determines if an arrangement contains a lease at inception based on whether it conveys the right to control the use of an identified asset in exchange for consideration. Lease right-of-use assets (“ROU assets”) and associated lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Certain lease agreements may include one or more options to extend or terminate a lease. Lease terms are inclusive of these options if it is reasonably certain that the Company will exercise such options. ROU assets also include any initial direct costs and prepayments less lease incentives. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Lease expense is recognized on a straight-line basis over the lease term. ROU assets and the corresponding operating lease liabilities are included in other assets and other liabilities in our consolidated balance sheets. Finance leases are included in property and equipment, other current liabilities, and other long-term liabilities in our consolidated balance sheets. Impairment of Long-Lived Assets When events, circumstances or operating results indicate that the carrying values of long-lived assets might not be recoverable through future operations, the Company prepares projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate that the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Management determined there was no impairment for the years ended December 31, 2022, 2021 and 2020. Goodwill Goodwill reflects the excess of the consideration transferred, including the fair value of any contingent consideration over the assigned fair values of the identifiable net assets acquired. Goodwill is not amortized and is assigned at the reporting unit level and tested for impairment on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. Goodwill is assessed using either a qualitative assessment or quantitative approach to determine whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. The qualitative assessment evaluates factors including macroeconomic conditions, industry-specific and company-specific considerations, legal and regulatory environments, and historical performance. If the Company determines that is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative assessment is performed. Otherwise, no further assessment is required. The quantitative approach compares the estimated fair value of the reporting unit to its carrying amount, including goodwill. Impairment is indicated if the estimated fair value or the reporting unit is less than the carrying amount of the reporting unit, and an impairment charge is recognized for the differential. Investment in Equity Securities In 2021, the Company invested $12.0 million in the preferred stock of a private company. The investment is accounted for, in accordance with ASC 321 Investments — Equity Securities, at its cost less any impairment. The equity investment is recorded in other assets on the consolidated balance sheets. No impairment has been recognized since the date of investment. Amortizable and Other Intangible Assets The Company amortizes identifiable finite lived intangible assets consisting of developed technology, customer relationships, contractual backlog and the STI trade name on a straight-line basis over the assets’ estimated useful lives. The basis of amortization approximates the pattern in which the assets are utilized, over their estimated useful lives. The Array Technologies trade name has been determined to have an indefinite life and, therefore, is not amortized but is subject to an annual impairment test or at any other time when impairment indicators exist. The Company did not recognize any impairment charges for the years ended December 31, 2022, 2021 and 2020. Deferred Offering Costs Deferred offering costs consist primarily of registration fees, filing fees, listing fees, specific legal and accounting costs, and transfer agent fees, which are direct and incremental fees related to the offerings. Deferred offering costs were offset against the proceeds. Debt Discount and Issuance Costs Debt discount and issuance costs incurred to issue debt are deferred and amortized using the effective interest method as a component of interest expense over the life of the related debt agreement. Amortization expense of debt discount and deferred issuance costs was $6.9 million, $15.0 million (including $9.6 million in write-offs in connection with unscheduled principal payoffs that occurred in February and August of 2021) and $3.4 million, respectively, for the years ended December 31, 2022, 2021 and 2020. Revenue Recognition In accordance with ASC 606, the Company recognizes revenues from the sale of solar tracking systems and parts and determines its revenue recognition through the following steps (i) identification of the contract or contracts with a customer, (ii) identification of the performance obligations within the contract, (iii) determination of the transaction price, (iv) allocation of the transaction price to the performance obligations within the contract, and (v) recognition of revenue when, or as the performance obligation has been satisfied. Performance Obligations The majority of the Company’s contracts with customers are accounted for as one performance obligation, because the Company is integrating the solar tracking system components and related services as part of a single project. Certain contracts associated with customers using the federal investment tax credit (“ITC”) for solar energy projects and other standalone tracker component sales are accounted for as multiple performance obligations because the delivery of the components and other services specified in the contract do not represent a single integrated project. In contracts with a single performance obligation, the Company’s obligation is satisfied over-time as control is transferred to the customer by measuring the progress toward complete satisfaction of the performance obligation using an input (i.e., the “cost-to-cost”) method. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company uses the expected cost-plus margin approach to estimate the standalone selling price of each performance obligation. Revenue recognized for the Company’s federal investment tax credit (“ITC”) related contracts and standalone system component is recorded at a point in time and recognized when obligations under the terms of the contract with our customer are satisfied. Generally, this occurs with the transfer of control of the asset, which is typically upon delivery to the customer in line with shipping terms. Any losses incurred on point-in-time projects are recognized as the goods are delivered. In certain situations, the Company recognizes revenue under a bill-and-hold arrangement with its customers. In arrangements related to the Federal Solar ITC, the customers purchase material prior to the start of construction of a solar project in order to meet the Five Percent Safe Harbor test to qualify for the Federal Solar ITC. In all bill-and-hold arrangements, because the customers lack sufficient storage capacity to accept a large amount of material prior to the start of construction, they request that the Company keep the product in our custody. The material is bundled or palletized in the Company’s warehouses, identified separately as belonging to the respective customer and is ready for immediate transport to the customer project upon customer request. Additionally, title and risk of loss has passed to the customer and the Company does not have the ability to use the product or direct it to another customer. In assessing the recognition of revenue, the Company also evaluates whether two or more contracts should be combined and accounted for as one contract and if the combined or single contract should be accounted for as multiple performance obligations which could change the amount of revenue and profit (loss) recorded in a period. Contracts are often modified through change orders to account for changes in specifications or design, manner of performance, equipment, materials, scope of work, and/or the period of completion of the project. Although the Company evaluates each change order to determine whether such modification creates a separate performance obligation, the majority of change orders are for goods or services that are not distinct within the context of the original contract and, therefore, not treated as separate performance obligations but rather as a modification of the existing contract and performance obligation. We account for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated products. Accordingly, we record amounts billed for shipping and handling costs as a component of revenue and classify such costs as a component of cost of revenue. Contract Estimates Accounting for contracts utilizing the cost-to-cost measure of progress is based on various assumptions to project the outcome of future events that can exceed a year. These assumptions include the cost and availability of materials. The Company reviews and updates its contract-related estimates on an ongoing basis and recognizes adjustments for any project specific facts and circumstances that could impact the measurement of the extent of progress, such as the total costs to complete the contracts, under the cumulative catch-up method. Under this method, the impact of the adjustment on profit recorded to date is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance is recognized using the adjusted estimate. At contract inception, any variable consideration such as liquidated damages are estimated based on probability of occurrence and then re-evaluated for probability at the end of the quarterly period. Contract Balances The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled accounts receivable for goods delivered but not invoiced, and deferred revenue (contract liabilities) on the consolidated balance sheets. The majority of the Company’s contract amounts are billed as work progresses in accordance with agreed-upon contractual terms, which generally coincide with the shipment of one or more phases of the project. Billing sometimes occurs subsequent to revenue recognition, resulting in unbilled accounts receivable. The changes in unbilled accounts receivable and the corresponding amounts recorded in revenue relate to fluctuations in the timing and volume of billings for the Company’s revenue recognized over-time. Warranty Obligations The Company offers a multi-year assurance type warranty for its products against manufacturer defects and does not contain service elements. For these assurance type warranties, a provision for estimated future costs related to warranty expense is recorded when they are probable and reasonably estimable, which is typically when products are delivered. This provision is based on historical information on the nature, frequency and average cost of claims for each product line. When little or no experience exists for an immature product line, the estimate is based on comparable product lines. These estimates are re-evaluated on an ongoing basis using best-available information and revisions to estimates are made as necessary. Claims estimated to be payable in the following year are classified as current liabilities and those payable beyond one year are classified as long-term liabilities. Income Taxes The Company provides for income taxes based on the provisions of ASC Topic 740 Income Taxes (“ASC 740”), which, among other things, requires that recognition of deferred income taxes be measured by the provisions of enacted tax rates in effect at the date of the consolidated financial statements. A valuation allowance is provided to reduce deferred income tax assets if it is more likely than not that all, or some portion, of such deferred tax assets will not be recognized. Provision for estimated income taxes is based upon elements of income and expense reported in the consolidated statements of operations. The Company also files certain corporate state income tax returns. Generally, the Company is subject to examination by U.S. federal, state and non-U.S. income tax authorities. The current provision for income taxes represents actual or estimated amounts payable on tax return filings each year. Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying consolidated balance sheets, and for operating loss and tax credit carryforwards. The change in deferred tax assets and liabilities for the period measures the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws on deferred tax assets and liabilities are reflected as adjustments to the tax provision or benefit in the period of enactment. Adjustments for penalties and interest, if any, are also reflected in the current year tax provision or benefit. The Company determines whether uncertain tax positions are more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits within interest expense and other expenses, respectively, in the consolidated statements of operations. No material interest or penalties were incurred in 2022. Equity-Based Compensation The Company recognizes equity-based compensation expense based on the equity award’s grant date fair value. The determination of the fair value of equity awards issued to employees of the Company is based upon the underlying share price and a number of assumptions, including volatility, performance period, risk-free interest rate and expected dividends. The Company values equity awards with a market condition using a Monte Carlo simulation model. The Company accounts for forfeitures as they occur. The grant date fair value of each unit is amortized on a straight-line basis over the requisite service period. Temporary Equity Equity instruments that are redeemable for cash or other assets are classified as temporary equity if the instrument is redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, which is subsequently adjusted at each balance sheet date if the instrument is currently redeemable, or probable of becoming redeemable. The Series A Redeemable Perpetual Preferred Stock of the Company, par value $0.001 per share (the “Series A Shares”) issued in connection with the Securities Purchase Agreement as described in Note 11 – Redeemable Perpetual Preferred Stock are classified as temporary equity in the accompanying consolidated financial statements. The Company elected the accreted redemption value method under which it accretes changes in redemption value over the period from the date of issuance of the Series A Shares to the earliest costless redemption date (the fifth anniversary) using the effective interest method. Such adjustments are included in preferred undeclared dividends and accretion on Series A Shares on the Company’s consolidated statements of changes in redeemable perpetual preferred stock and stockholders’ equity (deficit) and treated similarly to a dividend on preferred stock in accordance with U.S. GAAP. Earnings per Share Basic earnings per share (“EPS”), is computed by dividing net income available to common shareholders by the weighted average shares outstanding during the period. Diluted EPS takes into account the potential dilution that could occur if securities or other contracts to issue shares, such as stock options, unvested restricted stock, or convertible debt, were exercised and converted into shares. The convertible debt is not currently convertible. Diluted EPS is computed by dividing net income available to common shareholders by the weighted average shares outstanding during the period, increased by the number of additional shares that would have been outstanding if the potential shares had been issued and were dilutive. Credit Concentration Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and accounts receivable. The Company has no significant off balance sheet concentrations of credit risk. The Company maintains its cash with financial institutions that are believed to be of high credit quality and has not experienced any material losses relating to cash balances. Our customer base consists primarily of large solar developers, independent power producers, utilities and EPCs. We do not require collateral on our accounts receivable. At December 31, 2022, the Company’s largest customer and five largest customers accounted for 7.9% and 23.4%, respectively, of total accounts receivable. At December 31, 2021, the Company’s largest and five largest customers constituted 17.6% and 44.6% of trade accounts receivable, respectively. During the year ended December 31, 2022, two customers accounted for 11.8% and 10.6%, respectively, of total revenue. During the year ended December 31, 2021, two customers accounted for 12.6% and 10.2%, respectively, of total revenue. During the year ended December 31, 2020, we had two customers each generating over 10% of total revenue for a combined total of 21.5%. Further, our accounts receivable are from companies within the solar industry and, as such, we are exposed to normal industry credit risk. We continually evaluate our reserves for potential credit losses and establish reserves for such losses. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company follows a fair value hierarchy which requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs may be used to measure fair value, as follows: •Level 1 - Quoted prices in active markets for identical assets or liabilities. •Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. •Level 3 - Unobservable inputs that are supported by little or no market activity that are significant to the fair value of the assets or liabilities. The fair values of the Company’s cash, accounts receivable, and accounts payable approximate their carrying values due to their short maturities. The carrying value of the Company’s notes payable, capped call, and related party loans approximates their fair values, as they are based on current market rates at which the Company could borrow funds with similar terms. The Company follows the provisions of ASC 820 Fair Value Measurement for nonfinancial assets and liabilities measured at fair value on a non-recurring basis. As it relates to the Company, this applies to certain nonfinancial assets and liabilities acquired in business combinations and measurement of goodwill impairment and non-amortizable intangibles and is thereby measured at fair value, which was determined by the Company with the assistance of third-party valuations.

Acquisition of STI

12 Months Ended

Dec. 31, 2022

Business Combination and Asset Acquisition [Abstract]

Acquisition of STI

On January 11, 2022, the Company completed the STI Acquisition pursuant to the purchase agreement, dated November 10, 2021, by and among Amixa Capital, S.L. and Aurica Trackers, S.L., each a company duly organized under the laws of the Kingdom of Spain (together, the “Sellers”) and Mr. Javier Reclusa Etayo (the “STI Purchase Agreement”). The STI Acquisition was funded primarily with borrowings from the Convertible Notes (as defined below) and the issuance of the Series A Shares. The STI Acquisition provided the Company with an immediate presence in Spain, Western Europe, Brazil and South Africa. Transaction expenses incurred in connection with the acquisition are $5.6 million recorded in the general and administrative line item on the consolidated statement of operations for the year ended December 31, 2022. In accordance with the Purchase Agreement, the Company paid closing consideration to the Sellers consisting of $410.5 million in cash and (13,894,800 shares) of the Company’s common stock with an estimated fair value of $200.2 million based on the closing share price on the date of acquisition. The fair value of the purchase consideration was $610.8 million and resulted in the Company owning 100% of the interests in STI. The Company has performed a valuation of the acquisition assets and liabilities and determined the related accounting impact. The information presented below has been adjusted to give effect to the restatement discussed in Note 21.

The consideration paid to acquire STI consisted of the following (in thousands):


Cash consideration for STI	$	409,647
Cash consideration for transaction expenses of STI	896
Total cash consideration	410,543
Non-cash equity consideration	200,224
Total consideration transferred	610,767
Total purchase price consideration	$	610,767

The STI Acquisition was accounted for as a business combination in accordance with ASC 805 Business Combinations. The equity consideration transferred consisted of the Company’s common stock and was measured at fair value based on the closing stock price on the Acquisition Date. The purchase price was allocated to the assets acquired and liabilities assumed based on management’s estimate of the respective fair values at the Acquisition Date. Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were the expected synergies of the combined entities that are expected to be realized from the STI Acquisition. None of the goodwill is expected to be deductible for income tax purposes.

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the Acquisition Date (in thousands):


Fair Value of Net Assets Acquired and Liabilities Assumed:	Acquisition Date		Measurement Adjustment		Remeasured Acquisition Date
Cash and cash equivalents	$	36,725	$	—	$	36,725
Accounts receivable	110,789		—		110,789
Inventories	47,517		—		47,517
Prepaid expenses and other	23,399		—		23,399
Property, plant and equipment	4,434		—		4,434
Other intangible assets	304,431		—		304,431
Other assets	325		2,655		2,980
Total assets acquired	$	527,620	$	2,655	$	530,275

Accounts payable	65,761		—		65,761
Deferred revenue	20,345		—		20,345
Short-term debt	44,338		—		44,338
Other liabilities	10,115		2,655		12,770
Income tax payable	7,576		—		7,576
Deferred tax liability	95,510		—		95,510
Other long-term liabilities	4,524		—		4,524
Long-term debt	12,053		—		12,053
Total liabilities assumed	$	260,222	$	2,655	$	262,877

Fair value of net assets acquired	267,398				267,398
Allocation to goodwill	$	343,369			$	343,369

The purchase price allocation was based upon Management’s estimates with the assistance of a third party valuation. The estimates of the fair values of the assets acquired and liabilities assumed were estimated to approximate carrying values since they are short term in nature, and they are receivable or payable on demand. These assets and liabilities were cash and cash equivalents, accounts receivable, inventories, prepaid expenses and other, accounts payable, other liabilities, and deferred revenue. The deferred tax liability was determined utilizing statutory rates in effect at the time of the acquisition, as applied to the respective intangible assets by jurisdiction. For assets and liabilities excluded from the scope of the intangible assets and property, plant and equipment valuation, the Company considered net book value to be a reasonable proxy as of the Acquisition Date.

The purchase price allocation includes $304.4 million of acquired identifiable intangible assets.


(in thousands, except useful lives)	Estimated Fair Value		Estimated Weighted Average Useful Life in Years
Backlog	$	50,000	1
Customer relationships	228,408		10
Trade name	26,023		20
Total	$	304,431

The fair value of the identifiable intangible assets has been estimated using the Excess Earnings Method (customer relationships and backlog) and Relief from Royalty Method (trade name). Significant inputs using the Excess Earnings Method and Level 3 inputs in the fair value hierarchy include economic life, estimated revenue, expenses based on historical results and forecasts, and a discount rate based on a weighted average cost of capital for customer relationships of 15% for Spain, 16.5% for Brazil and 14.0% for Spain foreign sourced projects and for order backlog of 8.5% for Spain, 9.5% for Brazil and 7.5% for Spain foreign sourced projects. Significant inputs to the Relief from Royalty method model include estimates of future revenue, economic life, estimated royalty rate of 1.25%, and a discount rate based on a weighted average cost of capital 15.2%. The weighted average cost of capital was determined based on the Company’s capital structure, cost of capital, inherent business risk profile and long-term growth expectations. The intangible assets are being amortized over their estimated useful lives on a straight-line basis that reflects the economic benefit of the asset. The determination of the useful lives is based upon various industry studies, historical acquisition experience, economic factors, and future forecasted cash flows of the Company following the STI Acquisition.

The amounts of revenue and net loss of STI included in the Company’s consolidated statement of operations from the Acquisition Date through December 31, 2022 are $369.7 million and $(21.5) million, respectively.

Pro Forma Financial Information (Unaudited)

The following unaudited pro forma financial information presents the combined results of operations of the Company and STI as if the acquisition had occurred on January 1, 2021, after giving effect to certain unaudited pro forma adjustments. The unaudited pro forma adjustments reflected herein include only those adjustments that are directly attributable to the STI Acquisition including amortization of intangibles, debt financing expenses and tax benefits. The unaudited pro forma financial information does not reflect any adjustments for anticipated expense savings resulting from the STI Acquisition and is not necessarily indicative of the operating results that would have actually occurred had the STI Acquisition been consummated on January 1, 2021, (in thousands):


	Year Ended December 31,
	2022		2021
Revenue	$	1,645,962	$	1,118,903
Net income (loss)	$	36,285	$	(74,215)

Accounts Receivable

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Accounts Receivable

Accounts receivable consists of the following (in thousands):


	December 31,
	2022		2021
Accounts receivable	$	423,071	$	236,149
Less: allowance for credit losses	(1,888)		(140)
Accounts receivable, net	$	421,183	$	236,009

Included in accounts receivable are amounts retained by project owners that represent funds withheld by our customers until the products are installed by a third-party, arranged by the customer, and the project is declared operational. Such retention amounts were $47.4 million and $13.5 million as of December 31, 2022 and 2021, respectively. All retention amounts outstanding as of December 31, 2022 are collectible within the next 12 months.

The following is the activity of the reserve for credit losses on accounts receivable which includes trade accounts receivable and unbilled accounts receivable (in thousands):


	December 31,
	2022		2021
Beginning balance	$	(140)	$	(663)
Provision for credit losses	(2,599)		303
Collected	731		130
Written-off	120		90
Ending balance	$	(1,888)	$	(140)

Inventories

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following (in thousands):


	December 31,
	2022		2021
Raw materials	$	72,241	$	85,470
Finished goods	169,192		127,598
Reserve for excess or obsolete inventory	(8,274)		(7,415)
Total	$	233,159	$	205,653

As of December 31, 2022, inventory valued using the average cost method and the FIFO method were $209.3 million and $23.8 million, respectively. No inventory was valued using the FIFO method as of December 31, 2021.

The following table presents the change in the inventory reserve balances (in thousands):


	December 31,
	2022		2021
Beginning balance	$	(7,415)	$	(6,425)
Increases	(4,044)		(1,766)
Write-offs	3,185		776
Ending balance	$	(8,274)	$	(7,415)

Property, Plant, and Equipment

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, plant and equipment consisted of the following (in thousands, except for useful lives):


		December 31,
	Estimated Useful Life (Years)	2022		2021
Land	N/A	$	1,583	$	1,340
Buildings and land improvements	15-39	7,411		2,451
Manufacturing equipment	7	18,983		13,924
Furniture, fixtures and equipment	5-7	3,583		476
Vehicles	5	585		161
Hardware and software	3-5	3,706		1,683
Assets in progress	N/A	5,142		1,880
Total		40,993		21,915
Less: accumulated depreciation		(17,819)		(11,223)
Property, plant and equipment, net		$	23,174	$	10,692

Depreciation expense was $2.6 million, $2.4 million and $2.2 million for the years ended December 31, 2022, 2021 and 2020, respectively, of which $1.6 million, $2.0 million and $2.0 million, respectively, was allocated to cost of revenues and $1.0 million, $0.4 million and $0.2 million, respectively, is included in depreciation and amortization in the accompanying consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Goodwill

At December 31, 2021 goodwill related to the Former Parent’s acquisition of the Company was $69.7 million, net of accumulated impairment of $51.9 million.

As a result of the STI Acquisition, the Company recorded $343.4 million of goodwill and began reporting two segments, Array Legacy Operations and the newly acquired STI Operations.

The following table presents change in goodwill balances by reportable segment (in thousands):


	Array Legacy Operations		STI Operations		Total
Beginning balance as of December 31, 2021	$	69,727	$	—	$	69,727
Acquisition of STI	—		343,369		343,369
Foreign currency translation	—		3,088		3,088
Ending balance as of December 31, 2022	$	69,727	$	346,457	$	416,184

At March 31, 2022, the Company determined that the decrease in its stock price from December 31, 2021 and the continuing negative impact of the price of raw materials to the gross margin of the Array Legacy Operations reporting unit during the quarter were events indicating that the fair value of the Array Legacy Operations reporting unit may be less than its carrying amount. Based on the Company’s quantitative goodwill impairment analysis of the Array Legacy Operations reporting unit at March 31, 2022, the fair value exceeded the carrying value and accordingly, no impairment was recorded.

The Company completed its annual goodwill impairment test, utilizing a qualitative impairment analysis, and concluded goodwill was not impaired as of December 31, 2022.

Other Intangible Assets

Other intangible assets consisted of the following (in thousands, except for useful lives):


		December 31,
	Estimated Useful Life (Years)	2022		2021
Amortizable:
Costs:
Developed technology	14	$	203,800	$	203,800
Customer relationship	10	321,935		89,500
Backlog	1	51,015		—
Trade name	20	25,682		—
Total amortizable intangibles		602,432		293,300
Accumulated amortization:
Developed technology		94,347		79,790
Customer relationship		81,268		49,057
Backlog		49,507		—
Trade name		1,246		—
Total accumulated amortization		226,368		128,847
Total amortizable intangibles, net		376,064		164,453

Non-amortizable costs:
Trade name		10,300		10,300
Total other intangible assets, net		$	386,364	$	174,753

Amortization expense related to intangible assets was $98.2 million, $23.5 million and $25.3 million for the years ended December 31, 2022, 2021 and 2020, respectively.

The following table presents estimated future annual amortization expense (in thousands):


	Amount
2023	$	49,733
2024	47,923
2025	47,923
2026	43,616
2027	38,973
Thereafter	147,896
	$	376,064

Income Taxes

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

The components of the Company’s income (loss) before provision for income taxes are as follows (in thousands):


	Year Ended December 31,
	2022		2021		2020
U.S.	$	34,344	$	(61,332)	$	77,778
Foreign	(39,296)		211		—
Income (loss) before provision for income taxes	$	(4,952)	$	(61,121)	$	77,778

The provision for income taxes charged to operations consists of the following (in thousands):


	Year Ended December 31,
	2022		2021		2020
Current expense (benefit):
Federal	$	12,826	$	(8)	$	17,248
State	1,630		(668)		4,196
Foreign	7,725		60		—
	22,181		(616)		21,444
Deferred expense (benefit):
Federal	(6,160)		(9,085)		(2,799)
State	(960)		(1,017)		60
Foreign	(24,445)		—		—
	(31,565)		(10,102)		(2,739)
Total income tax expense (benefit)	$	(9,384)	$	(10,718)	$	18,705

Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands):


	December 31,
	2022		2021
Deferred tax assets:
Bad debts	$	234	$	32
Inventories	2,780		2,411
Accrued warranties	3,575		1,242
Accrued compensation	637		315
Net operating loss	1,014		1,944
Equity-based compensation	2,240		948
Lease liabilities	4,588		2,661
Premium on capped call	10,792		12,356
Interest expense carryforward	6,750		5,301
Capitalized research and development expenses	1,752		—
Other	2,435		275
Deferred tax assets	36,797		27,485
Valuation allowance	(1,449)		(222)
Deferred tax assets, net	35,348		27,263
Deferred tax liabilities:
Property, plant, and equipment	(1,592)		(1,083)
Intangible assets	(85,927)		(14,165)
ROU assets	(3,969)		(2,670)
Deferred tax liabilities	(91,488)		(17,918)
Deferred tax asset (liability), net	$	(56,140)	$	9,345

A reconciliation of income tax expense computed at the federal statutory rate of 21% to actual income tax expense at the Company’s effective rate is as follows (in thousands):


	Year Ended December 31,
	2022		2021		2020
Income tax rate reconciliation
Income tax expense (benefit) at U.S. statutory rate	$	(1,040)	$	(12,835)	$	16,333
State income taxes	530		(1,545)		3,375
Officer’s compensation	740		435		—
Equity-based compensation	712		1,542		852
Contingent consideration	(947)		567		5,553
Tax credits	(421)		(620)		(79)
Effect of CARES Act	—		—		(6,608)
Non-U.S. income taxed at different rate than U.S. statutory rate	(4,274)		—		—
Non-U.S. tax incentives	(4,183)		—		—
Foreign derived intangible income benefit	(1,668)		—		(1,201)
Transaction costs	1,628		950		—
Change in valuation allowance	(534)		14		—
Nondeductible expenses	10		69		437
Other	63		705		43
Total income tax expense (benefit)	$	(9,384)	$	(10,718)	$	18,705

The Company operates under a non-U.S. tax incentive which reduces the overall effective tax rate of the Company. As of December 31, 2022, the Company had satisfied the conditions enumerated in these agreements. Included in the accompanying Consolidated Financial Statements are tax benefits of $4.2 million for 2022 from the non-U.S. tax incentive.

As of December 31, 2022, the Company has federal income tax net operating loss (“NOL”) carryforwards of approximately $4.8 million that do not expire, state income tax NOL carryforwards of approximately $4.5 million that will expire in future years beginning in 2029, and foreign NOLs are immaterial. As of December 31, 2021, the Company has federal income tax NOL carryforwards of approximately $5.1 million that do not expire, state income tax NOL carryforwards of approximately $9.7 million that will expire in future years beginning in 2029, and foreign NOLs are immaterial.

Realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate type and in the appropriate jurisdictions. In assessing the ability to realize a portion of the deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. It is not more likely than not that deferred tax assets from certain U.S. Federal, state and foreign net operating loss would be realized due to type and location of future earnings and as such the Company has a valuation allowance of $1.4 million and $0.2 million for the years ended years ended December 31, 2022 and 2021. A valuation allowance of $1.8 million was recorded as of the acquisition date of STI for deferred tax assets.

ASC 740 addresses the determination of how tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. In accordance with ASC 740, the Company must recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The Company’s assessments of its tax positions in accordance with ASC 740 did not result in changes that had a material impact on results of operations, financial condition or liquidity. The Company had no unrecognized income tax benefits at either December 31, 2022 or 2021.

The Company files income tax returns in the U.S. federal jurisdiction, in multiple U.S. states, as well as in non-U.S. jurisdictions. Through global expansion and the acquisition of STI, the Company has a significant presence in Spain and Brazil. The Company and its subsidiaries are routinely examined by various U.S. and non-U.S. taxing authorities. The Company is not subject to U.S. federal, state and non-U.S. income tax examinations by tax authorities for years before 2017. There are currently no income tax audits in any material jurisdictions.

The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Repatriation of funds could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or state income taxes and the impact of foreign currency movements. At December 31, 2022, management believed that sufficient liquidity was available in the U.S. The Company will consider repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

As of December 31, 2022, the Company has accumulated deficits in undistributable earnings in material non-U.S. jurisdictions. As such, no deferred taxes have been recorded.

The Company does not receive tax basis for payments made related to the Tax Receivable Agreement (“TRA”) payable to the former owner. Refer to Note 15 - Commitments and Contingencies, for detail on the TRA, which was a contingent consideration at the time of the Array acquisition.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Accrued Warranty Reserve

12 Months Ended

Dec. 31, 2022

Guarantees and Product Warranties [Abstract]

Accrued Warranty Reserve

The following table presents changes in the accrued warranty reserve balances (in thousands):


	December 31,
	2022		2021
Beginning balance	$	3,192	$	3,049
Provision for warranties issued	5,289		1,064
Payments	(1,868)		(373)
Warranty expirations	(1,137)		(548)
Ending balance	$	5,476	$	3,192

Debt

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Debt

Senior Secured Credit Facility

The senior secured credit facility consisted of the following (in thousands):


	December 31,
	2022		2021
Term loan facility	$	312,475	$	326,775
Revolving credit facility	—		—
	312,475		326,775
Unamortized discount and issuance costs	(19,135)		(23,282)
Senior secured credit facility, net of unamortized debt discount and issuance costs	293,340		303,493
Current portion of term loan facility	(4,300)		(4,300)
Senior secured credit facility, net of current portion and unamortized discount and issuance costs	$	289,040	$	299,193

On October 14, 2020, the Company entered into a senior secured credit facility which was amended on February 23, 2021 (the “First Amendment”) and again on February 26, 2021 (the “Second Amendment”). The senior secured facility consisted originally of (i) a $575 million senior secured 7-year term loan facility (the “Term Loan Facility”) and (ii) a $150 million senior secured 5-year revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facility”). The First Amendment, in the case of Eurocurrency borrowings, lowered the London interbank offered rate floor to 50 basis points from 100 basis points and lowered the applicable margin to 325 basis points from 400 basis points per annum. The Second Amendment increased the borrowing capacity of the Revolving Credit Facility from $150 million to $200 million.

The outstanding balance on the Term Loan Facility was $312.5 million and $326.8 million as of December 31, 2022 and 2021, respectively. The balance of the Term Loan Facility is presented in the accompanying consolidated balance sheets, net of debt discount and issuance costs of $19.1 million and $23.3 million at December 31, 2022 and 2021, respectively.

Under the Revolving Credit Facility, the Company had no outstanding balance as of both December 31, 2022 and 2021, $38.8 million and $13.6 million in standby letters of credit as of December 31, 2022 and 2021, respectively, and availability of $161.2 million and $186.4 million as of December 31, 2022 and 2021, respectively.

Terms and Conditions of the Senior Secured Credit Facility

Interest Rates

The interest rates applicable to the loans under the Term Loan Facility equal, at our option, either, (i) in the case of ABR borrowings, the highest of (a) the Federal Funds Rate as of such day plus 50 basis points, (b) the prime rate and (c) the adjusted LIBOR rate as of such day for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, provided that in no event shall the ABR be less than 150 basis points, plus, in each case, the applicable margin of 300 basis points per annum; or (ii) in the case of Eurocurrency borrowings, the greater of (a) the LIBOR for the relevant currency, adjusted for statutory reserve requirements, and (b) 100 basis points, plus, in each case, the applicable margin of 400 basis points per annum. Pursuant to the First

Amendment, (i) the applicable margin (a) with respect to ABR borrowings was reduced to 225 basis points and (b) with respect to Eurocurrency borrowings was reduced to 325 basis points and (ii) the LIBOR floor referred to in clause (ii)(b) above was reduced from 100 to 50 basis points. Applicable interest rate at December 31, 2022 was 7.94%

The interest rates applicable to the loans under the Revolving Facility equal, at our option, either, (i) in the case of ABR borrowings, the highest of (a) the Federal Funds Rate as of such day plus 50 basis points, (b) the prime rate and (c) the adjusted LIBOR rate as of such day for a deposit in U.S. dollars with a maturity of one month plus 100 basis points, provided that in no event shall the ABR be less than 150 basis points, plus, in each case, the applicable margin of 225 basis points per annum; or (ii) in the case of Eurocurrency borrowings, the greater of (a) the London interbank offered rate for the relevant currency, adjusted for statutory reserve requirements, and (b) 50 basis points, plus, in each case, the applicable margin of 325 basis points per annum.

Prepayments and Amortization

The Term Loan Facility amortizes in equal quarterly installments in aggregate annual amounts equal to 1.00% per annum of the original principal amount of the loans funded thereunder. There is no scheduled amortization under the Revolving Credit Facility.

Loans under the Revolving Credit Facility may be voluntarily prepaid in whole, or in part, in each case without premium or penalty. Loans under the Term Loan Facility may be voluntarily prepaid in whole, or in part, in each case without premium or penalty (other than a 1% premium with respect to prepayments on account of certain “repricing events,” subject to exceptions, occurring within 12 months of the closing date of the Senior Secured Credit Facility).

Additionally, the Term Loan Facility requires an annual excess cash flow calculation, for which the prescribed formula did not result in requiring the Company to make an advance principal payment for the year ended December 31, 2022.

Restrictive Covenants and Other Matters

The Revolving Credit Facility includes a springing financial maintenance covenant that is tested on the last day of each fiscal quarter if the outstanding loans and certain other credit extensions under the Revolving Credit Facility exceed 35% of the aggregate amount of commitments thereunder, subject to customary exclusions and conditions. If the financial maintenance covenant is triggered, the first lien net leverage ratio will be tested for compliance not to exceed 7.10 to 1.00. As of December 31, 2022, the Company was in compliance with all the required covenants.

The Senior Secured Credit Facility also contains affirmative and negative covenants customary for financings of this type, including covenants that restrict our incurrence of indebtedness and liens, dispositions, investments, acquisitions, restricted payments, and transactions with affiliates. The Senior Secured Credit Facility also includes customary events of default, including the occurrence of a change of control.

Guarantees and Security

The obligations under the Senior Secured Credit Facility are guaranteed by ATI Investment Sub, Inc. and its wholly owned domestic subsidiaries other than certain immaterial subsidiaries and other excluded subsidiaries. The obligations under the Senior Secured Credit Facility are secured by a first priority security interest in substantially all of the future property and assets of the guarantor and the borrower, Array Tech, Inc. (f/k/a Array

Technologies, Inc.), including accounts receivable, inventory, equipment, general intangibles, intellectual property, investment property, other personal property, material owned real property, cash and proceeds of the foregoing.

Convertible Debt

Convertible debt consisted of the following (in thousands):


	December 31,
	2022		2021
1.00% Convertible Senior Notes	$	425,000	$	425,000
Unamortized discount and issuance costs	(11,248)		(13,137)
1.00% Convertible Senior Notes, net	$	413,752	$	411,863

On December 3, 2021 and December 9, 2021, the Company completed a $425.0 million private offering ($375 million and $50 million, respectively), of its 1.00% Convertible Senior Notes due 2028, resulting in proceeds of $413.3 million ($364.7 million and $48.6 million, respectively) after deducting the original issue discount of 2.75%. The Convertible Notes were issued pursuant to an indenture, dated December 3, 2021, between the Company and U.S. Bank National Association, as trustee (the “Indenture”).

For the year ended December 31, 2022, interest expense related to the Convertible Notes was $6.1 million, of which, $4.2 million was contractual interest and of $1.9 million was amortization of debt discount and issuance costs. Interest expense for the year ended December 31, 2021 was $0.4 million, of which, $0.3 million was contractual interest and $0.1 million amortization of debt discount and issuance costs. The discount and issuance costs will be amortized over the life of the debt using the effective interest rate of 1.5%.

The Convertible Notes are senior unsecured obligations of the Company that mature on December 1, 2028, unless earlier converted, redeemed, or repurchased. The Convertible Notes bear interest at a rate of 1.00% per year, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2022.

The Convertible Notes were not convertible during the year ended December 31, 2022 and none have been converted to date. As the average market price of the Company’s common stock has not exceeded the exercise price since inception, there was no dilutive impact to earnings per share for the year ended December 31, 2022.

Redemption

At any time prior to the close of business on the business day immediately preceding June 1, 2028, the Convertible Notes are convertible at the option of the holders only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price then in effect on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Convertible Notes on each such trading

day; (3) if the Company calls such Convertible Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, but only with respect to the Convertible Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as described in the Indenture. On or after June 1, 2028 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Convertible Notes may convert all or any portion of their Convertible Notes at any time regardless of the foregoing circumstances. Upon conversion of the Convertible Notes, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted and pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election, in respect of the remainder, if any, of the Company’s conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted.

The Company may redeem (an “Optional Redemption”) for cash all or any portion of the Convertible Notes, at its option, on or after December 6, 2025, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Convertible Notes, at least $100 million aggregate principal amount of Convertible Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for the Convertible Notes.

The conversion rate for the Convertible Notes was initially 41.9054 shares of the Company’s common stock per $1,000 principal amount of the Convertible Notes, which was equivalent to an initial conversion price of approximately $23.86 per share of common stock or 10.1 million shares of common stock. The initial conversion price of the Convertible Notes represented a premium of approximately 32.5% to the last reported sale price of the Company’s common stock on the Nasdaq Global Market on November 30, 2021. The conversion rate for the Convertible Notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Convertible Notes or if the Company delivers a notice of redemption in respect of the Convertible Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Notes for a holder who elects to convert its Convertible Notes (or any portion thereof) in connection with such a corporate event or convert its Convertible Notes called (or deemed called) for redemption during the related Redemption Period (as defined in the Indenture), as the case may be.

If the Company undergoes a Fundamental Change (as defined in the Indenture), holders may require, subject to certain conditions and exceptions, the Company to repurchase for cash all or any portion of their Convertible Notes at a Fundamental Change Repurchase Price (as defined in the Indenture) equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest, to, but excluding, the Fundamental Change Repurchase Date (as defined in the Indenture).

The Indenture includes customary covenants and sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company or certain of its subsidiaries after which the Convertible Notes become automatically due and payable.

Capped Calls

In connection with the issuances of the Convertible Notes, the Company paid $52.9 million, in aggregate, to enter into Capped Call Option Agreements to reduce the potential dilution to holders of the Company’s common stock after a conversion of the Convertible Notes. Specifically, upon the exercise of the capped call instruments issued pursuant to the agreements (the “Capped Calls”), the Company would receive shares of its common stock equal to approximately 17.8 million shares (a) multiplied by (i) the lower of $36.0200 or the then-current market price of its common stock, less (ii) the applicable exercise price, and (b) divided by the then-current market price of its common stock. The results of this formula are that the Company would receive more shares as the market price of its common stock exceeds the exercise price and approaches the cap, which was initially $36.0200 per share.

Consequently, if the Convertible Notes are converted, then the number of shares to be issued by the Company would be effectively partially offset by the shares of common stock received by the Company under the Capped Calls as they are exercised. The formula above would be adjusted in the event of certain specified extraordinary events affecting the Company, including a merger; a tender offer; nationalization, insolvency or delisting of the Company’s common stock; changes in law; failure to deliver; insolvency filing; stock splits, combinations, dividends, repurchases or similar events; or an announcement of certain of the preceding actions.

The Company can also elect to receive the equivalent value of cash in lieu of shares of common stock upon settlement, except in certain circumstances. The Capped Calls expire on December 1, 2028 and terminate upon the occurrence of certain extraordinary events such as a merger, tender offer, nationalization, insolvency, delisting, event of default, a change in law, failure to deliver, an announcement of certain of these events, or an early conversion of the Convertible Notes. Although intended to reduce the net number of shares of common stock issued after a conversion of the Convertible Notes, the Capped Calls were separately negotiated transactions, are not a part of the terms of the Convertible Notes, and do not affect the rights of the holders of the Convertible Notes. The Capped Calls meet the criteria for equity classification because they are indexed to the Company’s common stock and the Company has discretion to settle the Capped Calls in shares or cash. As a result, the amount paid for the Capped Calls was recorded as a reduction to additional paid-in capital. The Capped Calls are excluded from the calculation of diluted net income (loss) per share attributable to common stockholders as their effect is antidilutive.

The Company made a tax election to integrate the Convertible Notes and the Capped Calls. The accounting impact of this tax election makes the Capped Calls deductible as original issue discount interest for tax purposes over the term of the note, and results in a $10.8 million deferred tax asset recorded as an adjustment to additional paid-in capital on the consolidated balance sheets as of December 31, 2022.

Other Debt

In connection with the STI Acquisition, the Company assumed the debt obligations of STI outstanding with various local banking and credit institutions (“Other Debt”). As of December 31, 2022, the total outstanding balance on these debt obligations was $52.0 million, of which, approximately $20.3 million is subject to fixed interest rates ranging from 0.55% to 4.52%. The remaining $31.7 million is subject to variable interest rates ranging from 1.99% to 3.96%. Total interest expense for Other Debt in 2022 was $2.4 million.

Aggregate Debt Maturities

Aggregate future debt maturities are as follows (in thousands):


	Amount
2023	$	38,691
2024	13,583
2025	8,257
2026	6,453
2027	297,442
Thereafter	425,000
	$	789,426

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Redeemable Perpetual Preferred Stock	12 Months Ended
Redeemable Perpetual Preferred Stock	Dec. 31, 2022
Temporary Equity Disclosure [Abstract]
Redeemable Perpetual Preferred Stock	Redeemable Perpetual Preferred Stock Series A Redeemable Perpetual Preferred Stock The Company entered into a Securities Purchase Agreement (the “SPA”) with certain investors (the “Purchasers”) pursuant to which, on August 11, 2021, the Company issued 350,000 shares of its newly designated Series A Shares and 7,098,765 shares of the Company’s common stock for an aggregate purchase price of $346.0 million (the “Initial Closing”). Further, pursuant to the SPA, on September 27, 2021, the Company issued and sold to the Purchasers 776,235 shares of common stock for an aggregate purchase price of $0.01 million (the “Prepaid Forward Contract”). The Company used the net proceeds to repay the $102.0 million outstanding balance under its existing Revolving Credit Facility and prepay $100.0 million of the Company’s Term Loan Facility. The Series A Shares have no maturity date. The SPA gives the Company the option to require the Purchasers to purchase, up to an additional 150,000 shares of Series A Shares until June 30, 2023 and up to 3,375,000 shares of common stock (or up to 6,100,000 shares of common stock in the event of certain price-related adjustments), subject to certain equitable adjustments pursuant to any stock dividend, stock split, stock combination, reclassification or similar transaction, for an aggregate purchase price up to $148.0 million (the “Delayed Draw Commitment”). On January 7, 2022, pursuant to the Delayed Draw Commitment, the Company issued and sold to the Purchasers, 50,000 shares of Series A Shares and 1,125,000 shares of the Company’s common stock in an additional closing for an aggregate purchase price of $49.4 million (the “Additional Closing”). The Company evaluated the accounting for the instruments issued pursuant to the SPA and determined the Series A Shares and common stock issued in the Initial Closing, as well as the Prepaid Forward Contract, and Delayed Draw Commitment are freestanding instruments accounted for in equity. The Series A Shares are recorded in temporary equity on the consolidated balance sheets as they have redemption features upon certain triggering events that are outside the Company’s control, such as a fundamental change. The proceeds of the Series A Shares, net of transaction costs and discount of $334.6 million have been allocated to each instrument based on its relative fair value. At the Initial Closing date, $229.8 million was allocated to the Series A Shares, $105.4 million to common stock, $12.4 million to the Delayed Draw Commitment, which was recorded as a debit to additional paid-in-capital, and $11.7 million to the Prepaid Forward Contract. Direct costs associated with the issuance of the Securities were $11.1 million, which along with the $4.4 million discount, have been accounted for as a reduction in the proceeds of the Securities. The net proceeds of $334.6 million have been allocated to Series A Shares of $229.8 million, common stock of $105.4 million and additional paid-in capital of $12.4 million for the committed financing put right. The Additional Closing proceeds, net of transaction costs and discount of $1.3 million, were allocated among the Series A Shares and common stock based on the proceeds of $33.1 million and $15.9 million, respectively. The Company has presented the Series A Shares in temporary equity and accreting the carrying amount to its full redemption amount from the date of issuance to the earliest redemption date using the effective interest method. Such accretion totaled $23.2 million and $7.4 million for the years ended December 31, 2022 and 2021, respectively. Dividends On or prior to the fifth anniversary of the Initial Closing, the Company may pay dividends on the Series A Shares either in (i) cash at the then-applicable Cash Regular Dividend Rate (as defined below), (ii) through accrual to the Liquidation Preference at the Accrued Regular Dividend Rate of 6.25% (the “Permitted Accrued Dividends,”) or (iii) a combination thereof. Following the fifth anniversary of the Initial Closing, dividends are payable only in cash. To the extent the Company does not declare such dividends and pay in cash following the fifth anniversary of the Initial Closing, the dividends accrue to the Liquidation Preference (“Default Accrued Dividends”) at the then-applicable Cash Regular Dividend Rate plus 200 basis points. In the event there are Default Accrued Dividends outstanding for six consecutive quarters, the Company, at the option of the holders of the Series A Shares, will pay 100% of the amount of Default Accrued Dividends by delivering to such holder a number of shares of the Company’s common stock equal to the quotient of (i) the amount of Default Accrued Dividends divided by (ii) 95% of the 30-day VWAP of the Company’s common stock (“Non-Cash Dividend”). The “Cash Regular Dividend Rate” of the Series A Shares means (i) initially, 5.75% per annum on the Liquidation Preference and (ii) increased by (a) 50 basis points on each of the fifth, sixth and seventh anniversaries of the Initial Closing and (b) 100 basis points on each of the eighth, ninth and tenth anniversaries of the Initial Closing. The “Accrued Regular Dividend Rate” on the Series A Shares means 6.25% per annum on the Liquidation Preference. As used herein, “Liquidation Preference” means, with respect to any shares of the Series A Shares, the initial liquidation preference of $1,000 per share plus any accrued dividends of such share as the time of the determination. During the first nine months of fiscal year 2022, the Company accrued dividends on the Series A Shares at the Accrued Regular Dividend rate of 6.25% totaling $18.7 million. This amount was settled with the payment of cash in September 2022. As of December 31, 2022 the Company has accrued and unpaid dividends of $6.4 million. The Series A Shares have similar characteristics of an “Increasing Rate Security” as described by SEC Staff Accounting Bulletin Topic 5Q, Increasing Rate Preferred Stock. As a result, the discount on Series A Shares is considered an unstated dividend cost that is amortized over the period preceding commencement of the perpetual dividend using the effective interest method, by charging imputed dividend cost against retained earnings, or additional paid in capital in the absence of retained earnings, and increasing the carrying amount of the Series A Shares by a corresponding amount. Accordingly, the discount is amortized over five years using the effective yield method. Fees Until June 30, 2023, the Company will pay the Purchasers a cash commitment premium on the unpurchased portion of Delayed Draw Commitment as follows: a.0% through the six-month anniversary of the Initial Closing; b.1.5% from the six-month anniversary of the Initial Closing through the 12-month anniversary of the Initial Closing; and c.3.0% from the 12-month anniversary of the Initial Closing through June 30, 2023. The Company may terminate some or all of the Delayed Draw Commitment, from time to time, at its sole discretion. Ranking and Liquidation Preference The Series A Shares rank senior to the Common Stock with respect to dividend rights and rights upon the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (a “Liquidation”). Upon a Liquidation, each of Series A Redeemable Share would be entitled to receive an amount per share (the “Liquidation, Redemption or Repurchase Amount”) equal to the greater of (i) the Liquidation Preference of such share, plus all accrued and unpaid dividends (including any Accrued Dividends) thereon and (ii) an amount in cash equal to the sum of (a) 130.0% of the Initial Liquidation Preference (as defined below) of such share, minus (b) the cumulative amount of cash dividends paid in respect of such share prior to such payment. As used herein, “Liquidation Preference” means, with respect to any of the Series A Shares, the initial liquidation preference of $1,000 per share (the “Initial Liquidation Preference”) plus any Accrued Dividends of such share as of the time of determination. Redemption Rights The Company may redeem all or any portion of the Series A Shares (in increments of not less than $200 million based on the Liquidation Preference of the Series A Shares to be redeemed at such time (or such lesser amount to the extent the Company chooses to redeem all of the outstanding shares of Series A Shares)) for an amount in cash equal to the Liquidation, Redemption or Repurchase Amount. Upon a “Fundamental Change” (involving a change of control, bankruptcy, insolvency or liquidation of the Company as further described in the Certificate of Designations), each Holder shall have the right to require the Company to redeem all or any part of the Holder’s Series A Shares for an amount in cash equal to the Liquidation, Redemption or Repurchase Amount. Voting Rights Each Holder of Series A Shares will have one vote per share on any matter on which Holders of Series A Shares are entitled to vote separately as a class (as described below), whether at a meeting or by written consent. The Holders of Series A Shares do not otherwise have any voting rights.

Common and Preferred Stock	12 Months Ended
Common and Preferred Stock	Dec. 31, 2022
Equity [Abstract]
Common and Preferred Stock	Common and Preferred Stock Common Stock Each holder of Common Stock shall be entitled to one vote for each share of Common Stock held as of the applicable record date on any matter that is submitted to a vote or for the consent of the stockholders of the Company. The holders of Common Stock shall be entitled to share equally, on a per share basis, in such dividends and other distributions of cash, property or shares of stock of the Company as may be declared by the Board of Directors of the Company (the “Board”), subject to the preferences applicable to holders of Preferred Stock. In the event of a voluntary or involuntary liquidation, dissolution, distribution of assets or winding up of the Company, all assets of the Corporation of whatever kind available for distribution to the holders of Common Stock shall be divided among and paid ratably to the holders of Common Stock, subject to the preferences applicable to holders of Preferred Stock. Preferred Stock Preferred Stock may be issued from time to time by the Company for such consideration as may be fixed by the Company’s Board of Directors (the “Board”). The Board is authorized to provide for one or more series of Preferred Stock and to fix the designation of such series, the voting rights, preferences and relative, participating, optional and other special rights, and the qualifications, limitations or restrictions thereof, of such series of Preferred Stock and the number of shares of such series, as may be permitted under the General Corporation Law of the State of Delaware. The powers, preferences and relative, participating, optional and other special rights of, and the qualifications, limitations or restrictions thereof, of each series of Preferred Stock, if any, may differ from those of any and all other series at any time outstanding.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Revenue

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue

The Company disaggregates its revenue from contracts with customers by those sales recorded over-time and sales recorded at a point in time.

The following table presents the Company’s disaggregated (in thousands):


	Year Ended December 31,
	2022		2021		2020
Over-time revenue	$	1,155,848	$	519,003	$	503,238
Point in time revenue	481,698		334,315		369,424
Total revenue	$	1,637,546	$	853,318	$	872,662

Contract assets consisting of unbilled receivables are recorded within accounts receivable on the consolidated balance sheets on a contract-by-contract basis at the end of the reporting period and consisted of the following (in thousands):


	December 31,
	2022		2021		2020
Unbilled receivables	$	101,513	$	111,224	$	18,073

The Company also receives advances or deposits from its customers, before revenue is recognized, resulting in contract liabilities. The changes in contract liabilities (i.e., deferred revenue) relate to advanced orders and

payments received by the Company. Contract liabilities consisting of deferred revenue recorded on a contract-by-contract basis at the end of each reporting period were as follows (in thousands):


	December 31,
	2022		2021		2020
Deferred revenue	$	178,922	$	99,575	$	149,821

During the years ended December 31, 2022 and 2021, the Company converted $84.7 million and $149.8 million deferred revenue to revenue, respectively, which represented 85% and 100% of the prior years’ deferred revenue balance, respectively.

Bill-and-Hold Arrangement

Revenue recognized for the Company’s ITC related contracts and standalone system component sales are recorded at a point in time and recognized when obligations under the terms of the contract with our customer are satisfied. Generally, this occurs with the transfer of control of the asset, which is typically upon delivery to the customer in line with shipping terms. In certain situations, when product is still in our custody and title and risk of loss has passed to the customer (known as a bill-and-hold arrangement), revenue will be recognized when all the specific requirements for transfer of control under a bill-and-hold arrangement have been met.

In 2022, the Company had one contract with a customer for the sale of goods and services that contained bill-and-hold obligations such as storage, handling and other custodial duties. The related revenue was approximately $13.7 million, which was paid in full as of December 31, 2022 and the product was shipped to the customer in January 2023. The Company had $168.9 million in total revenue with customers for the sale of goods and services that contained bill-and-hold obligations such as storage, handling and other custodial duties for the years ended December 31, 2021.

Remaining Performance Obligations

As of December 31, 2022, the Company had $719.3 million of remaining performance obligations. The Company expects to recognize revenue on 100% of these performance obligations in the next twelve months.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

Earnings per Share

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Earnings per Share

The following table sets forth the computation of basic and diluted income (loss) per share (in thousands, except per share amounts):


	Year Ended December 31,
	2022		2021		2020
Net income (loss)	$	4,432	$	(50,403)	$	59,073
Preferred dividends and accretion	(48,054)		(15,715)		—
Net income (loss) to common shareholders	(43,622)		(66,118)		59,073

Basic:
Weighted average common shares outstanding	149,819		129,984		121,467
Earnings (loss) per share	$	(0.29)	$	(0.51)	$	0.49

Diluted:
Weighted average common shares outstanding	149,819		129,984		121,467
Effect of Restricted Stock and Performance Awards	—		—		47
Weighted average dilutive shares	149,819		129,984		121,514
Income (loss) per share	$	(0.29)	$	(0.51)	$	0.49

Potentially dilutive common shares issued pursuant to equity-based awards of 500,006 were not included as their effect was anti-dilutive for the year ended December 31, 2020. Potentially dilutive common shares issuable pursuant to equity-based awards of 2,165,217 and 1,078,096 were not included for the years ended December 31, 2022 and 2021, respectively, as their potential effect was anti-dilutive since the Company generated a net loss to common shareholders. There were no potentially dilutive common shares issuable pursuant to the Convertible Notes for the years ended December 31, 2022 and 2021, as the par value of the Convertible Notes is required to be paid in cash upon conversion and the stock price has not exceeded the conversion price on the Convertible Notes.

There were 26,671,594 Class B Units and 1,000 Class C Units of Former Parent issued to certain employees or directors of the Company which were not included in the calculation of basic or diluted EPS for the year ended December 31, 2020, as the Class B and Class C units do not represent potential units of the Company.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Litigation

The Company, in the normal course of business, is subject to claims and litigation. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company would accrue a liability for the estimated loss.

On August 30, 2017, the Company filed its first amended complaint in the U.S. District Court for the District of New Mexico against Nextracker LLC, Daniel S. Shugar, Marco Garcia, Flextronics International U.S.A., Inc., Scott Graybeal and Colin Mitchell (collectively, the “Defendants”) asserting (among other claims) trade secret misappropriation, tortious interference with contract, fraud, and breach of contract (the “Nextracker Litigation”).

On July 15, 2022, the Company settled its claims against Defendants for $42.8 million and received payment on August 4, 2022.

On May 14, 2021, a putative class action was filed in the U.S. District Court for the Southern District of New York (the “Southern District of New York” or the “Court”) against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11, 12(a)(2) and 15 of the Securities Exchange Act of 1933 (“Plymouth Action”). The Plymouth Action alleges misstatements and/or omissions in the Company’s registration statements and prospectuses related to the Company’s October 2020 initial public offering (“IPO”), the Company’s December 2020 offering (the “2020 Follow-On Offering”), and the Company’s March 2021 offering (the “2021 Follow-On Offering”) during the putative class period of October 14, 2020 through May 11, 2021.

On June 30, 2021, a second putative class action was filed in the Southern District of New York against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11 and 15 of the Securities Exchange Act of 1933 (“Keippel Action”). The Keippel Action similarly alleged misstatements and/or omissions in certain of the Company’s registration statements and prospectuses related to the Company’s IPO, the Company’s 2020 Follow-On Offering, and the Company’s 2021 Follow-On Offering during the putative class period of October 14, 2020 through May 11, 2021. On July 6, 2021, the Court entered an order that the Keippel Action was in all material respects substantially similar to the Plymouth Action that both actions arise out of the same or similar operative facts, and that the parties are substantially the same parties. The Court accordingly consolidated the Keippel Action with the Plymouth Action for all pretrial purposes and, ordered all filings to be made in the Plymouth Action.

On July 16, 2021, a verified derivative complaint was filed in the Southern District of New York against certain officers and directors of the Company (“First SDNY Derivative Action”). The complaint alleges: (1) violations of Section 14(a) of the Securities Exchange Act of 1934 for misleading proxy statements, (2) breach of fiduciary duty, (3) unjust enrichment, (4) abuse of control, (5) gross mismanagement, (6) corporate waste, (7) aiding and abetting breach of fiduciary duty, and (8) contribution under sections 10(b) and 21D of the Securities Exchange Act of 1934.

On July 30, 2021, a second and related verified derivative complaint was filed in the Southern District of New York against certain officers and directors of the Company (“Second SDNY Derivative Action”). The complaint alleges: (1) violations of Section 14(a) of the Securities Exchange Act of 1934 for causing the issuance of a false/misleading proxy statement, (2) breach of fiduciary duty, and (3) aiding and abetting breaches of fiduciary duty. On August 24, 2021, the Second SDNY Derivative Action was consolidated with the First SDNY Derivative Action, the Court appointed co-lead counsel, and the case was temporarily stayed pending the entry of an order on all motions to dismiss directed at the pleadings filed in the Plymouth Action. The stay shall remain in effect until the later of (a) the entry of an order on any motions to dismiss the Plymouth Action or, (b) to the extent the complaint in the Plymouth Action is amended, the entry of an order on any motions to dismiss any such amended complaints in the Plymouth Action.

On September 21, 2021, the Court in the Plymouth Action appointed a group comprised of institutional investors Plymouth County Retirement Association and Carpenters Pension Trust Fund for Northern California as lead plaintiff.

On December 7, 2021, an amended class action complaint was filed by lead plaintiff in the Plymouth Action against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11, 12(a)(2), and 15 of the Securities Exchange Act of 1933, on behalf of a putative class of persons and entities that purchased or otherwise acquired the Company’s securities during the period from October 14, 2020 through May 11, 2021 (the “Consolidated Amended Complaint”). The Consolidated Amended Complaint alleges misstatements and/or omissions in: (1) certain of the Company’s registration statements and prospectuses related to the Company’s IPO, the Company’s 2020 Follow-On Offering, and the Company’s 2021 Follow-On Offering; (2) in the Company’s Annual Report on Form 10-K and associated press release announcing results for the fourth quarter and full fiscal year 2020; and (3) in the Company’s November 5, 2020 and March 9, 2021 earnings calls.

On August 17, 2022, the Court in the Plymouth Action set a briefing schedule for any motion to dismiss with the opening motion and supporting memorandum to be filed on or before October 17, 2022, any opposition to be filed on or before December 16, 2022, and any reply in support of the motion to be filed on or before January 16, 2023. The Company and other defendants in the Plymouth Action filed a joint motion to dismiss (the “Motion to Dismiss”) the Consolidated Amended Complaint on October 17, 2022. The lead plaintiff filed a motion opposing the Motion to Dismiss on December 16, 2022, and the Company and other defendants filed a reply in support of the motion to dismiss on January 17, 2023.

On August 3, 2022, a verified derivative complaint was filed in the Court of Chancery of the State of Delaware (the “Court of Chancery”) against certain officers and directors of the Company, asserting claims for: (1) breach of fiduciary duty and (2) unjust enrichment (“First Delaware Derivative Action”).

On August 11, 2022, a second verified derivative complaint was filed against certain officers and directors of the Company Court of Chancery, asserting claims for: (1) breach of fiduciary duty; (2) aiding and abetting breaches of fiduciary duty; (3) waste of corporate assets; (4) unjust enrichment; (5) insider selling; and (6) aiding and abetting insider selling (“Second Delaware Derivative Action”).

On September 2, 2022, the Second Delaware Derivative Action was consolidated with the First Delaware Derivative Action, the Court of Chancery appointed co-lead counsel, and the case was temporarily stayed pending the entry of an order on all motions to dismiss directed at the pleadings filed in the Plymouth Action. The stay shall remain in effect until the later of (a) the entry of an order on the pending motion to dismiss the Consolidated Amended Complaint in the Plymouth Action, (b) to the extent the Consolidated Amended Complaint in the Plymouth Action is further amended, the entry of an order on any motions to dismiss any such amended complaints in the Plymouth Action, or (c) the public announcement of a settlement of the Plymouth Action.

At this time the Company believes that the likelihood of any material loss related to these matters is remote given the preliminary stage of the claims and strength of the Company’s defenses. The Company has not recorded any material loss contingency in the consolidated balance sheets as of December 31, 2022.

Contingent Consideration

Tax Receivable Agreement

Concurrent with the Former Parent’s acquisition of Array Technologies Patent Holdings Co., LLC on July 8, 2016, Array Tech, Inc. entered into a TRA with the former majority shareholder of the Company. The TRA is

valued based on the future expected payments under the agreement. The TRA provides for the payment by Array Tech, Inc. to the former owners for certain federal, state, local and non-U.S. tax benefits deemed realized in post-closing taxable periods by the Company, from the use of certain deductions generated by the increase in the tax value of the developed technology. The TRA is accounted for as contingent consideration and subsequent changes in fair value of the contingent liability are recognized in contingent consideration in the consolidated statements of operations. As of December 31, 2022 and December 31, 2021, the fair value of the TRA was $8.6 million and $14.6 million, respectively.

The Company considers certain factors to estimate the future expected TRA payments to the former owners include the timing of tax payments, a discount rate, book income projections, timing of expected adjustments to calculate taxable income and the projected rate of use for attributes defined in the TRA. These factors are classified as Level 3 inputs within the fair value hierarchy as discussed in Note 2 – Summary of Significant Accounting Policies.

The following table summarizes the activity related to our estimated TRA obligation (in thousands):


	TRA Liability
Balance, December 31, 2020	19,691
IRS Settlement	2,696
Fair value adjustment	(7,810)
Balance, December 31, 2021	14,577
Fair value adjustment	(4,507)
Payments	(1,483)
Balance, December 31, 2022	$	8,587

Payments made under the TRA incorporate tax positions taken by the Company and are due within 125 days following the filing of the Company’s U.S. federal and state income tax returns under procedures described in the TRA. The current portion of the TRA liability is based on expected tax returns. The TRA will continue until all tax benefit payments have been made or the Company elects early termination under the terms described in the TRA.

The undiscounted future expected payments under the TRA are as follows (in thousands):


	Amount
2023	$	1,806
2024	1,762
2025	1,615
2026	1,425
2027	1,232
Thereafter	2,516
	$	10,356

Earn-Out Liability

The Company had a liability to its selling stockholders for contingent consideration consisting of earn-out payments in the form of cash upon the occurrence of certain events, including the sale, transfer, assignment, pledge, encumbrance, distribution or disposition of shares held by the acquirer to a third-party; initial public

offering of the equity securities of Former Parent, acquirer or the Company; the sale of equity securities or assets of Former Parent, acquirer or the Company to a third-party; or a merger, consolidation, recapitalization or reorganization of Former Parent, acquirer or the Company. The maximum aggregate earn-out consideration was $25.0 million. The earn-out liability was fully paid in the year ended December 31, 2020.

Surety Bond

The Company is required to provide surety bonds to various parties as required for certain transactions initiated during the ordinary course of business to guarantee the Company’s performance in accordance with contractual or legal obligations. These off-balance sheet arrangements do not adversely impact the Company’s liquidity or capital resources. As of December 31, 2022, the Company had surety bonds outstanding in the amount of $199.3 million.

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

The carrying values and the estimated fair values of debt financial instruments were as follows (in thousands):


	2022				2021
	Carrying Value		Fair Value		Carrying Value		Fair Value
Convertible Notes	$	413,752	$	430,236	$	411,863	$	410,771

The fair value of the Convertible Notes is estimated using Level 2 inputs, as they are not registered securities nor listed on any securities exchange but may be traded by qualified institutional buyers.

The fair value of the Term Loans and Other Debt is estimated using Level 2 inputs. The carrying values of the Term Loans outstanding under the Senior Secured Credit facility recorded in consolidated balance sheets approximate fair value due to the variable interest rate.

Other Debt totaling $52.0 million, consists of $31.7 million variable rate obligations and $20.3 million fixed rate obligations. Of the $20.3 million fixed rate obligations, $14.9 million mature in 2023 and $5.4 million mature in 2024. Due to the relative short term maturity of these obligation, the Company believes current carrying value approximates fair value. The carrying value of the $31.7 million variable rate obligations approximate fair value due to the variable nature of the interest rate.

Equity Based Compensation

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Equity Based Compensation

Equity-Based Compensation

2020 Equity Incentive Plan

On October 14, 2020, the Company’s 2020 Equity Incentive Plan (the “2020 Plan”) became effective. The 2020 Plan authorized 6,683,919 new shares, subject to adjustments pursuant to the 2020 Plan.

Restricted Stock Units

Pursuant to the 2020 Plan, the Company grants restricted stock units (“RSUs”) to employees and board of director members. The fair value of the RSUs is determined using the market value of common stock on the grant date.

RSU activity under the 2020 Plan was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value
Outstanding non-vested, December 31, 2019	—	$	—
Shares granted	500,006	$	22.00
Shares vested	—	$	—
Shares forfeited	—	$	—
Outstanding non-vested, December 31, 2020	500,006	$	22.00
Shares granted	661,924	$	23.17
Shares vested	(157,473)	$	22.00
Shares forfeited	(74,048)	$	27.51
Outstanding non-vested, December 31, 2021	930,409	$	22.39
Shares granted	1,484,782	$	10.93
Shares vested	(458,849)	$	20.00
Shares forfeited	(255,518)	$	15.42
Outstanding non-vested, December 31, 2022	1,700,824	$	13.81

Performance Stock Units

The Company has granted performance stock units (“PSUs”) to certain executives. The PSUs cliff vest after three years and upon meeting certain revenue and adjusted EPS targets. The PSUs also contain a modifier based on the total stock return (“TSR”) compared to a certain index which modifies the number of PSUs that vest. The PSUs were valued using a Monte-Carlo simulation method on the date of grant based on the U.S. Treasury Constant Maturity rates. The following assumptions were used in the Monte Carlo simulation for computing the grant date fair value of the PSUs with a market condition for each grant year:


	2022		2021
Volatility	60	%	66	%
Risk-free interest rate	2.83	%	0.28	%
Dividend yield	—	%	—	%

PSU activity under the 2020 Plan was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value
PSUs
Outstanding non-vested, December 31, 2020	—	$	—
Shares granted	177,472	$	28.25
Shares vested	—	$	—
Shares forfeited	(29,785)	$	30.74
Outstanding non-vested, December 31, 2021	147,687	$	27.75
Shares granted	466,916	$	10.88
Shares vested	—	$	—
Shares forfeited	(150,210)	$	20.81
Outstanding non-vested, December 31, 2022	464,393	$	11.96

For the years ended December 31, 2022, 2021 and 2020, the Company recognized $14.8 million, $16.3 million and $4.8 million, respectively, in equity-based compensation. At December 31, 2022, the Company had $17.9 million of unrecognized compensation costs related to RSUs and PSU, which is expected to be recognized over approximately 1.9 years and 2.2 years, respectively.

Class B Units and Class C Units of Former Parent

The Company accounted for equity grants to employees of Class B units and Class C units (collectively, the “Units”) of Former Parent as equity-based compensation under ASC 718 Compensation-Stock Compensation. The Units contain vesting provisions and do not forfeit upon termination. Equity-based compensation cost is measured at the grant date fair value and is recognized on a straight-line basis over the requisite service period, including those Units with graded vesting with a corresponding credit to additional paid-in capital as a capital contribution from Former Parent. The amount of equity-based compensation at any date is equal to the portion of the grant date value of the award that is vested.

The Units issued to employees are measured at fair value on the grant date using an option pricing model. The Company utilizes the estimated weighted average of the Company’s expected fund life dependent on various exit scenarios to estimate the expected term of the awards. Expected volatility is based on the average of historical and implied volatility of a set of comparable companies, adjusted for size and leverage. The risk-free rates are based on the yields of U.S. Treasury instruments with comparable terms. Actual results may vary depending on the assumptions applied within the model.

On November 19, 2019 and May 19, 2020, Former Parent issued 22,326,653 and 4,344,941, respectively, Class B Units to certain employees of the Company. On March 28, 2020, Former Parent issued 1,000 Class C Units to a member of the board of directors of the Company.

On March 23, 2021, in connection with the closing of the 2021 Follow-On Offering, all of the outstanding Class B and Class C Units of Former Parent were immediately vested per the terms of the equity awards, resulting in the Company accelerating the recognition of equity-based compensation expense of $8.9 million for the year ended December 31, 2021.

Employee Stock Purchase Plan

The Company’s Compensation Committee approved the Employee Stock Purchase Plan in December 2021. The Plan allows employees to purchase shares at a 15% discount off the lower of the stock price at the beginning or ending of the six months window through payroll deductions. The plan is considered compensatory in nature and the Company recorded equity-based compensation expense on the plan beginning in 2022. During the year ended December 31, 2022, the Company recorded $0.1 million in equity-based compensation related to the Employee Stock Purchase Plan.

401(k) Plan

We have a defined contribution plan (“401(k) Plan”) which allows eligible employees to contribute up to 75% of their compensation up to the Internal Revenue Service maximum. We match each employee’s deferrals (contributions) at 100% for the first 3% and 50% of the fourth and fifth percentages of compensation and may make additional contributions at our discretion. Employees are immediately vested in the contributions made by us. Our contributions to the 401(k) Plan were $1.5 million, $1.1 million, and $0.8 million for the years ended December 31, 2022, 2021 and 2020, respectively, and are recorded in cost of revenue and general and administrative expense. We have made no discretionary contributions to the 401(k) Plan to date.

Leases

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Leases

Effective January 1, 2021, the Company adopted ASC 842 Leases (“ASC 842”) using the modified retrospective approach. The Company elected the use of the package of practical expedients permitted under the transition guidance which allows the Company not to reassess whether a contract contains a lease, carry forward the historical lease classification and not reassess initial direct lease costs. The Company also elected to apply the short-term measurement and recognition exemption in which the right-of-use (“ROU”) assets and lease liabilities are not recognized for short-term leases. Adoption of this standard resulted in recording of net operating lease ROU assets and corresponding operating lease liabilities of $13.2 million and $13.5 million, respectively. The standard did not materially affect the consolidated statements of income and had no impact on the consolidated statements of cash flows.

The following table summarizes the Company’s ROU assets and lease liabilities (in thousands):


		December 31,
	Location on the Consolidated Balance Sheets	2022		2021
ROU Assets	Other assets	$	17,770	$	11,245

Lease liabilities, current portion	Other current liabilities	$	6,509	$	5,909
Lease liabilities, long-term portion	Other long-term liabilities	13,897		5,359
Total lease liabilities		$	20,406	$	11,268

The components of lease cost related to the Company’s operating leases were as follows (in thousands):


	Year Ended December 31,
	2022		2021
Operating lease expense	$	7,701	$	6,635
Variable lease expense	1,089		106
Short-term lease expense	327		—
Total lease expense	$	9,117	$	6,741

Future minimum operating lease payments as of December 31, 2022, are as follows (in thousands):


	Operating Leases
2023	$	6,966
2024	5,598
2025	4,399
2026	1,606
2027	1,453
Thereafter	2,908
Total lease payments	22,930
Less: Imputed lease interest	(2,524)
Total lease liabilities	$	20,406

Other information pertaining to operating leases consists of the following:


	Year Ended December 31,
	2022		2021
Weighted average remaining lease-term	4.2 years		3.8 years
Weighted average discount rate	5.4	%	5.0	%

Supplemental cash flow and other information related to operating leases are as follows (in thousands):


	Year Ended December 31,
	2022		2021
Operating cash flows from operating leases	$	5,380	$	6,644
Non cash investing activities:
Lease liabilities arising from obtaining right-of-use assets	$	12,558	$	17,363

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Consent Fees-Related Party The Company incurred $2.2 million in consent fees with its former majority shareholder to allow a carryback of post-acquisition net operating losses to pre-acquisition periods under the CARES Act. The remaining balance due was $0.5 million as of December 31, 2022 and is classified as accounts payable – related party in the consolidated balance sheet. Special Distribution to Former Parent On October 14, 2020, the Company made a special distribution of $589 million to Former Parent (the “Special Distribution”). Contingent Consideration - see Note 15 – Commitments and Contingencies

Segment and Geographic Information

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Segment and Geographic Information

ASC 280 Segment Reporting establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Historically, the Company managed its business on the basis of one operating and reportable segment. During the year ended December 31, 2022, the Company changed its reportable segments as a result of the STI Acquisition; the Company now operates as two segments; Array Legacy Operations and STI Operations.

Segment revenue and gross profit were as follows during the periods presented (in thousands):


	Year Ended December 31,
	2022						2021		2020
	Array Legacy Operations		STI Operations		Total		Array Legacy Operations		Array Legacy Operations
Revenue	$	1,267,883	$	369,663	$	1,637,546	$	853,318	$	872,662
Gross Profit	$	168,170	$	59,106	$	227,276	$	82,859	$	202,801

The total assets of the Array Legacy segment are $843 million or approximately 49% of total consolidated assets. The total assets of the STI segment are $863 million or approximately 51% of total consolidated assets.

The following table presents revenues by geographic region, based on the customers project location (in thousands):


	Year Ended December 31,
	2022		2021		2020
U.S.	$	1,286,064	$	826,639	$	805,070
Spain	129,292		7,281		181
Brazil	144,464		—		—
Australia	9,429		5,509		45,216
Rest of the world	68,297		13,889		22,195
Total revenue	$	1,637,546	$	853,318	$	872,662

The following table presents property, plant and equipment, net by geographic region at the end of the period (in thousands):


	December 31,
	2022		2021
U.S.	$	17,789	$	9,959
Spain	2,676		—
Brazil	1,676		—
Australia	1		—
Rest of the world	1,032		733
Total property, plant and equipment, net	$	23,174	$	10,692

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Restatement (Unaudited)

12 Months Ended

Dec. 31, 2022

Accounting Changes and Error Corrections [Abstract]

Restatement (Unaudited)

Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements

During the preparation of the Company’s consolidated financial statements for the year ended December 31, 2022, the Company noted that intangible assets acquired and goodwill recognized in connection with the STI Acquisition were not initially recorded at proper amounts and were not allocated to the appropriate entities or maintained in the appropriate functional currency. In addition, an asset capitalized in connection with the STI Acquisition was identified that should have been expensed as incurred.

The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate the unaudited quarterly condensed consolidated financial statements for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30, 2022.

The following presents the restated unaudited quarterly condensed financial statements as of March 31, 2022, June 30, 2022 and September 30, 2022 and for the three month period ended March 31, 2022, the three and six month periods ended June 30, 2022 and the three and nine month periods ended September 30, 2022.

Consolidated Balance Sheets


	March 31, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	49,491	$	—	$	49,491
Accounts receivable, net	390,921		—		390,921
Inventories, net	299,010		—		299,010
Income tax receivables	31,079		—		31,079
Prepaid expenses and other	46,495		(825)		45,670
Total current assets	816,996		(825)		816,171
Property, plant and equipment, net	16,878		—		16,878
Goodwill	379,840		62,382		442,222
Other intangible assets, net	470,690		11,345		482,035
Deferred tax assets	—		—		—
Other assets	31,314		(4,770)		26,544
Total assets	$	1,715,718	$	68,132	$	1,783,850

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	187,466	$	—	$	187,466
Accounts payable - related party	478		—		478
Accrued expenses and other	54,837		—		54,837
Accrued warranty reserve	3,201		—		3,201
Income tax payable	6,452				6,452
Deferred revenue	121,624		—		121,624
Current portion of contingent consideration	—		—		—
Current portion of debt	48,180		—		48,180
Other current liabilities	10,886		—		10,886
Total current liabilities	433,124		—		433,124
Long-term liabilities
Deferred tax liability	92,931		6,329		99,260
Contingent consideration, net of current portion	9,363		—		9,363
Other long-term liabilities	7,102		—		7,102
Long-term warranty	4,743		—		4,743
Long-term debt, net of current portion	778,248		—		778,248
Total long-term liabilities	892,387		6,329		898,716
Total liabilities	1,325,511		6,329		1,331,840
Commitments and contingencies (Note 16)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 400,000 shares issued as of March 31, 2022; liquidation preference of $400.0 million as of March 31, 2022	281,792		—		281,792


Stockholders’ equity (deficit)
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of March 31, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,173,507 shares issued as of March 31, 2022	150		—		150
Additional paid-in capital	411,232		—		411,232
Accumulated deficit	(293,956)		(3,883)		(297,839)
Accumulated other comprehensive (loss) income	(9,011)		65,686		56,675
Total stockholders’ equity	108,415		61,803		170,218
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,715,718	$	68,132	$	1,783,850

Consolidated Balance Sheets


	June 30, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	51,046	$	—	$	51,046
Accounts receivable, net	452,836		—		452,836
Due from affiliates	—		—		—
Inventories, net	329,951		—		329,951
Income tax receivables	16,217		—		16,217
Prepaid expenses and other	52,831		(825)		52,006
Total current assets	902,881		(825)		902,056
Property, plant and equipment, net	17,802		—		17,802
Goodwill	378,706		38,988		417,694
Other intangible assets, net	421,862		14,687		436,549
Deferred tax assets	18,521		—		18,521
Other assets	30,573		(4,564)		26,009
Total assets	$	1,770,345	$	48,286	$	1,818,631

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	231,798	$	—	231,798
Accounts payable - related party	478		—		478
Accrued expenses and other	51,072		—		51,072
Accrued warranty reserve	2,911		—		2,911
Income tax payable	419				419
Deferred revenue	167,556		—		167,556
Current portion of debt	51,494		—		51,494
Other current liabilities	6,949		—		6,949
Total current liabilities	512,677		—		512,677
Long-term liabilities
Deferred tax liability	84,819		1,771		86,590
Contingent consideration, net of current portion	7,686		—		7,686
Other long-term liabilities	9,723		—		9,723
Long-term warranty	4,056		—		4,056
Long-term debt, net of current portion	793,557		—		793,557
Total long-term liabilities	899,841		1,771		901,612
Total liabilities	1,412,518		1,771		1,414,289
Commitments and contingencies (Note 16)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 412,606 shares issued as of June 30, 2022; liquidation preference of $413.0 million as of June 30, 2022.	293,974		—		293,974


Stockholders’ equity					—
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of June 30, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,279,160 shares issued as of June 30, 2022	150		—		150
Additional paid-in capital	401,614		—		401,614
Accumulated deficit	(299,182)		(3,681)		(302,863)
Accumulated other comprehensive (loss) income	(38,729)		50,196		11,467
Total stockholders’ equity	63,853		46,515		110,368
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,770,345	$	48,286	$	1,818,631

Consolidated Balance Sheets


	September 30, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	62,778	$	—	$	62,778
Accounts receivable, net	485,174		—		485,174
Inventories, net	269,775		—		269,775
Income tax receivables	12,765		—		12,765
Prepaid expenses and other	41,309		(825)		40,484
Total current assets	871,801		(825)		870,976
Property, plant and equipment, net	20,024		—		20,024
Goodwill	359,629		41,744		401,373
Other intangible assets, net	384,084		15,799		399,883
Deferred tax assets	18,785		—		18,785
Other assets	27,502		(4,357)		23,145
Total assets	$	1,681,825	$	52,361	$	1,734,186

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	199,358	$	—	199,358
Accounts payable - related party	478		—		478
Accrued expenses and other	91,102		—		91,102
Accrued warranty reserve	4,237		—		4,237
Income tax payable	10,587				10,587
Deferred revenue	154,692		—		154,692
Current portion of contingent consideration	—		—		—
Current portion of debt	47,686		—		47,686
Other current liabilities	4,981		—		4,981
Total current liabilities	513,121		—		513,121
Long-term liabilities
Deferred tax liability	74,139		2,725		76,864
Contingent consideration, net of current portion	7,113		—		7,113
Other long-term liabilities	9,113		—		9,113
Long-term warranty	3,852		—		3,852
Long-term debt, net of current portion	725,109		—		725,109
Total long-term liabilities	819,326		2,725		822,051
Total liabilities	1,332,447		2,725		1,335,172
Commitments and contingencies (Note 16)


Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 400,000 shares issued as of September 30, 2022; liquidation preference of $400.0 million as of September 30, 2022	287,561		—		287,561
Stockholders’ equity					—
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of September 30, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,334,261 shares issued as of September 30, 2022	150		—		150
Additional paid-in capital	392,862		—		392,862
Accumulated deficit	(258,360)		(3,859)		(262,219)
Accumulated other comprehensive (loss) income	(72,835)		53,495		(19,340)
Total stockholders’ equity	61,817		49,636		111,453
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,681,825	$	52,361	$	1,734,186

Consolidated Statements of Operations


	Three Months Ended March 31, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	300,586	$	—	$	300,586
Cost of revenue	273,999		—		273,999
Gross profit	26,587		—		26,587

Operating expenses
General and administrative	39,827		5,598		45,425
Contingent consideration	(3,731)		—		(3,731)
Depreciation and amortization	22,652		585		23,237
Total operating expenses	58,748		6,183		64,931

Income (loss) from operations	(32,161)		(6,183)		(38,344)

Other expense
Other income (expense), net	743		—		743
Foreign currency gain	3,863		—		3,863
Interest expense	(6,942)		—		(6,942)
Total other expense	(2,336)		—		(2,336)
Income (loss) before income tax expense (benefit)	(34,497)		(6,183)		(40,680)
Income tax expense (benefit)	(12,443)		(2,300)		(14,743)
Net income (loss)	(22,054)		(3,883)		(25,937)
Preferred dividends and accretion	11,606		—		11,606
Net income (loss) to common shareholders	$	(33,660)	$	(3,883)	$	(37,543)

Earnings (loss) per share
Basic	$	(0.23)	$	(0.03)	$	(0.25)
Diluted	$	(0.23)	$	(0.03)	$	(0.25)
Weighted average number of shares
Basic	148,288		—		148,288
Diluted	148,288		—		148,288

Consolidated Statements of Operations


	Three Months Ended June 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	419,865	$	—	$	419,865
Cost of revenue	379,919		—		379,919
Gross profit	39,946		—		39,946

Operating expenses
General and administrative	29,143		(207)		28,936
Contingent consideration	(1,678)		—		(1,678)
Depreciation and amortization	24,389		1,631		26,020
Total operating expenses	51,854		1,424		53,278

Income (loss) from operations	(11,908)		(1,424)		(13,332)

Other expense
Other income (expense), net	(371)		—		(371)
Foreign currency gain (loss)	(1,736)		—		(1,736)
Interest expense	(8,021)		—		(8,021)
Total other expense	(10,128)		—		(10,128)
Loss before income tax benefit	(22,036)		(1,424)		(23,460)
Income tax benefit	(16,810)		(1,626)		(18,436)
Net loss	(5,226)		202		(5,024)
Preferred dividends and accretion	12,182		—		12,182
Net loss to common shareholders	$	(17,408)	$	202	$	(17,206)

Loss per common share
Basic	$	(0.12)	$	—	$	(0.11)
Diluted	$	(0.12)	$	—	$	(0.11)
Weighted average number of common shares
Basic	150,203		—		150,203
Diluted	150,203		—		150,203

Consolidated Statements of Operations


	Three Months Ended September 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	515,024	$	—	$	515,024
Cost of revenue	434,801		—		434,801
Gross profit	80,223		—		80,223

Operating expenses
General and administrative	38,911		(208)		38,703
Contingent consideration	(572)		—		(572)
Depreciation and amortization	23,364		1,534		24,898
Total operating expenses	61,703		1,326		63,029

Income (loss) from operations	18,520		(1,326)		17,194

Other income (expense)
Other expense, net	(399)		—		(399)
Legal settlement	42,750		—		42,750
Foreign currency gain (loss)	(159)		—		(159)
Interest expense	(8,746)		—		(8,746)
Total other income (expense)	33,446		—		33,446
Income (loss) before income tax (benefit) expense	51,966		(1,326)		50,640
Income tax (benefit) expense	11,144		(1,148)		9,996
Net income (loss)	40,822		(178)		40,644
Preferred dividends and accretion	12,257		—		12,257
Net income (loss) to common shareholders	$	28,565	$	(178)	$	28,387

Income (loss) per common share
Basic	$	0.19	$	—	$	0.19
Diluted	$	0.19	$	—	$	0.19
Weighted average number of common shares
Basic	150,322		—		150,322
Diluted	151,382		—		151,382

Consolidated Statements of Operations


	Six Months Ended June 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	720,451	$	—	$	720,451
Cost of revenue	653,918		—		653,918
Gross profit	66,533		—		66,533

Operating expenses
General and administrative	68,970		5,391		74,361
Contingent consideration	(5,409)		—		(5,409)
Depreciation and amortization	47,041		2,216		49,257
Total operating expenses	110,602		7,607		118,209

Income (loss) from operations	(44,069)		(7,607)		(51,676)

Other expense
Other income (expense), net	372		—		372
Foreign currency gain (loss)	2,127		—		2,127
Interest expense	(14,963)		—		(14,963)
Total other expense	(12,464)		—		(12,464)
Loss before income tax benefit	(56,533)		(7,607)		(64,140)
Income tax benefit	(29,253)		(3,926)		(33,179)
Net loss	(27,280)		(3,681)		(30,961)
Preferred dividends and accretion	23,788		—		23,788
Net loss to common shareholders	$	(51,068)	$	(3,681)	$	(54,749)

Loss per common share
Basic	$	(0.34)	$	(0.02)	$	(0.37)
Diluted	$	(0.34)	$	(0.02)	$	(0.37)
Weighted average number of common shares
Basic	149,246		—		149,246
Diluted	149,246		—		149,246

Consolidated Statements of Operations


	Nine Months Ended September 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	1,235,475	$	—	$	1,235,475
Cost of revenue	1,088,719		—		1,088,719
Gross profit	146,756		—		146,756

Operating expenses
General and administrative	107,881		5,183		113,064
Contingent consideration	(5,981)		—		(5,981)
Depreciation and amortization	70,405		3,750		74,155
Total operating expenses	172,305		8,933		181,238

Income (loss) from operations	(25,549)		(8,933)		(34,482)

Other income (expense)
Other expense, net	(27)		—		(27)
Legal settlement	42,750		—		42,750
Foreign currency gain (loss)	1,968		—		1,968
Interest expense	(23,709)		—		(23,709)
Total other income (expense)	20,982		—		20,982
Income (loss) before income tax (benefit) expense	(4,567)		(8,933)		(13,500)
Income tax (benefit) expense	(18,109)		(5,074)		(23,183)
Net income (loss)	13,542		(3,859)		9,683
Preferred dividends and accretion	36,045		—		36,045
Net income (loss) to common shareholders	$	(22,503)	$	(3,859)	$	(26,362)

Income (loss) per common share
Basic	$	(0.15)	$	(0.03)	$	(0.18)
Diluted	$	(0.15)	$	(0.03)	$	(0.18)
Weighted average number of common shares
Basic	149,604		—		149,604
Diluted	149,604		—		149,604

Consolidated Statements of Comprehensive Income (Loss)


	Three Months Ended March 31, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net loss	$	(22,054)	$	(3,883)	$	(25,937)
Change in foreign currency translation adjustments	(9,011)		65,686		56,675
Comprehensive income (loss)	$	(31,065)	$	61,803	$	30,738

Consolidated Statements of Comprehensive Loss


	Three Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	(5,226)	$	202	$	(5,024)
Change in foreign currency translation adjustments	(29,718)		(15,490)		(45,208)
Comprehensive loss	$	(34,944)	$	(15,288)	$	(50,232)

Consolidated Statements of Comprehensive Income


	Three Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	40,822	$	(178)	$	40,644
Change in foreign currency translation adjustments	(34,106)		3,299		(30,807)
Comprehensive income	$	6,716	$	3,121	$	9,837

Consolidated Statements of Comprehensive Income (Loss)


	Six Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net loss	$	(27,280)	$	(3,681)	$	(30,961)
Change in foreign currency translation adjustments	(38,729)		50,196		11,467
Comprehensive income (loss)	$	(66,009)	$	46,515	$	(19,494)

Consolidated Statements of Comprehensive Income (Loss)


	Nine Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	13,542	$	(3,859)	$	9,683
Change in foreign currency translation adjustments	(72,835)		53,495		(19,340)
Comprehensive income (loss)	$	(59,293)	$	49,636	$	(9,657)

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Three Months Ended March 31, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		4,413		—		—		4,413
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,147	15		215,863		—		—		215,878

Preferred cumulative dividends plus accretion	—	11,606		—	—		—	—		(11,606)		—		—		(11,606)
Net loss	—	—		—	—		—	—		—		(22,054)		—		(22,054)
Other comprehensive loss	—	—		—	—		—	—		—		—		(9,011)		(9,011)
Balance, March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(293,956)	$	(9,011)	$	108,415

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,883)		—		(3,883)
Other comprehensive income	—	—		—	—		—	—		—		—		65,686		65,686
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,883)	$	65,686	$	61,803

As Restated


Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		4,413		—		—		4,413
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,147	15		215,863		—		—		215,878

Preferred cumulative dividends plus accretion	—	11,606		—	—		—	—		(11,606)		—		—		(11,606)
Net loss	—	—		—	—		—	—		—		(25,937)		—		(25,937)
Other comprehensive income	—	—		—	—		—	—		—		—		56,675		56,675
Balance, March 31, 2022 - As Restated	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(297,839)	$	56,675	$	170,218

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Three Months Ended June 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(293,956)	$	(9,011)	$	108,415
Equity-based compensation	—	—		—	—		105	—		2,944		—		—		2,944
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(380)		—		—		(380)
Preferred cumulative dividends plus accretion	13	12,182		—	—		—	—		(12,182)		—		—		(12,182)
Net loss	—	—		—	—		—	—		—		(5,226)		—		(5,226)
Other comprehensive loss	—	—		—	—		—	—		—		—		(29,718)		(29,718)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853

Adjustments
Balance at March 31, 2022	—	$	—	—	$	—	—	$	—	$	—	$	(3,883)	$	65,686	$	61,803
Net income	—	—		—	—		—	—		—		202		—		202
Other comprehensive loss	—	—		—	—		—	—		—		—		(15,490)		(15,490)
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515

As Restated
Balance at March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(297,839)	$	56,675	$	170,218


Equity-based compensation	—	—		—	—		105	—		2,944		—		—		2,944
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(380)		—		—		(380)
Preferred cumulative dividends plus accretion	13	12,182		—	—		—	—		(12,182)		—		—		(12,182)
Net loss	—	—		—	—		—	—		—		(5,024)		—		(5,024)
Other comprehensive loss	—	—		—	—		—	—		—		—		(45,208)		(45,208)
Balance, June 30, 2022 - As Restated	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368

Statement of Changes in Shareholders' Equity/(Deficit) - Three Months Ended September 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853
Equity-based compensation	—	—		—	—		55	—		4,097		—		—		4,097
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(592)		—		—		(592)
Preferred cumulative dividends plus accretion	—	12,257		—	—		—	—		(12,257)		—		—		(12,257)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		40,822		—		40,822
Other comprehensive loss	—	—		—	—		—	—		—		—		(34,106)		(34,106)
Balance at September 30, 2022	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(258,360)	$	(72,835)	$	61,817

Adjustments
Balance at June 30, 2022	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515
Net loss	—	—		—	—		—	—		—		(178)		—		(178)
Other comprehensive loss	—	—		—	—		—	—		—		—		3,299		3,299
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,859)	$	53,495	$	49,636

As Restated
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368


Equity-based compensation	—	—		—	—		55	—		4,097		—		—		4,097
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(592)		—		—		(592)
Preferred cumulative dividends plus accretion	—	12,257		—	—		—	—		(12,257)		—		—		(12,257)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		40,644		—		40,644
Other comprehensive loss	—	—		—	—		—	—		—		—		(30,807)		(30,807)
Balance, September 30, 2022 - As Restated	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(262,219)	$	(19,340)	$	111,453

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Six Months Ended June 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		7,357		—		—		7,357
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,252	15		215,483		—		—		215,498

Preferred cumulative dividends plus accretion	13	23,788		—	—		—	—		(23,788)		—		—		(23,788)
Net loss	—	—		—	—		—	—		—		(27,280)		—		(27,280)
Other comprehensive loss	—	—		—	—		—	—		—		—		(38,729)		(38,729)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,681)		—		(3,681)
Other comprehensive income	—	—		—	—		—	—		—		—		50,196		50,196
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515

As Restated
Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)


Equity-based compensation	—	—		—	—		—	—		7,357		—		—		7,357
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,252	15		215,483		—		—		215,498
Issuance of common stock, net	—	—		—	—		—	—		—		—		—		—
Preferred cumulative dividends plus accretion	13	23,788		—	—		—	—		(23,788)		—		—		(23,788)
Net loss	—	—		—	—		—	—		—		(30,961)		—		(30,961)
Other comprehensive income	—	—		—	—		—	—		—		—		11,467		11,467
Balance, June 30, 2022 - As Restated	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Nine Months Ended September 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		161	—		11,454		—		—		11,454
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,146	15		214,891		—		—		214,906

Preferred cumulative dividends plus accretion	13	36,045		—	—		—	—		(36,045)		—		—		(36,045)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		13,542		—		13,542
Other comprehensive loss	—	—		—	—		—	—		—		—		(72,835)		(72,835)
Balance at September 30, 2022	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(258,360)	$	(72,835)	$	61,817

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,859)		—		(3,859)
Other comprehensive income	—	—		—	—		—	—		—		—		53,495		53,495
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,859)	$	53,495	$	49,636

As Restated


Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		161	—		11,454		—		—		11,454
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,146	15		214,891		—		—		214,906
Issuance of common stock, net	—	—		—	—		—	—		—		—		—		—
Preferred cumulative dividends plus accretion	13	36,045		—	—		—	—		(36,045)		—		—		(36,045)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		9,683		—		9,683
Other comprehensive loss	—	—		—	—		—	—		—		—		(19,340)		(19,340)
Balance, September 30, 2022 - As Restated	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(262,219)	$	(19,340)	$	111,453

Consolidated Statements of Cash Flows


	Three Months Ended March 31, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net income (loss)	$	(22,054)	$	(3,883)	$	(25,937)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Provision for (recovery of) bad debts	145		—		145
Deferred tax expense (benefit)	6,649		(2,300)		4,349
Depreciation and amortization	23,023		585		23,608
Amortization of debt discount and issuance costs	1,710		—		1,710
Equity-based compensation	4,508		—		4,508
Contingent consideration	(3,731)		—		(3,731)
Warranty provision	594		—		594
Provision for inventory obsolescence	409		—		409
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(44,268)		—		(44,268)
Inventories	(46,250)		—		(46,250)
Income tax receivables	(21,924)		—		(21,924)
Prepaid expenses and other	5,960		5,598		11,558
Accounts payable	59,551		—		59,551
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	7,027		—		7,027
Income tax payable	(8,760)		—		(8,760)
Lease liabilities	6,085		—		6,085
Deferred revenue	(18,639)		—		(18,639)
Net cash used in operating activities	(50,097)		—		(50,097)
Cash flows from investing activities
Purchase of property, plant and equipment	(2,357)		—		(2,357)
Acquisition of STI, net of cash acquired	(373,816)		—		(373,816)
Investment in equity security	—		—		—
Net cash used in investing activities	(376,173)		—		(376,173)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(175)		—		(175)
Common stock issuance costs	(450)		—		(450)
Proceeds from revolving credit facility	52,000		—		52,000
Payments on revolving credit facility	—		—		—
Proceeds from issuance of other debt	6,229		—		6,229


Principal payments on debt	(4,368)		—		(4,368)
Contingent consideration	(1,483)		—		(1,483)
Debt issuance costs	—		—		—
Net cash provided by (used in) financing activities	100,736		—		100,736
Effect of exchange rate changes on cash and cash equivalent balances	7,355		—		7,355
Net change in cash and cash equivalents	(318,179)		—		(318,179)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	49,491	$	—	$	49,491

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Consolidated Statements of Cash Flows


	Six Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net loss	$	(27,280)	$	(3,681)	$	(30,961)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for (recovery of) bad debts	510		—		510
Deferred tax benefit	(19,984)		(3,926)		(23,910)
Depreciation and amortization	47,579		2,216		49,795
Amortization of debt discount and issuance costs	3,286		—		3,286
Equity-based compensation	7,472		—		7,472
Contingent consideration	(5,409)		—		(5,409)
Warranty provision	1,215		—		1,215
Provision for inventory obsolescence	409		—		409
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(106,548)		—		(106,548)
Inventories	(77,191)		—		(77,191)
Income tax receivables	(7,062)		—		(7,062)
Prepaid expenses and other	(376)		5,391		5,015
Accounts payable	74,645		—		74,645
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	3,356		—		3,356
Income tax payable	(7,217)		—		(7,217)
Lease liabilities	4,700		—		4,700


Deferred revenue	47,263		—		47,263
Net cash used in operating activities	(60,764)		—		(60,764)
Cash flows from investing activities
Purchase of property, plant and equipment	(3,895)		—		(3,895)
Acquisition of STI, net of cash acquired	(373,818)		—		(373,818)
Investment in equity security	—		—		—
Net cash used in investing activities	(377,713)		—		(377,713)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(575)		—		(575)
Common stock issuance costs	(450)		—		(450)
Payments on revolving credit facility	(33,000)		—		(33,000)
Proceeds from issuance of other debt	30,599		—		30,599
Proceeds from revolving credit facility	101,000		—		101,000
Principal payments on debt	(22,377)		—		(22,377)
Contingent consideration	(1,483)		—		(1,483)
Debt issuance costs	—		—		—
Net cash provided by financing activities	122,697		—		122,697
Effect of exchange rate changes on cash and cash equivalent balances	(844)		—		(844)
Net change in cash and cash equivalents	(316,624)		—		(316,624)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	51,046	$	—	$	51,046

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Consolidated Statements of Cash Flows


	Nine Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net income (loss)	$	13,542	$	(3,859)	$	9,683
Adjustments to reconcile net income (loss) to net cash provided by, (used in) operating activities:
Provision for (recovery of) bad debts	660		—		660
Deferred tax benefit	(30,928)		(5,074)		(36,002)
Depreciation and amortization	71,207		3,750		74,957
Amortization of debt discount and issuance costs	5,003		—		5,003
Equity-based compensation	11,677		—		11,677


Contingent consideration	(5,981)		—		(5,981)
Warranty provision	4,341		—		4,341
Provision for inventory obsolescence	(2,333)		—		(2,333)
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(139,036)		—		(139,036)
Inventories	(14,273)		—		(14,273)
Income tax receivables	(3,610)		—		(3,610)
Prepaid expenses and other	11,146		5,183		16,329
Accounts payable	42,205		—		42,205
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	41,271		—		41,271
Warranty payments	(373)		—		(373)
Income tax payable	2,951		—		2,951
Lease liabilities	1,914		—		1,914
Deferred revenue	34,772		—		34,772
Net cash provided by, (used in) operating activities	44,023		—		44,023
Cash flows from investing activities
Purchase of property, plant and equipment	(6,690)		—		(6,690)
Acquisition of STI, net of cash acquired	(373,816)		—		(373,816)
Investment in equity security	—		—		—
Net cash used in investing activities	(380,506)		—		(380,506)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(1,167)		—		(1,167)
Common stock issuance costs	(450)		—		(450)
Dividends paid on Series A Preferred	(18,670)		—		(18,670)
Payments on revolving credit facility	(116,000)		—		(116,000)
Proceeds from issuance of other debt	39,219		—		39,219
Proceeds from revolving credit facility	116,000		—		116,000
Principal payments on debt	(33,286)		—		(33,286)
Contingent consideration	(1,483)		—		(1,483)
Net cash provided by financing activities	33,146		—		33,146
Effect of exchange rate changes on cash and cash equivalent balances	(1,555)		—		(1,555)
Net change in cash and cash equivalents	(304,892)		—		(304,892)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	62,778	$	—	$	62,778

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting and Presentation	Basis of Accounting and Presentation The accompanying consolidated financial statements were prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.
Recently Accounting Pronouncements	Recent Accounting PronouncementsIn October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). ASU 2021-08 requires contract assets and contract liabilities obtained in a business combination to be recognized and measured in accordance with Accounting Standards Codification (“ASC”) Topic 606 Revenue from Contracts with Customers (“ASC 606”). At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the recent update, such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company early adopted ASU 2021-08 as of January 1, 2022. See Note 3 – Acquisition of STI for further information and disclosures related to the STI Acquisition. The standard was applied to the acquisition accounting for STI.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Array Technologies, Inc. and its Subsidiaries. All intercompany accounts and transactions have been eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Although management believes its estimates are reasonable, actual results could differ from those estimates.
Impact of COVID-19 Pandemic, Impact of the Ongoing Conflict in Ukraine and Inflation	Impact of COVID-19 Pandemic We continue to closely monitor the ongoing impact of the COVID-19 pandemic in all the locations where we operate. At this time, the extent to which the pandemic may affect our business, operations and plans, including the resulting impact on our expenditures and capital needs, remains uncertain and is subject to change, but overall the pandemic appears to be having a lessening impact on our business and the markets in which we operate. On January 31, 2023, the Biden administration announced its plan to let the coronavirus public health emergency expire in May 2023. Impact of the Ongoing Conflict in Ukraine The ongoing conflict in Ukraine has reduced the availability of material that can be sourced in Europe and, as a result, increased logistics costs for the procurement of certain inputs and materials used in our products. We do not know ultimate severity or duration of the conflict in Ukraine, but we continue to monitor the situation and evaluate our procurement strategy and supply chain as to reduce any negative impact on our business, financial condition and results of operations. Inflation Inflationary pressures, while somewhat moderating recently, are expected to persist, at least in the near-term, and may continue to negatively impact our results of operation. To mitigate the inflationary pressures on our business, we have implemented selective price increases in certain markets, accelerated productivity initiatives and expanded our supplier base, while continuing to execute on overhead cost containment practices.
Foreign Currency Translation	Foreign Currency Translation For non-U.S. subsidiaries that operate in a local currency environment, assets and liabilities are translated into U.S. dollars at period end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the period. Translation adjustments for these subsidiaries are accumulated as a separate component of net parent investment. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired, and all other assets and liabilities are translated at period end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates, and all other income and expense items are translated at average exchange rates prevailing during the period. Gains and losses which result from remeasurement are included in earnings.
Cash and Cash Equivalents	Cash and Cash EquivalentsThe Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. We regularly maintain cash balances that exceed insured amounts, but we have experienced no losses associated with these amounts to date. At December 31, 2022 all cash balances were deposited with banks, and we had no cash equivalents.
Accounts Receivable	Accounts Receivable The Company’s accounts receivable are due primarily from solar contractors across the U.S. and internationally. Credit is extended in the normal course of business based on evaluation of a customer’s financial condition and, generally, collateral is not required. Trade receivables consist of uncollateralized customer obligations due under normal trade terms requiring payment within 30-60 days of the invoice date. Management regularly reviews outstanding accounts receivable and provides for estimated credit losses through an estimate of expected credit losses valuation account. The Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses, (“ASU 2016-13”) on January 1, 2021 which revised the methodology for measuring credit losses on financial instruments including trade accounts receivable and the timing of when such losses are recorded. The Company adopted ASU 2016-13 using a modified retrospective approach with a cumulative effect adjustment to the opening balance of retained earnings, which had no impact on the consolidated financial statements. The allowance for credit losses is a valuation account that is deducted from a financial asset’s amortized cost to present the net amount we expect to collect from the asset. We estimate allowances for credit losses using relevant available information from both internal and external sources. We monitor the estimated credit losses associated with our trade accounts receivable and unbilled accounts receivable based primarily on our collection history and the delinquency status of amounts owed to us, which we determine based on the aging of such receivables. In evaluating the level of established reserves, management makes judgments regarding the customers’ ability to make required payments, economic events, and other factors. As the financial conditions of these customers change, circumstances develop, or additional information becomes available, adjustments to the valuation account may be required. When deemed uncollectible, the receivable is charged against the valuation account for credit losses or directly written off. Unbilled receivables represent temporary timing differences between shipments made and billing milestones achieved and are recorded in the accounts receivable balances. Such amounts have not been billed due to pending commercial criteria such as billing on a specified date of the month or upon completion of mega-watt deliveries. Unbilled receivables are invoiced once the underlying commercial criteria have been met and we expect payment within 30 to 60 days.
Inventories	Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost or estimated net realizable value using primarily the weighted average method and some valued using the FIFO method. Provisions are made to reduce excess or obsolete inventories to their estimated net realizable values.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are recorded at cost, net of accumulated depreciation and amortization. Improvements, betterments and replacements which extend the life of an asset are capitalized. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are expensed as incurred. A gain or loss on the sale of property, plant and equipment is calculated as the difference between the cost of the asset disposed of, net of depreciation, and the sales proceeds received. A gain or loss on an asset disposal is recognized in the period that the sale occurs.
Leases	Leases Operating lease arrangements are comprised primarily of real estate and equipment agreements. The Company determines if an arrangement contains a lease at inception based on whether it conveys the right to control the use of an identified asset in exchange for consideration. Lease right-of-use assets (“ROU assets”) and associated lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Certain lease agreements may include one or more options to extend or terminate a lease. Lease terms are inclusive of these options if it is reasonably certain that the Company will exercise such options. ROU assets also include any initial direct costs and prepayments less lease incentives. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Lease expense is recognized on a straight-line basis over the lease term. ROU assets and the corresponding operating lease liabilities are included in other assets and other liabilities in our consolidated balance sheets. Finance leases are included in property and equipment, other current liabilities, and other long-term liabilities in our consolidated balance sheets.
Impairment of Long-Lived Assets	Impairment of Long-Lived AssetsWhen events, circumstances or operating results indicate that the carrying values of long-lived assets might not be recoverable through future operations, the Company prepares projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate that the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value.
Goodwill	GoodwillGoodwill reflects the excess of the consideration transferred, including the fair value of any contingent consideration over the assigned fair values of the identifiable net assets acquired. Goodwill is not amortized and is assigned at the reporting unit level and tested for impairment on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. Goodwill is assessed using either a qualitative assessment or quantitative approach to determine whether it is more likely than not that the fair value of the reporting unit is less than the carrying amount. The qualitative assessment evaluates factors including macroeconomic conditions, industry-specific and company-specific considerations, legal and regulatory environments, and historical performance. If the Company determines that is more likely than not that the fair value of a reporting unit is less than its carrying value, a quantitative assessment is performed. Otherwise, no further assessment is required. The quantitative approach compares the estimated fair value of the reporting unit to its carrying amount, including goodwill. Impairment is indicated if the estimated fair value or the reporting unit is less than the carrying amount of the reporting unit, and an impairment charge is recognized for the differential.
Investment in Equity Securities	Investment in Equity Securities In 2021, the Company invested $12.0 million in the preferred stock of a private company. The investment is accounted for, in accordance with ASC 321 Investments — Equity Securities, at its cost less any impairment. The equity investment is recorded in other assets on the consolidated balance sheets. No impairment has been recognized since the date of investment.
Amortizable and Other Intangible Assets	Amortizable and Other Intangible AssetsThe Company amortizes identifiable finite lived intangible assets consisting of developed technology, customer relationships, contractual backlog and the STI trade name on a straight-line basis over the assets’ estimated useful lives. The basis of amortization approximates the pattern in which the assets are utilized, over their estimated useful lives.
Indefinite-Lived Intangible Assets	The Array Technologies trade name has been determined to have an indefinite life and, therefore, is not amortized but is subject to an annual impairment test or at any other time when impairment indicators exist.
Deferred Offering Costs	Deferred Offering Costs Deferred offering costs consist primarily of registration fees, filing fees, listing fees, specific legal and accounting costs, and transfer agent fees, which are direct and incremental fees related to the offerings. Deferred offering costs were offset against the proceeds.
Debt Discount and Financing Costs	Debt Discount and Issuance CostsDebt discount and issuance costs incurred to issue debt are deferred and amortized using the effective interest method as a component of interest expense over the life of the related debt agreement.
Revenue Recognition	Revenue Recognition In accordance with ASC 606, the Company recognizes revenues from the sale of solar tracking systems and parts and determines its revenue recognition through the following steps (i) identification of the contract or contracts with a customer, (ii) identification of the performance obligations within the contract, (iii) determination of the transaction price, (iv) allocation of the transaction price to the performance obligations within the contract, and (v) recognition of revenue when, or as the performance obligation has been satisfied. Performance Obligations The majority of the Company’s contracts with customers are accounted for as one performance obligation, because the Company is integrating the solar tracking system components and related services as part of a single project. Certain contracts associated with customers using the federal investment tax credit (“ITC”) for solar energy projects and other standalone tracker component sales are accounted for as multiple performance obligations because the delivery of the components and other services specified in the contract do not represent a single integrated project. In contracts with a single performance obligation, the Company’s obligation is satisfied over-time as control is transferred to the customer by measuring the progress toward complete satisfaction of the performance obligation using an input (i.e., the “cost-to-cost”) method. Under the cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company uses the expected cost-plus margin approach to estimate the standalone selling price of each performance obligation. Revenue recognized for the Company’s federal investment tax credit (“ITC”) related contracts and standalone system component is recorded at a point in time and recognized when obligations under the terms of the contract with our customer are satisfied. Generally, this occurs with the transfer of control of the asset, which is typically upon delivery to the customer in line with shipping terms. Any losses incurred on point-in-time projects are recognized as the goods are delivered. In certain situations, the Company recognizes revenue under a bill-and-hold arrangement with its customers. In arrangements related to the Federal Solar ITC, the customers purchase material prior to the start of construction of a solar project in order to meet the Five Percent Safe Harbor test to qualify for the Federal Solar ITC. In all bill-and-hold arrangements, because the customers lack sufficient storage capacity to accept a large amount of material prior to the start of construction, they request that the Company keep the product in our custody. The material is bundled or palletized in the Company’s warehouses, identified separately as belonging to the respective customer and is ready for immediate transport to the customer project upon customer request. Additionally, title and risk of loss has passed to the customer and the Company does not have the ability to use the product or direct it to another customer. In assessing the recognition of revenue, the Company also evaluates whether two or more contracts should be combined and accounted for as one contract and if the combined or single contract should be accounted for as multiple performance obligations which could change the amount of revenue and profit (loss) recorded in a period. Contracts are often modified through change orders to account for changes in specifications or design, manner of performance, equipment, materials, scope of work, and/or the period of completion of the project. Although the Company evaluates each change order to determine whether such modification creates a separate performance obligation, the majority of change orders are for goods or services that are not distinct within the context of the original contract and, therefore, not treated as separate performance obligations but rather as a modification of the existing contract and performance obligation. We account for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated products. Accordingly, we record amounts billed for shipping and handling costs as a component of revenue and classify such costs as a component of cost of revenue. Contract Estimates Accounting for contracts utilizing the cost-to-cost measure of progress is based on various assumptions to project the outcome of future events that can exceed a year. These assumptions include the cost and availability of materials. The Company reviews and updates its contract-related estimates on an ongoing basis and recognizes adjustments for any project specific facts and circumstances that could impact the measurement of the extent of progress, such as the total costs to complete the contracts, under the cumulative catch-up method. Under this method, the impact of the adjustment on profit recorded to date is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance is recognized using the adjusted estimate. At contract inception, any variable consideration such as liquidated damages are estimated based on probability of occurrence and then re-evaluated for probability at the end of the quarterly period. Contract Balances The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled accounts receivable for goods delivered but not invoiced, and deferred revenue (contract liabilities) on the consolidated balance sheets. The majority of the Company’s contract amounts are billed as work progresses in accordance with agreed-upon contractual terms, which generally coincide with the shipment of one or more phases of the project. Billing sometimes occurs subsequent to revenue recognition, resulting in unbilled accounts receivable. The changes in unbilled accounts receivable and the corresponding amounts recorded in revenue relate to fluctuations in the timing and volume of billings for the Company’s revenue recognized over-time.
Warranty Obligations	Warranty Obligations The Company offers a multi-year assurance type warranty for its products against manufacturer defects and does not contain service elements. For these assurance type warranties, a provision for estimated future costs related to warranty expense is recorded when they are probable and reasonably estimable, which is typically when products are delivered. This provision is based on historical information on the nature, frequency and average cost of claims for each product line. When little or no experience exists for an immature product line, the estimate is based on comparable product lines. These estimates are re-evaluated on an ongoing basis using best-available information and revisions to estimates are made as necessary. Claims estimated to be payable in the following year are classified as current liabilities and those payable beyond one year are classified as long-term liabilities.
Income Taxes	Income Taxes The Company provides for income taxes based on the provisions of ASC Topic 740 Income Taxes (“ASC 740”), which, among other things, requires that recognition of deferred income taxes be measured by the provisions of enacted tax rates in effect at the date of the consolidated financial statements. A valuation allowance is provided to reduce deferred income tax assets if it is more likely than not that all, or some portion, of such deferred tax assets will not be recognized. Provision for estimated income taxes is based upon elements of income and expense reported in the consolidated statements of operations. The Company also files certain corporate state income tax returns. Generally, the Company is subject to examination by U.S. federal, state and non-U.S. income tax authorities. The current provision for income taxes represents actual or estimated amounts payable on tax return filings each year. Deferred tax assets and liabilities are recorded for the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and amounts reported in the accompanying consolidated balance sheets, and for operating loss and tax credit carryforwards. The change in deferred tax assets and liabilities for the period measures the deferred tax provision or benefit for the period. Effects of changes in enacted tax laws on deferred tax assets and liabilities are reflected as adjustments to the tax provision or benefit in the period of enactment. Adjustments for penalties and interest, if any, are also reflected in the current year tax provision or benefit. The Company determines whether uncertain tax positions are more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits within interest expense and other expenses, respectively, in the consolidated statements of operations. No material interest or penalties were incurred in 2022.
Equity-Based Compensation	Equity-Based CompensationThe Company recognizes equity-based compensation expense based on the equity award’s grant date fair value. The determination of the fair value of equity awards issued to employees of the Company is based upon the underlying share price and a number of assumptions, including volatility, performance period, risk-free interest rate and expected dividends. The Company values equity awards with a market condition using a Monte Carlo simulation model. The Company accounts for forfeitures as they occur. The grant date fair value of each unit is amortized on a straight-line basis over the requisite service period.
Temporary Equity	Temporary Equity Equity instruments that are redeemable for cash or other assets are classified as temporary equity if the instrument is redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, which is subsequently adjusted at each balance sheet date if the instrument is currently redeemable, or probable of becoming redeemable. The Series A Redeemable Perpetual Preferred Stock of the Company, par value $0.001 per share (the “Series A Shares”) issued in connection with the Securities Purchase Agreement as described in Note 11 – Redeemable Perpetual Preferred Stock are classified as temporary equity in the accompanying consolidated financial statements. The Company elected the accreted redemption value method under which it accretes changes in redemption value over the period from the date of issuance of the Series A Shares to the earliest costless redemption date (the fifth anniversary) using the effective interest method. Such adjustments are included in preferred undeclared dividends and accretion on Series A Shares on the Company’s consolidated statements of changes in redeemable perpetual preferred stock and stockholders’ equity (deficit) and treated similarly to a dividend on preferred stock in accordance with U.S. GAAP.
Earnings per Share	Earnings per ShareBasic earnings per share (“EPS”), is computed by dividing net income available to common shareholders by the weighted average shares outstanding during the period. Diluted EPS takes into account the potential dilution that could occur if securities or other contracts to issue shares, such as stock options, unvested restricted stock, or convertible debt, were exercised and converted into shares. The convertible debt is not currently convertible. Diluted EPS is computed by dividing net income available to common shareholders by the weighted average shares outstanding during the period, increased by the number of additional shares that would have been outstanding if the potential shares had been issued and were dilutive.
Credit Concentration	Credit Concentration Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and accounts receivable. The Company has no significant off balance sheet concentrations of credit risk. The Company maintains its cash with financial institutions that are believed to be of high credit quality and has not experienced any material losses relating to cash balances.
Fair Value	Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company follows a fair value hierarchy which requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs may be used to measure fair value, as follows: •Level 1 - Quoted prices in active markets for identical assets or liabilities. •Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. •Level 3 - Unobservable inputs that are supported by little or no market activity that are significant to the fair value of the assets or liabilities. The fair values of the Company’s cash, accounts receivable, and accounts payable approximate their carrying values due to their short maturities. The carrying value of the Company’s notes payable, capped call, and related party loans approximates their fair values, as they are based on current market rates at which the Company could borrow funds with similar terms. The Company follows the provisions of ASC 820 Fair Value Measurement for nonfinancial assets and liabilities measured at fair value on a non-recurring basis. As it relates to the Company, this applies to certain nonfinancial assets and liabilities acquired in business combinations and measurement of goodwill impairment and non-amortizable intangibles and is thereby measured at fair value, which was determined by the Company with the assistance of third-party valuations.

Acquisition of STI (Tables)

12 Months Ended

Dec. 31, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of business consideration paid to acquire

The consideration paid to acquire STI consisted of the following (in thousands):


Cash consideration for STI	$	409,647
Cash consideration for transaction expenses of STI	896
Total cash consideration	410,543
Non-cash equity consideration	200,224
Total consideration transferred	610,767
Total purchase price consideration	$	610,767

Schedule of business acquisitions, by acquisition

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the Acquisition Date (in thousands):


Fair Value of Net Assets Acquired and Liabilities Assumed:	Acquisition Date		Measurement Adjustment		Remeasured Acquisition Date
Cash and cash equivalents	$	36,725	$	—	$	36,725
Accounts receivable	110,789		—		110,789
Inventories	47,517		—		47,517
Prepaid expenses and other	23,399		—		23,399
Property, plant and equipment	4,434		—		4,434
Other intangible assets	304,431		—		304,431
Other assets	325		2,655		2,980
Total assets acquired	$	527,620	$	2,655	$	530,275

Accounts payable	65,761		—		65,761
Deferred revenue	20,345		—		20,345
Short-term debt	44,338		—		44,338
Other liabilities	10,115		2,655		12,770
Income tax payable	7,576		—		7,576
Deferred tax liability	95,510		—		95,510
Other long-term liabilities	4,524		—		4,524
Long-term debt	12,053		—		12,053
Total liabilities assumed	$	260,222	$	2,655	$	262,877

Fair value of net assets acquired	267,398				267,398
Allocation to goodwill	$	343,369			$	343,369

Schedule of purchase price allocation

The purchase price allocation includes $304.4 million of acquired identifiable intangible assets.


(in thousands, except useful lives)	Estimated Fair Value		Estimated Weighted Average Useful Life in Years
Backlog	$	50,000	1
Customer relationships	228,408		10
Trade name	26,023		20
Total	$	304,431

Schedule of business acquisition, pro forma information

The unaudited pro forma financial information does not reflect any adjustments for anticipated expense savings resulting from the STI Acquisition and is not necessarily indicative of the operating results that would have actually occurred had the STI Acquisition been consummated on January 1, 2021, (in thousands):


	Year Ended December 31,
	2022		2021
Revenue	$	1,645,962	$	1,118,903
Net income (loss)	$	36,285	$	(74,215)

Accounts Receivable (Tables)

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Schedule of account receivable

Accounts receivable consists of the following (in thousands):


	December 31,
	2022		2021
Accounts receivable	$	423,071	$	236,149
Less: allowance for credit losses	(1,888)		(140)
Accounts receivable, net	$	421,183	$	236,009

Schedule of allowance for credit loss

The following is the activity of the reserve for credit losses on accounts receivable which includes trade accounts receivable and unbilled accounts receivable (in thousands):


	December 31,
	2022		2021
Beginning balance	$	(140)	$	(663)
Provision for credit losses	(2,599)		303
Collected	731		130
Written-off	120		90
Ending balance	$	(1,888)	$	(140)

Inventories (Tables)

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Schedule of current inventory

Inventories consist of the following (in thousands):


	December 31,
	2022		2021
Raw materials	$	72,241	$	85,470
Finished goods	169,192		127,598
Reserve for excess or obsolete inventory	(8,274)		(7,415)
Total	$	233,159	$	205,653

Schedule of inventory reserve

The following table presents the change in the inventory reserve balances (in thousands):


	December 31,
	2022		2021
Beginning balance	$	(7,415)	$	(6,425)
Increases	(4,044)		(1,766)
Write-offs	3,185		776
Ending balance	$	(8,274)	$	(7,415)

Property, Plant, and Equipment (Tables)

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Summary of property, plant and equipment

Property, plant and equipment consisted of the following (in thousands, except for useful lives):


		December 31,
	Estimated Useful Life (Years)	2022		2021
Land	N/A	$	1,583	$	1,340
Buildings and land improvements	15-39	7,411		2,451
Manufacturing equipment	7	18,983		13,924
Furniture, fixtures and equipment	5-7	3,583		476
Vehicles	5	585		161
Hardware and software	3-5	3,706		1,683
Assets in progress	N/A	5,142		1,880
Total		40,993		21,915
Less: accumulated depreciation		(17,819)		(11,223)
Property, plant and equipment, net		$	23,174	$	10,692

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill

The following table presents change in goodwill balances by reportable segment (in thousands):


	Array Legacy Operations		STI Operations		Total
Beginning balance as of December 31, 2021	$	69,727	$	—	$	69,727
Acquisition of STI	—		343,369		343,369
Foreign currency translation	—		3,088		3,088
Ending balance as of December 31, 2022	$	69,727	$	346,457	$	416,184

Schedule of finite-lived intangible assets

Other intangible assets consisted of the following (in thousands, except for useful lives):


		December 31,
	Estimated Useful Life (Years)	2022		2021
Amortizable:
Costs:
Developed technology	14	$	203,800	$	203,800
Customer relationship	10	321,935		89,500
Backlog	1	51,015		—
Trade name	20	25,682		—
Total amortizable intangibles		602,432		293,300
Accumulated amortization:
Developed technology		94,347		79,790
Customer relationship		81,268		49,057
Backlog		49,507		—
Trade name		1,246		—
Total accumulated amortization		226,368		128,847
Total amortizable intangibles, net		376,064		164,453

Non-amortizable costs:
Trade name		10,300		10,300
Total other intangible assets, net		$	386,364	$	174,753

Schedule of indefinite-lived intangible assets

Other intangible assets consisted of the following (in thousands, except for useful lives):


		December 31,
	Estimated Useful Life (Years)	2022		2021
Amortizable:
Costs:
Developed technology	14	$	203,800	$	203,800
Customer relationship	10	321,935		89,500
Backlog	1	51,015		—
Trade name	20	25,682		—
Total amortizable intangibles		602,432		293,300
Accumulated amortization:
Developed technology		94,347		79,790
Customer relationship		81,268		49,057
Backlog		49,507		—
Trade name		1,246		—
Total accumulated amortization		226,368		128,847
Total amortizable intangibles, net		376,064		164,453

Non-amortizable costs:
Trade name		10,300		10,300
Total other intangible assets, net		$	386,364	$	174,753

Schedule of future annual amortization expense of amortizable intangible assets

The following table presents estimated future annual amortization expense (in thousands):


	Amount
2023	$	49,733
2024	47,923
2025	47,923
2026	43,616
2027	38,973
Thereafter	147,896
	$	376,064

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of income (loss) before provision for income taxes

The components of the Company’s income (loss) before provision for income taxes are as follows (in thousands):


	Year Ended December 31,
	2022		2021		2020
U.S.	$	34,344	$	(61,332)	$	77,778
Foreign	(39,296)		211		—
Income (loss) before provision for income taxes	$	(4,952)	$	(61,121)	$	77,778

Schedule of components of income tax expense (benefit)

The provision for income taxes charged to operations consists of the following (in thousands):


	Year Ended December 31,
	2022		2021		2020
Current expense (benefit):
Federal	$	12,826	$	(8)	$	17,248
State	1,630		(668)		4,196
Foreign	7,725		60		—
	22,181		(616)		21,444
Deferred expense (benefit):
Federal	(6,160)		(9,085)		(2,799)
State	(960)		(1,017)		60
Foreign	(24,445)		—		—
	(31,565)		(10,102)		(2,739)
Total income tax expense (benefit)	$	(9,384)	$	(10,718)	$	18,705

Schedule of deferred tax assets and liabilities

Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands):


	December 31,
	2022		2021
Deferred tax assets:
Bad debts	$	234	$	32
Inventories	2,780		2,411
Accrued warranties	3,575		1,242
Accrued compensation	637		315
Net operating loss	1,014		1,944
Equity-based compensation	2,240		948
Lease liabilities	4,588		2,661
Premium on capped call	10,792		12,356
Interest expense carryforward	6,750		5,301
Capitalized research and development expenses	1,752		—
Other	2,435		275
Deferred tax assets	36,797		27,485
Valuation allowance	(1,449)		(222)
Deferred tax assets, net	35,348		27,263
Deferred tax liabilities:
Property, plant, and equipment	(1,592)		(1,083)
Intangible assets	(85,927)		(14,165)
ROU assets	(3,969)		(2,670)
Deferred tax liabilities	(91,488)		(17,918)
Deferred tax asset (liability), net	$	(56,140)	$	9,345

Schedule of effective income tax rate reconciliation

A reconciliation of income tax expense computed at the federal statutory rate of 21% to actual income tax expense at the Company’s effective rate is as follows (in thousands):


	Year Ended December 31,
	2022		2021		2020
Income tax rate reconciliation
Income tax expense (benefit) at U.S. statutory rate	$	(1,040)	$	(12,835)	$	16,333
State income taxes	530		(1,545)		3,375
Officer’s compensation	740		435		—
Equity-based compensation	712		1,542		852
Contingent consideration	(947)		567		5,553
Tax credits	(421)		(620)		(79)
Effect of CARES Act	—		—		(6,608)
Non-U.S. income taxed at different rate than U.S. statutory rate	(4,274)		—		—
Non-U.S. tax incentives	(4,183)		—		—
Foreign derived intangible income benefit	(1,668)		—		(1,201)
Transaction costs	1,628		950		—
Change in valuation allowance	(534)		14		—
Nondeductible expenses	10		69		437
Other	63		705		43
Total income tax expense (benefit)	$	(9,384)	$	(10,718)	$	18,705

Accrued Warranty Reserve (Tables)

12 Months Ended

Dec. 31, 2022

Guarantees and Product Warranties [Abstract]

Schedule of accrued warranty reserve

The following table presents changes in the accrued warranty reserve balances (in thousands):


	December 31,
	2022		2021
Beginning balance	$	3,192	$	3,049
Provision for warranties issued	5,289		1,064
Payments	(1,868)		(373)
Warranty expirations	(1,137)		(548)
Ending balance	$	5,476	$	3,192

Debt (Tables)

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Schedule of senior secured debt instruments

The senior secured credit facility consisted of the following (in thousands):


	December 31,
	2022		2021
Term loan facility	$	312,475	$	326,775
Revolving credit facility	—		—
	312,475		326,775
Unamortized discount and issuance costs	(19,135)		(23,282)
Senior secured credit facility, net of unamortized debt discount and issuance costs	293,340		303,493
Current portion of term loan facility	(4,300)		(4,300)
Senior secured credit facility, net of current portion and unamortized discount and issuance costs	$	289,040	$	299,193

Summary of convertible debt

Convertible debt consisted of the following (in thousands):


	December 31,
	2022		2021
1.00% Convertible Senior Notes	$	425,000	$	425,000
Unamortized discount and issuance costs	(11,248)		(13,137)
1.00% Convertible Senior Notes, net	$	413,752	$	411,863

Schedule of maturities of debt

Aggregate future debt maturities are as follows (in thousands):


	Amount
2023	$	38,691
2024	13,583
2025	8,257
2026	6,453
2027	297,442
Thereafter	425,000
	$	789,426

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Revenue (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue

The following table presents the Company’s disaggregated (in thousands):


	Year Ended December 31,
	2022		2021		2020
Over-time revenue	$	1,155,848	$	519,003	$	503,238
Point in time revenue	481,698		334,315		369,424
Total revenue	$	1,637,546	$	853,318	$	872,662


	December 31,
	2022		2021		2020
Unbilled receivables	$	101,513	$	111,224	$	18,073

Contract liabilities consisting of deferred revenue recorded on a contract-by-contract basis at the end of each reporting period were as follows (in thousands):


	December 31,
	2022		2021		2020
Deferred revenue	$	178,922	$	99,575	$	149,821

Earnings per Share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Schedule of earnings per share, basic and diluted

The following table sets forth the computation of basic and diluted income (loss) per share (in thousands, except per share amounts):


	Year Ended December 31,
	2022		2021		2020
Net income (loss)	$	4,432	$	(50,403)	$	59,073
Preferred dividends and accretion	(48,054)		(15,715)		—
Net income (loss) to common shareholders	(43,622)		(66,118)		59,073

Basic:
Weighted average common shares outstanding	149,819		129,984		121,467
Earnings (loss) per share	$	(0.29)	$	(0.51)	$	0.49

Diluted:
Weighted average common shares outstanding	149,819		129,984		121,467
Effect of Restricted Stock and Performance Awards	—		—		47
Weighted average dilutive shares	149,819		129,984		121,514
Income (loss) per share	$	(0.29)	$	(0.51)	$	0.49

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Summary of liability related to estimated contingent consideration

The following table summarizes the activity related to our estimated TRA obligation (in thousands):


	TRA Liability
Balance, December 31, 2020	19,691
IRS Settlement	2,696
Fair value adjustment	(7,810)
Balance, December 31, 2021	14,577
Fair value adjustment	(4,507)
Payments	(1,483)
Balance, December 31, 2022	$	8,587

Undiscounted future expected payments under the TRA

The undiscounted future expected payments under the TRA are as follows (in thousands):


	Amount
2023	$	1,806
2024	1,762
2025	1,615
2026	1,425
2027	1,232
Thereafter	2,516
	$	10,356

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of carrying values and estimated fair values of debt instruments

The carrying values and the estimated fair values of debt financial instruments were as follows (in thousands):


	2022				2021
	Carrying Value		Fair Value		Carrying Value		Fair Value
Convertible Notes	$	413,752	$	430,236	$	411,863	$	410,771

Equity Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Disclosure of share-based compensation arrangements by share-based payment award

RSU activity under the 2020 Plan was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value
Outstanding non-vested, December 31, 2019	—	$	—
Shares granted	500,006	$	22.00
Shares vested	—	$	—
Shares forfeited	—	$	—
Outstanding non-vested, December 31, 2020	500,006	$	22.00
Shares granted	661,924	$	23.17
Shares vested	(157,473)	$	22.00
Shares forfeited	(74,048)	$	27.51
Outstanding non-vested, December 31, 2021	930,409	$	22.39
Shares granted	1,484,782	$	10.93
Shares vested	(458,849)	$	20.00
Shares forfeited	(255,518)	$	15.42
Outstanding non-vested, December 31, 2022	1,700,824	$	13.81

The following assumptions were used in the Monte Carlo simulation for computing the grant date fair value of the PSUs with a market condition for each grant year:


	2022		2021
Volatility	60	%	66	%
Risk-free interest rate	2.83	%	0.28	%
Dividend yield	—	%	—	%

PSU activity under the 2020 Plan was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value
PSUs
Outstanding non-vested, December 31, 2020	—	$	—
Shares granted	177,472	$	28.25
Shares vested	—	$	—
Shares forfeited	(29,785)	$	30.74
Outstanding non-vested, December 31, 2021	147,687	$	27.75
Shares granted	466,916	$	10.88
Shares vested	—	$	—
Shares forfeited	(150,210)	$	20.81
Outstanding non-vested, December 31, 2022	464,393	$	11.96

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Summary of right of use assets lease liabilities

The following table summarizes the Company’s ROU assets and lease liabilities (in thousands):


		December 31,
	Location on the Consolidated Balance Sheets	2022		2021
ROU Assets	Other assets	$	17,770	$	11,245

Lease liabilities, current portion	Other current liabilities	$	6,509	$	5,909
Lease liabilities, long-term portion	Other long-term liabilities	13,897		5,359
Total lease liabilities		$	20,406	$	11,268

Schedule of operating lease expenses

The components of lease cost related to the Company’s operating leases were as follows (in thousands):


	Year Ended December 31,
	2022		2021
Operating lease expense	$	7,701	$	6,635
Variable lease expense	1,089		106
Short-term lease expense	327		—
Total lease expense	$	9,117	$	6,741

Other information pertaining to operating leases consists of the following:


	Year Ended December 31,
	2022		2021
Weighted average remaining lease-term	4.2 years		3.8 years
Weighted average discount rate	5.4	%	5.0	%

Supplemental cash flow and other information related to operating leases are as follows (in thousands):


	Year Ended December 31,
	2022		2021
Operating cash flows from operating leases	$	5,380	$	6,644
Non cash investing activities:
Lease liabilities arising from obtaining right-of-use assets	$	12,558	$	17,363

Schedule of future minimum operating lease payments maturity

Future minimum operating lease payments as of December 31, 2022, are as follows (in thousands):


	Operating Leases
2023	$	6,966
2024	5,598
2025	4,399
2026	1,606
2027	1,453
Thereafter	2,908
Total lease payments	22,930
Less: Imputed lease interest	(2,524)
Total lease liabilities	$	20,406

Segment and Geographic Information (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Schedule of segment revenue and gross profit

Segment revenue and gross profit were as follows during the periods presented (in thousands):


	Year Ended December 31,
	2022						2021		2020
	Array Legacy Operations		STI Operations		Total		Array Legacy Operations		Array Legacy Operations
Revenue	$	1,267,883	$	369,663	$	1,637,546	$	853,318	$	872,662
Gross Profit	$	168,170	$	59,106	$	227,276	$	82,859	$	202,801

Revenue from external customers by geographic areas

The following table presents revenues by geographic region, based on the customers project location (in thousands):


	Year Ended December 31,
	2022		2021		2020
U.S.	$	1,286,064	$	826,639	$	805,070
Spain	129,292		7,281		181
Brazil	144,464		—		—
Australia	9,429		5,509		45,216
Rest of the world	68,297		13,889		22,195
Total revenue	$	1,637,546	$	853,318	$	872,662

The following table presents property, plant and equipment, net by geographic region at the end of the period (in thousands):


	December 31,
	2022		2021
U.S.	$	17,789	$	9,959
Spain	2,676		—
Brazil	1,676		—
Australia	1		—
Rest of the world	1,032		733
Total property, plant and equipment, net	$	23,174	$	10,692

Restatement (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Changes and Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

Consolidated Balance Sheets


	March 31, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	49,491	$	—	$	49,491
Accounts receivable, net	390,921		—		390,921
Inventories, net	299,010		—		299,010
Income tax receivables	31,079		—		31,079
Prepaid expenses and other	46,495		(825)		45,670
Total current assets	816,996		(825)		816,171
Property, plant and equipment, net	16,878		—		16,878
Goodwill	379,840		62,382		442,222
Other intangible assets, net	470,690		11,345		482,035
Deferred tax assets	—		—		—
Other assets	31,314		(4,770)		26,544
Total assets	$	1,715,718	$	68,132	$	1,783,850

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	187,466	$	—	$	187,466
Accounts payable - related party	478		—		478
Accrued expenses and other	54,837		—		54,837
Accrued warranty reserve	3,201		—		3,201
Income tax payable	6,452				6,452
Deferred revenue	121,624		—		121,624
Current portion of contingent consideration	—		—		—
Current portion of debt	48,180		—		48,180
Other current liabilities	10,886		—		10,886
Total current liabilities	433,124		—		433,124
Long-term liabilities
Deferred tax liability	92,931		6,329		99,260
Contingent consideration, net of current portion	9,363		—		9,363
Other long-term liabilities	7,102		—		7,102
Long-term warranty	4,743		—		4,743
Long-term debt, net of current portion	778,248		—		778,248
Total long-term liabilities	892,387		6,329		898,716
Total liabilities	1,325,511		6,329		1,331,840
Commitments and contingencies (Note 16)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 400,000 shares issued as of March 31, 2022; liquidation preference of $400.0 million as of March 31, 2022	281,792		—		281,792


Stockholders’ equity (deficit)
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of March 31, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,173,507 shares issued as of March 31, 2022	150		—		150
Additional paid-in capital	411,232		—		411,232
Accumulated deficit	(293,956)		(3,883)		(297,839)
Accumulated other comprehensive (loss) income	(9,011)		65,686		56,675
Total stockholders’ equity	108,415		61,803		170,218
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,715,718	$	68,132	$	1,783,850

Consolidated Balance Sheets


	June 30, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	51,046	$	—	$	51,046
Accounts receivable, net	452,836		—		452,836
Due from affiliates	—		—		—
Inventories, net	329,951		—		329,951
Income tax receivables	16,217		—		16,217
Prepaid expenses and other	52,831		(825)		52,006
Total current assets	902,881		(825)		902,056
Property, plant and equipment, net	17,802		—		17,802
Goodwill	378,706		38,988		417,694
Other intangible assets, net	421,862		14,687		436,549
Deferred tax assets	18,521		—		18,521
Other assets	30,573		(4,564)		26,009
Total assets	$	1,770,345	$	48,286	$	1,818,631

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	231,798	$	—	231,798
Accounts payable - related party	478		—		478
Accrued expenses and other	51,072		—		51,072
Accrued warranty reserve	2,911		—		2,911
Income tax payable	419				419
Deferred revenue	167,556		—		167,556
Current portion of debt	51,494		—		51,494
Other current liabilities	6,949		—		6,949
Total current liabilities	512,677		—		512,677
Long-term liabilities
Deferred tax liability	84,819		1,771		86,590
Contingent consideration, net of current portion	7,686		—		7,686
Other long-term liabilities	9,723		—		9,723
Long-term warranty	4,056		—		4,056
Long-term debt, net of current portion	793,557		—		793,557
Total long-term liabilities	899,841		1,771		901,612
Total liabilities	1,412,518		1,771		1,414,289
Commitments and contingencies (Note 16)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 412,606 shares issued as of June 30, 2022; liquidation preference of $413.0 million as of June 30, 2022.	293,974		—		293,974


Stockholders’ equity					—
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of June 30, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,279,160 shares issued as of June 30, 2022	150		—		150
Additional paid-in capital	401,614		—		401,614
Accumulated deficit	(299,182)		(3,681)		(302,863)
Accumulated other comprehensive (loss) income	(38,729)		50,196		11,467
Total stockholders’ equity	63,853		46,515		110,368
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,770,345	$	48,286	$	1,818,631

Consolidated Balance Sheets


	September 30, 2022
(in thousands, except per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
ASSETS
Current assets
Cash and cash equivalents	$	62,778	$	—	$	62,778
Accounts receivable, net	485,174		—		485,174
Inventories, net	269,775		—		269,775
Income tax receivables	12,765		—		12,765
Prepaid expenses and other	41,309		(825)		40,484
Total current assets	871,801		(825)		870,976
Property, plant and equipment, net	20,024		—		20,024
Goodwill	359,629		41,744		401,373
Other intangible assets, net	384,084		15,799		399,883
Deferred tax assets	18,785		—		18,785
Other assets	27,502		(4,357)		23,145
Total assets	$	1,681,825	$	52,361	$	1,734,186

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	199,358	$	—	199,358
Accounts payable - related party	478		—		478
Accrued expenses and other	91,102		—		91,102
Accrued warranty reserve	4,237		—		4,237
Income tax payable	10,587				10,587
Deferred revenue	154,692		—		154,692
Current portion of contingent consideration	—		—		—
Current portion of debt	47,686		—		47,686
Other current liabilities	4,981		—		4,981
Total current liabilities	513,121		—		513,121
Long-term liabilities
Deferred tax liability	74,139		2,725		76,864
Contingent consideration, net of current portion	7,113		—		7,113
Other long-term liabilities	9,113		—		9,113
Long-term warranty	3,852		—		3,852
Long-term debt, net of current portion	725,109		—		725,109
Total long-term liabilities	819,326		2,725		822,051
Total liabilities	1,332,447		2,725		1,335,172
Commitments and contingencies (Note 16)


Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 400,000 shares issued as of September 30, 2022; liquidation preference of $400.0 million as of September 30, 2022	287,561		—		287,561
Stockholders’ equity					—
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of September 30, 2022	—		—		—
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,334,261 shares issued as of September 30, 2022	150		—		150
Additional paid-in capital	392,862		—		392,862
Accumulated deficit	(258,360)		(3,859)		(262,219)
Accumulated other comprehensive (loss) income	(72,835)		53,495		(19,340)
Total stockholders’ equity	61,817		49,636		111,453
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$	1,681,825	$	52,361	$	1,734,186

Consolidated Statements of Operations


	Three Months Ended March 31, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	300,586	$	—	$	300,586
Cost of revenue	273,999		—		273,999
Gross profit	26,587		—		26,587

Operating expenses
General and administrative	39,827		5,598		45,425
Contingent consideration	(3,731)		—		(3,731)
Depreciation and amortization	22,652		585		23,237
Total operating expenses	58,748		6,183		64,931

Income (loss) from operations	(32,161)		(6,183)		(38,344)

Other expense
Other income (expense), net	743		—		743
Foreign currency gain	3,863		—		3,863
Interest expense	(6,942)		—		(6,942)
Total other expense	(2,336)		—		(2,336)
Income (loss) before income tax expense (benefit)	(34,497)		(6,183)		(40,680)
Income tax expense (benefit)	(12,443)		(2,300)		(14,743)
Net income (loss)	(22,054)		(3,883)		(25,937)
Preferred dividends and accretion	11,606		—		11,606
Net income (loss) to common shareholders	$	(33,660)	$	(3,883)	$	(37,543)

Earnings (loss) per share
Basic	$	(0.23)	$	(0.03)	$	(0.25)
Diluted	$	(0.23)	$	(0.03)	$	(0.25)
Weighted average number of shares
Basic	148,288		—		148,288
Diluted	148,288		—		148,288

Consolidated Statements of Operations


	Three Months Ended June 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	419,865	$	—	$	419,865
Cost of revenue	379,919		—		379,919
Gross profit	39,946		—		39,946

Operating expenses
General and administrative	29,143		(207)		28,936
Contingent consideration	(1,678)		—		(1,678)
Depreciation and amortization	24,389		1,631		26,020
Total operating expenses	51,854		1,424		53,278

Income (loss) from operations	(11,908)		(1,424)		(13,332)

Other expense
Other income (expense), net	(371)		—		(371)
Foreign currency gain (loss)	(1,736)		—		(1,736)
Interest expense	(8,021)		—		(8,021)
Total other expense	(10,128)		—		(10,128)
Loss before income tax benefit	(22,036)		(1,424)		(23,460)
Income tax benefit	(16,810)		(1,626)		(18,436)
Net loss	(5,226)		202		(5,024)
Preferred dividends and accretion	12,182		—		12,182
Net loss to common shareholders	$	(17,408)	$	202	$	(17,206)

Loss per common share
Basic	$	(0.12)	$	—	$	(0.11)
Diluted	$	(0.12)	$	—	$	(0.11)
Weighted average number of common shares
Basic	150,203		—		150,203
Diluted	150,203		—		150,203

Consolidated Statements of Operations


	Three Months Ended September 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	515,024	$	—	$	515,024
Cost of revenue	434,801		—		434,801
Gross profit	80,223		—		80,223

Operating expenses
General and administrative	38,911		(208)		38,703
Contingent consideration	(572)		—		(572)
Depreciation and amortization	23,364		1,534		24,898
Total operating expenses	61,703		1,326		63,029

Income (loss) from operations	18,520		(1,326)		17,194

Other income (expense)
Other expense, net	(399)		—		(399)
Legal settlement	42,750		—		42,750
Foreign currency gain (loss)	(159)		—		(159)
Interest expense	(8,746)		—		(8,746)
Total other income (expense)	33,446		—		33,446
Income (loss) before income tax (benefit) expense	51,966		(1,326)		50,640
Income tax (benefit) expense	11,144		(1,148)		9,996
Net income (loss)	40,822		(178)		40,644
Preferred dividends and accretion	12,257		—		12,257
Net income (loss) to common shareholders	$	28,565	$	(178)	$	28,387

Income (loss) per common share
Basic	$	0.19	$	—	$	0.19
Diluted	$	0.19	$	—	$	0.19
Weighted average number of common shares
Basic	150,322		—		150,322
Diluted	151,382		—		151,382

Consolidated Statements of Operations


	Six Months Ended June 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Revenue	$	720,451	$	—	$	720,451
Cost of revenue	653,918		—		653,918
Gross profit	66,533		—		66,533

Operating expenses
General and administrative	68,970		5,391		74,361
Contingent consideration	(5,409)		—		(5,409)
Depreciation and amortization	47,041		2,216		49,257
Total operating expenses	110,602		7,607		118,209

Income (loss) from operations	(44,069)		(7,607)		(51,676)

Other expense
Other income (expense), net	372		—		372
Foreign currency gain (loss)	2,127		—		2,127
Interest expense	(14,963)		—		(14,963)
Total other expense	(12,464)		—		(12,464)
Loss before income tax benefit	(56,533)		(7,607)		(64,140)
Income tax benefit	(29,253)		(3,926)		(33,179)
Net loss	(27,280)		(3,681)		(30,961)
Preferred dividends and accretion	23,788		—		23,788
Net loss to common shareholders	$	(51,068)	$	(3,681)	$	(54,749)

Loss per common share
Basic	$	(0.34)	$	(0.02)	$	(0.37)
Diluted	$	(0.34)	$	(0.02)	$	(0.37)
Weighted average number of common shares
Basic	149,246		—		149,246
Diluted	149,246		—		149,246

Consolidated Statements of Operations


	Nine Months Ended September 30, 2022
(in thousands, expect per share and share amounts) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Revenue	$	1,235,475	$	—	$	1,235,475
Cost of revenue	1,088,719		—		1,088,719
Gross profit	146,756		—		146,756

Operating expenses
General and administrative	107,881		5,183		113,064
Contingent consideration	(5,981)		—		(5,981)
Depreciation and amortization	70,405		3,750		74,155
Total operating expenses	172,305		8,933		181,238

Income (loss) from operations	(25,549)		(8,933)		(34,482)

Other income (expense)
Other expense, net	(27)		—		(27)
Legal settlement	42,750		—		42,750
Foreign currency gain (loss)	1,968		—		1,968
Interest expense	(23,709)		—		(23,709)
Total other income (expense)	20,982		—		20,982
Income (loss) before income tax (benefit) expense	(4,567)		(8,933)		(13,500)
Income tax (benefit) expense	(18,109)		(5,074)		(23,183)
Net income (loss)	13,542		(3,859)		9,683
Preferred dividends and accretion	36,045		—		36,045
Net income (loss) to common shareholders	$	(22,503)	$	(3,859)	$	(26,362)

Income (loss) per common share
Basic	$	(0.15)	$	(0.03)	$	(0.18)
Diluted	$	(0.15)	$	(0.03)	$	(0.18)
Weighted average number of common shares
Basic	149,604		—		149,604
Diluted	149,604		—		149,604

Consolidated Statements of Comprehensive Income (Loss)


	Three Months Ended March 31, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net loss	$	(22,054)	$	(3,883)	$	(25,937)
Change in foreign currency translation adjustments	(9,011)		65,686		56,675
Comprehensive income (loss)	$	(31,065)	$	61,803	$	30,738

Consolidated Statements of Comprehensive Loss


	Three Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	(5,226)	$	202	$	(5,024)
Change in foreign currency translation adjustments	(29,718)		(15,490)		(45,208)
Comprehensive loss	$	(34,944)	$	(15,288)	$	(50,232)

Consolidated Statements of Comprehensive Income


	Three Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	40,822	$	(178)	$	40,644
Change in foreign currency translation adjustments	(34,106)		3,299		(30,807)
Comprehensive income	$	6,716	$	3,121	$	9,837

Consolidated Statements of Comprehensive Income (Loss)


	Six Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net loss	$	(27,280)	$	(3,681)	$	(30,961)
Change in foreign currency translation adjustments	(38,729)		50,196		11,467
Comprehensive income (loss)	$	(66,009)	$	46,515	$	(19,494)

Consolidated Statements of Comprehensive Income (Loss)


	Nine Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustment		As Restated
Net income (loss)	$	13,542	$	(3,859)	$	9,683
Change in foreign currency translation adjustments	(72,835)		53,495		(19,340)
Comprehensive income (loss)	$	(59,293)	$	49,636	$	(9,657)

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Three Months Ended March 31, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		4,413		—		—		4,413
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,147	15		215,863		—		—		215,878

Preferred cumulative dividends plus accretion	—	11,606		—	—		—	—		(11,606)		—		—		(11,606)
Net loss	—	—		—	—		—	—		—		(22,054)		—		(22,054)
Other comprehensive loss	—	—		—	—		—	—		—		—		(9,011)		(9,011)
Balance, March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(293,956)	$	(9,011)	$	108,415

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,883)		—		(3,883)
Other comprehensive income	—	—		—	—		—	—		—		—		65,686		65,686
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,883)	$	65,686	$	61,803

As Restated


Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		4,413		—		—		4,413
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,147	15		215,863		—		—		215,878

Preferred cumulative dividends plus accretion	—	11,606		—	—		—	—		(11,606)		—		—		(11,606)
Net loss	—	—		—	—		—	—		—		(25,937)		—		(25,937)
Other comprehensive income	—	—		—	—		—	—		—		—		56,675		56,675
Balance, March 31, 2022 - As Restated	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(297,839)	$	56,675	$	170,218

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Three Months Ended June 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(293,956)	$	(9,011)	$	108,415
Equity-based compensation	—	—		—	—		105	—		2,944		—		—		2,944
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(380)		—		—		(380)
Preferred cumulative dividends plus accretion	13	12,182		—	—		—	—		(12,182)		—		—		(12,182)
Net loss	—	—		—	—		—	—		—		(5,226)		—		(5,226)
Other comprehensive loss	—	—		—	—		—	—		—		—		(29,718)		(29,718)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853

Adjustments
Balance at March 31, 2022	—	$	—	—	$	—	—	$	—	$	—	$	(3,883)	$	65,686	$	61,803
Net income	—	—		—	—		—	—		—		202		—		202
Other comprehensive loss	—	—		—	—		—	—		—		—		(15,490)		(15,490)
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515

As Restated
Balance at March 31, 2022	400	$	281,792	—	$	—	150,174	$	150	$	411,232	$	(297,839)	$	56,675	$	170,218


Equity-based compensation	—	—		—	—		105	—		2,944		—		—		2,944
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(380)		—		—		(380)
Preferred cumulative dividends plus accretion	13	12,182		—	—		—	—		(12,182)		—		—		(12,182)
Net loss	—	—		—	—		—	—		—		(5,024)		—		(5,024)
Other comprehensive loss	—	—		—	—		—	—		—		—		(45,208)		(45,208)
Balance, June 30, 2022 - As Restated	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368

Statement of Changes in Shareholders' Equity/(Deficit) - Three Months Ended September 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853
Equity-based compensation	—	—		—	—		55	—		4,097		—		—		4,097
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(592)		—		—		(592)
Preferred cumulative dividends plus accretion	—	12,257		—	—		—	—		(12,257)		—		—		(12,257)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		40,822		—		40,822
Other comprehensive loss	—	—		—	—		—	—		—		—		(34,106)		(34,106)
Balance at September 30, 2022	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(258,360)	$	(72,835)	$	61,817

Adjustments
Balance at June 30, 2022	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515
Net loss	—	—		—	—		—	—		—		(178)		—		(178)
Other comprehensive loss	—	—		—	—		—	—		—		—		3,299		3,299
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,859)	$	53,495	$	49,636

As Restated
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368


Equity-based compensation	—	—		—	—		55	—		4,097		—		—		4,097
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	—	—		—	—		—	—		(592)		—		—		(592)
Preferred cumulative dividends plus accretion	—	12,257		—	—		—	—		(12,257)		—		—		(12,257)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		40,644		—		40,644
Other comprehensive loss	—	—		—	—		—	—		—		—		(30,807)		(30,807)
Balance, September 30, 2022 - As Restated	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(262,219)	$	(19,340)	$	111,453

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Six Months Ended June 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		—	—		7,357		—		—		7,357
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,252	15		215,483		—		—		215,498

Preferred cumulative dividends plus accretion	13	23,788		—	—		—	—		(23,788)		—		—		(23,788)
Net loss	—	—		—	—		—	—		—		(27,280)		—		(27,280)
Other comprehensive loss	—	—		—	—		—	—		—		—		(38,729)		(38,729)
Balance at June 30, 2022	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(299,182)	$	(38,729)	$	63,853

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,681)		—		(3,681)
Other comprehensive income	—	—		—	—		—	—		—		—		50,196		50,196
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,681)	$	50,196	$	46,515

As Restated
Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)


Equity-based compensation	—	—		—	—		—	—		7,357		—		—		7,357
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,252	15		215,483		—		—		215,498
Issuance of common stock, net	—	—		—	—		—	—		—		—		—		—
Preferred cumulative dividends plus accretion	13	23,788		—	—		—	—		(23,788)		—		—		(23,788)
Net loss	—	—		—	—		—	—		—		(30,961)		—		(30,961)
Other comprehensive income	—	—		—	—		—	—		—		—		11,467		11,467
Balance, June 30, 2022 - As Restated	413	$	293,974	—	$	—	150,279	$	150	$	401,614	$	(302,863)	$	11,467	$	110,368

Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - Nine Months Ended September 30, 2022


	Temporary Equity			Permanent Equity
(in thousands, share amounts) (unaudited)	Series A Redeemable Perpetual Preferred Stock			Preferred Stock			Common Stock
As Previously Reported	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity (Deficit)
Balance at December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		161	—		11,454		—		—		11,454
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,146	15		214,891		—		—		214,906

Preferred cumulative dividends plus accretion	13	36,045		—	—		—	—		(36,045)		—		—		(36,045)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		13,542		—		13,542
Other comprehensive loss	—	—		—	—		—	—		—		—		(72,835)		(72,835)
Balance at September 30, 2022	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(258,360)	$	(72,835)	$	61,817

Adjustments
Balance, December 31, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—	$	—
Net loss	—	—		—	—		—	—		—		(3,859)		—		(3,859)
Other comprehensive income	—	—		—	—		—	—		—		—		53,495		53,495
Total Adjustments	—	$	—	—	$	—	—	$	—	$	—	$	(3,859)	$	53,495	$	49,636

As Restated


Balance, December 31, 2021	350	$	237,462	—	$	—	135,027	$	135	$	202,562	$	(271,902)	$	—	$	(69,205)
Equity-based compensation	—	—		—	—		161	—		11,454		—		—		11,454
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	50	32,724		—	—		15,146	15		214,891		—		—		214,906
Issuance of common stock, net	—	—		—	—		—	—		—		—		—		—
Preferred cumulative dividends plus accretion	13	36,045		—	—		—	—		(36,045)		—		—		(36,045)
Dividends paid	(13)	(18,670)		—	—		—	—		—		—		—		—
Net income	—	—		—	—		—	—		—		9,683		—		9,683
Other comprehensive loss	—	—		—	—		—	—		—		—		(19,340)		(19,340)
Balance, September 30, 2022 - As Restated	400	$	287,561	—	$	—	150,334	$	150	$	392,862	$	(262,219)	$	(19,340)	$	111,453

Consolidated Statements of Cash Flows


	Three Months Ended March 31, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net income (loss)	$	(22,054)	$	(3,883)	$	(25,937)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Provision for (recovery of) bad debts	145		—		145
Deferred tax expense (benefit)	6,649		(2,300)		4,349
Depreciation and amortization	23,023		585		23,608
Amortization of debt discount and issuance costs	1,710		—		1,710
Equity-based compensation	4,508		—		4,508
Contingent consideration	(3,731)		—		(3,731)
Warranty provision	594		—		594
Provision for inventory obsolescence	409		—		409
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(44,268)		—		(44,268)
Inventories	(46,250)		—		(46,250)
Income tax receivables	(21,924)		—		(21,924)
Prepaid expenses and other	5,960		5,598		11,558
Accounts payable	59,551		—		59,551
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	7,027		—		7,027
Income tax payable	(8,760)		—		(8,760)
Lease liabilities	6,085		—		6,085
Deferred revenue	(18,639)		—		(18,639)
Net cash used in operating activities	(50,097)		—		(50,097)
Cash flows from investing activities
Purchase of property, plant and equipment	(2,357)		—		(2,357)
Acquisition of STI, net of cash acquired	(373,816)		—		(373,816)
Investment in equity security	—		—		—
Net cash used in investing activities	(376,173)		—		(376,173)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(175)		—		(175)
Common stock issuance costs	(450)		—		(450)
Proceeds from revolving credit facility	52,000		—		52,000
Payments on revolving credit facility	—		—		—
Proceeds from issuance of other debt	6,229		—		6,229


Principal payments on debt	(4,368)		—		(4,368)
Contingent consideration	(1,483)		—		(1,483)
Debt issuance costs	—		—		—
Net cash provided by (used in) financing activities	100,736		—		100,736
Effect of exchange rate changes on cash and cash equivalent balances	7,355		—		7,355
Net change in cash and cash equivalents	(318,179)		—		(318,179)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	49,491	$	—	$	49,491

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Consolidated Statements of Cash Flows


	Six Months Ended June 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net loss	$	(27,280)	$	(3,681)	$	(30,961)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for (recovery of) bad debts	510		—		510
Deferred tax benefit	(19,984)		(3,926)		(23,910)
Depreciation and amortization	47,579		2,216		49,795
Amortization of debt discount and issuance costs	3,286		—		3,286
Equity-based compensation	7,472		—		7,472
Contingent consideration	(5,409)		—		(5,409)
Warranty provision	1,215		—		1,215
Provision for inventory obsolescence	409		—		409
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(106,548)		—		(106,548)
Inventories	(77,191)		—		(77,191)
Income tax receivables	(7,062)		—		(7,062)
Prepaid expenses and other	(376)		5,391		5,015
Accounts payable	74,645		—		74,645
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	3,356		—		3,356
Income tax payable	(7,217)		—		(7,217)
Lease liabilities	4,700		—		4,700


Deferred revenue	47,263		—		47,263
Net cash used in operating activities	(60,764)		—		(60,764)
Cash flows from investing activities
Purchase of property, plant and equipment	(3,895)		—		(3,895)
Acquisition of STI, net of cash acquired	(373,818)		—		(373,818)
Investment in equity security	—		—		—
Net cash used in investing activities	(377,713)		—		(377,713)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(575)		—		(575)
Common stock issuance costs	(450)		—		(450)
Payments on revolving credit facility	(33,000)		—		(33,000)
Proceeds from issuance of other debt	30,599		—		30,599
Proceeds from revolving credit facility	101,000		—		101,000
Principal payments on debt	(22,377)		—		(22,377)
Contingent consideration	(1,483)		—		(1,483)
Debt issuance costs	—		—		—
Net cash provided by financing activities	122,697		—		122,697
Effect of exchange rate changes on cash and cash equivalent balances	(844)		—		(844)
Net change in cash and cash equivalents	(316,624)		—		(316,624)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	51,046	$	—	$	51,046

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Consolidated Statements of Cash Flows


	Nine Months Ended September 30, 2022
(in thousands) (unaudited)	As Previously Reported		Restatement Adjustments		As Restated
Cash flows from operating activities
Net income (loss)	$	13,542	$	(3,859)	$	9,683
Adjustments to reconcile net income (loss) to net cash provided by, (used in) operating activities:
Provision for (recovery of) bad debts	660		—		660
Deferred tax benefit	(30,928)		(5,074)		(36,002)
Depreciation and amortization	71,207		3,750		74,957
Amortization of debt discount and issuance costs	5,003		—		5,003
Equity-based compensation	11,677		—		11,677


Contingent consideration	(5,981)		—		(5,981)
Warranty provision	4,341		—		4,341
Provision for inventory obsolescence	(2,333)		—		(2,333)
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(139,036)		—		(139,036)
Inventories	(14,273)		—		(14,273)
Income tax receivables	(3,610)		—		(3,610)
Prepaid expenses and other	11,146		5,183		16,329
Accounts payable	42,205		—		42,205
Accounts payable - related party	(132)		—		(132)
Accrued expenses and other	41,271		—		41,271
Warranty payments	(373)		—		(373)
Income tax payable	2,951		—		2,951
Lease liabilities	1,914		—		1,914
Deferred revenue	34,772		—		34,772
Net cash provided by, (used in) operating activities	44,023		—		44,023
Cash flows from investing activities
Purchase of property, plant and equipment	(6,690)		—		(6,690)
Acquisition of STI, net of cash acquired	(373,816)		—		(373,816)
Investment in equity security	—		—		—
Net cash used in investing activities	(380,506)		—		(380,506)
Cash flows from financing activities
Proceeds from Series A issuance	33,098		—		33,098
Proceeds from common stock issuance	15,885		—		15,885
Series A equity issuance costs	(1,167)		—		(1,167)
Common stock issuance costs	(450)		—		(450)
Dividends paid on Series A Preferred	(18,670)		—		(18,670)
Payments on revolving credit facility	(116,000)		—		(116,000)
Proceeds from issuance of other debt	39,219		—		39,219
Proceeds from revolving credit facility	116,000		—		116,000
Principal payments on debt	(33,286)		—		(33,286)
Contingent consideration	(1,483)		—		(1,483)
Net cash provided by financing activities	33,146		—		33,146
Effect of exchange rate changes on cash and cash equivalent balances	(1,555)		—		(1,555)
Net change in cash and cash equivalents	(304,892)		—		(304,892)
Cash and cash equivalents, beginning of period	367,670				367,670
Cash and cash equivalents, end of period	$	62,778	$	—	$	62,778

Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$	200,224	—		200,224

Organization and Business (Details)		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
Organization and Business (Details)	Oct. 14, 2020 shares	Sep. 30, 2022 shares	Jun. 30, 2022 shares	Mar. 31, 2022 shares	Jun. 30, 2022 shares	Sep. 30, 2022 shares	Dec. 31, 2022 shares	Dec. 31, 2021 shares	Dec. 31, 2020 shares
Business Acquisition, Contingent Consideration [Line Items]
Stock split conversion ratio	1.19994
Diluted (in shares)	119,994,467	151,382,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,514,000
Basic (in shares)	119,994,467	150,322,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,467,000
Member units
Business Acquisition, Contingent Consideration [Line Items]
Number of shares converted (in shares)	1,000
Common Stock
Business Acquisition, Contingent Consideration [Line Items]
Number of shares issued upon conversion (in shares)	100,000,000

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($) $ / shares	Aug. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares	Dec. 31, 2022 USD ($) option $ / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($)	Jan. 01, 2021
Class of Stock [Line Items]
Operating lease, right-of-use asset, statement of financial position					Other assets	Other assets	Other assets	Other assets
Operating lease, liability, current, statement of financial position					Other current liabilities, Other long-term liabilities		Other current liabilities, Other long-term liabilities	Other current liabilities, Other long-term liabilities
Lessee, operating lease, number of options to extend or terminate (or more) \| option					1
Impairment of long lived assets					$ 0	$ 0	$ 0
Balance of investment in equity securities						12,000,000
Impairment charge recognized					0	0	0
Amortization of debt discount and issuance costs	$ 1,710,000	$ 3,286,000		$ 5,003,000	$ 6,857,000	$ 15,036,000	$ 3,366,000
Write off of deferred debt issuance cost			$ 9,600,000
Temporary equity, par value (in dollars per share) \| $ / shares	$ 0.001	$ 0.001		$ 0.001	$ 0.001	$ 0.001
Largest Customer \| Customer Concentration Risk \| Trade Accounts Receivable
Class of Stock [Line Items]
Concentration risk percentage					7.90%	17.60%
Five Largest Customers \| Customer Concentration Risk \| Trade Accounts Receivable
Class of Stock [Line Items]
Concentration risk percentage					23.40%	44.60%
Two Customers \| Customer Concentration Risk \| Trade Accounts Receivable
Class of Stock [Line Items]
Concentration risk percentage							21.50%
Customer One \| Customer Concentration Risk \| Trade Accounts Receivable
Class of Stock [Line Items]
Concentration risk percentage					11.80%	12.60%
Customer Two \| Customer Concentration Risk \| Trade Accounts Receivable
Class of Stock [Line Items]
Concentration risk percentage					10.60%	10.20%
Series A Redeemable Perpetual Preferred Stock
Class of Stock [Line Items]
Temporary equity, par value (in dollars per share) \| $ / shares					$ 0.001

Acquisition of STI - Narrative (Details) - USD ($)		12 Months Ended
Acquisition of STI - Narrative (Details) - USD ($)	Jan. 11, 2022	Dec. 31, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Percentage, estimated royalty rate	1.25%
Percentage, weighted average cost of capital, discount rate	15.20%
Spain \| Customer relationship
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	15.00%
Spain \| Customer relationship for foreign sourced projects
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	14.00%
Spain \| Backlog
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	8.50%
Spain \| Backlog
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	7.50%
Brazil \| Customer relationship
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	16.50%
Brazil \| Backlog
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	9.50%
STI
Business Acquisition [Line Items]
Cash consideration for transaction expenses of STI	$ (896,000)	$ 5,600,000
Total cash consideration	$ 410,543,000
Business acquisition, equity interest issued or issuable, number of shares (in shares)	13,894,800
Stock consideration paid for acquisition of STI	$ 200,200,000
Total consideration transferred	$ 610,767,000
Percentage of share capital acquired	100.00%
Goodwill, expected tax deductible amount	$ 0
Acquired identifiable intangible assets	$ 304,431,000	$ 304,431,000	$ 304,431,000
Pro forma information, revenue of acquiree since acquisition date, actual			369,700,000
Pro forma information, net income of acquiree or loss since acquisition date, actual			$ (21,500,000)

Acquisition of STI - Schedule of Business Consideration Paid to Acquire (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Jan. 11, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Non-cash equity consideration		$ 200,224	$ 200,224	$ 200,224	$ 200,224	$ 0	$ 0
STI
Business Acquisition [Line Items]
Cash consideration for STI	$ 409,647
Cash consideration for transaction expenses of STI	896				$ (5,600)
Total cash consideration	410,543
Non-cash equity consideration	200,224
Total consideration transferred	$ 610,767

Acquisition of STI - Schedule of Business Acquisitions, by Acquisition (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jan. 11, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Allocation to goodwill	$ 416,184	$ 401,373	$ 417,694	$ 442,222		$ 69,727
STI
Business Acquisition [Line Items]
Cash and cash equivalents	36,725				$ 36,725
Accounts receivable	110,789				110,789
Inventories	47,517				47,517
Prepaid expenses and other	23,399				23,399
Property, plant and equipment	4,434				4,434
Other intangible assets	304,431				304,431
Other assets	2,980				325
Other assets, measurement adjustment	2,655
Total assets acquired	530,275				527,620
Total assets acquired, measurement adjustment	2,655
Accounts payable	65,761				65,761
Deferred revenue	20,345				20,345
Short-term debt	44,338				44,338
Other liabilities	12,770				10,115
Other liabilities, measurement adjustment	2,655
Income tax payable	7,576				7,576
Deferred tax liability	95,510				95,510
Other long-term liabilities	4,524				4,524
Long-term debt	12,053				12,053
Total liabilities assumed	262,877				260,222
Total liabilities assumed, measurement adjustment	2,655
Fair value of net assets acquired	267,398				267,398
Allocation to goodwill	$ 343,369				$ 343,369

Acquisition of STI - Schedule of Purchase Price Allocation (Details) - STI - USD ($) $ in Thousands	Jan. 11, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Acquired identifiable intangible assets	$ 304,431	$ 304,431
Trade name
Business Acquisition [Line Items]
Indefinite-lived intangible, estimated fair value	$ 26,023
Intangible assets, estimated weighted average useful life (in years)	20 years
Backlog
Business Acquisition [Line Items]
Finite-lived intangibles, estimated fair value	$ 50,000
Intangible assets, estimated weighted average useful life (in years)	1 year
Customer relationships
Business Acquisition [Line Items]
Finite-lived intangibles, estimated fair value	$ 228,408
Intangible assets, estimated weighted average useful life (in years)	10 years

Acquisition of STI - Business Acquisition, Pro Forma Information (Details) - STI - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Revenue	$ 1,645,962	$ 1,118,903
Net income (loss)	$ 36,285	$ (74,215)

Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Accounts receivable	$ 423,071				$ 236,149
Less: allowance for credit losses	(1,888)				(140)
Accounts receivable, net	421,183	$ 485,174	$ 452,836	$ 390,921	236,009
Amounts retained by project owners under contracts	$ 47,400				$ 13,500

Accounts Receivable - Activity of Credit Losses On Accounts Receivables (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ (140)	$ (663)
Provision for credit losses	(2,599)	303
Collected	731	130
Written-off	120	90
Ending balance	$ (1,888)	$ (140)

Inventories - Schedule of Current Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 72,241				$ 85,470
Finished goods	169,192				127,598
Reserve for excess or obsolete inventory	(8,274)				(7,415)	$ (6,425)
Inventories, net	$ 233,159	$ 269,775	$ 329,951	$ 299,010	$ 205,653

Inventories - Narrative (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Average cost inventory amount	$ 209,300,000
FIFO inventory amount	$ 23,800,000	$ 0

Inventories - Activity of Inventory Reserves (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Inventory Valuation Reserves [Roll Forward]
Beginning balance	$ (7,415)	$ (6,425)
Increases	(4,044)	(1,766)
Write-offs	3,185	776
Ending balance	$ (8,274)	$ (7,415)

Property, Plant, and Equipment - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 40,993				$ 21,915
Less: accumulated depreciation	(17,819)				(11,223)
Property, plant and equipment, net	23,174	$ 20,024	$ 17,802	$ 16,878	10,692
Land
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	1,583				1,340
Buildings and land improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 7,411				2,451
Buildings and land improvements \| Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	15 years
Buildings and land improvements \| Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	39 years
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	7 years
Property, plant, and equipment, gross	$ 18,983				13,924
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 3,583				476
Furniture, fixtures and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	5 years
Furniture, fixtures and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	7 years
Vehicles
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	5 years
Property, plant, and equipment, gross	$ 585				161
Hardware and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 3,706				1,683
Hardware and software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	3 years
Hardware and software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (Years)	5 years
Assets in progress
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 5,142				$ 1,880

Property, Plant, and Equipment - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 2.6	$ 2.4	$ 2.2
Depreciation allocated to cost of revenue	1.6	2.0	2.0
Depreciation included in depreciation and amortization	$ 1.0	$ 0.4	$ 0.2

Goodwill and Other Intangible Assets - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jan. 11, 2022 USD ($)
Goodwill [Line Items]
Goodwill	$ 416,184	$ 69,727		$ 401,373	$ 417,694	$ 442,222
Acquisition of STI	$ 343,369
Number of operating segments \| segment	2	1
Amortization expense related to intangible assets	$ 98,200	$ 23,500	$ 25,300
Array
Goodwill [Line Items]
Goodwill		69,700
Accumulated impairment		$ 51,900
STI
Goodwill [Line Items]
Goodwill	343,369						$ 343,369
Acquisition of STI	$ 343,400

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 69,727
Acquisition of STI	343,369
Foreign currency translation	3,088
Goodwill, ending balance	416,184
Array Legacy Operations
Goodwill [Roll Forward]
Goodwill, beginning balance	69,727
Acquisition of STI	0
Foreign currency translation	0
Goodwill, ending balance	69,727
STI Operations
Goodwill [Roll Forward]
Goodwill, beginning balance	0
Acquisition of STI	343,369
Foreign currency translation	3,088
Goodwill, ending balance	$ 346,457

- Definition

+ References + Details

Goodwill and Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 602,432				$ 293,300
Finite-lived intangible assets, accumulated amortization	226,368				128,847
Total amortizable intangibles, net	376,064				164,453
Other intangible assets, net	386,364	$ 399,883	$ 436,549	$ 482,035	174,753
Total other intangible assets, net	386,364	$ 399,883	$ 436,549	$ 482,035	174,753
Trade name
Finite-Lived Intangible Assets [Line Items]
Non-amortizable costs:	$ 10,300				10,300
Developed technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	14 years
Finite-lived intangible assets, gross	$ 203,800				203,800
Finite-lived intangible assets, accumulated amortization	$ 94,347				79,790
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	10 years
Finite-lived intangible assets, gross	$ 321,935				89,500
Finite-lived intangible assets, accumulated amortization	$ 81,268				49,057
Backlog
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	1 year
Finite-lived intangible assets, gross	$ 51,015				0
Finite-lived intangible assets, accumulated amortization	$ 49,507				0
Trade name
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, estimated useful lives (years)	20 years
Indefinite-lived intangible assets, gross	$ 25,682				0
Indefinite-lived intangible assets, accumulated amortization	$ 1,246				$ 0

Goodwill and Other Intangible Assets - Schedule of Future Annual Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 49,733
2024	47,923
2025	47,923
2026	43,616
2027	38,973
Thereafter	147,896
Total amortizable intangibles, net	$ 376,064	$ 164,453

Income Taxes - Schedule of Income (Loss) Before Provision for Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
U.S.						$ 34,344	$ (61,332)	$ 77,778
Foreign						(39,296)	211	0
Income (loss) before income tax benefit	$ 50,640	$ (23,460)	$ (40,680)	$ (64,140)	$ (13,500)	$ (4,952)	$ (61,121)	$ 77,778

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Income Taxes - Schedule of Income Tax Provision (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current expense (benefit):
Federal						$ 12,826	$ (8)	$ 17,248
State						1,630	(668)	4,196
Foreign						7,725	60	0
Current income tax provision						22,181	(616)	21,444
Deferred expense (benefit):
Federal						(6,160)	(9,085)	(2,799)
State						(960)	(1,017)	60
Foreign						(24,445)	0	0
Deferred income tax provision (benefit)			$ 4,349	$ (23,910)	$ (36,002)	(31,565)	(10,102)	(2,739)
Total income tax expense (benefit)	$ 9,996	$ (18,436)	$ (14,743)	$ (33,179)	$ (23,183)	$ (9,384)	$ (10,718)	$ 18,705

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred Tax Assets (Liabilities)
Bad debts	$ 234	$ 32
Inventories	2,780	2,411
Accrued warranties	3,575	1,242
Accrued compensation	637	315
Net operating loss	1,014	1,944
Equity-based compensation	2,240	948
Lease liabilities	4,588	2,661
Premium on capped call	10,792	12,356
Interest expense carryforward	6,750	5,301
Capitalized research and development expenses	1,752	0
Other	2,435	275
Deferred tax assets	36,797	27,485
Valuation allowance	(1,449)	(222)
Deferred tax assets, net	35,348	27,263
Property, plant, and equipment	(1,592)	(1,083)
Intangible assets	(85,927)	(14,165)
ROU assets	(3,969)	(2,670)
Deferred tax liabilities	(91,488)	(17,918)
Deferred tax liabilities, net	$ (56,140)
Deferred tax assets, net		$ 9,345

Income Taxes - Effective Income Tax Rate Reconciliation Amount (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense (benefit) at U.S. statutory rate						$ (1,040)	$ (12,835)	$ 16,333
State income taxes						530	(1,545)	3,375
Officer’s compensation						740	435	0
Equity-based compensation						712	1,542	852
Contingent consideration						(947)	567	5,553
Tax credits						(421)	(620)	(79)
Effect of CARES Act						0	0	(6,608)
Non-U.S. income taxed at different rate than U.S. statutory rate						(4,274)	0	0
Non-U.S. tax incentives						(4,183)	0	0
Foreign derived intangible income benefit						(1,668)	0	(1,201)
Transaction costs						1,628	950	0
Change in valuation allowance						(534)	14	0
Nondeductible expenses						10	69	437
Other						63	705	43
Total income tax expense (benefit)	$ 9,996	$ (18,436)	$ (14,743)	$ (33,179)	$ (23,183)	$ (9,384)	$ (10,718)	$ 18,705

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
Income Taxes - Narrative (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 11, 2022
Income Tax Examination [Line Items]
Non-U.S. tax incentives	$ (4,183,000)	$ 0	$ 0
Valuation allowance	1,449,000	222,000
Unrecognized tax benefits	0	0
STI
Income Tax Examination [Line Items]
Valuation allowance				$ 1,800,000
Domestic Tax Authority
Income Tax Examination [Line Items]
Operating loss carryforwards	4,800,000	5,100,000
State and Local Jurisdiction
Income Tax Examination [Line Items]
Operating loss carryforwards	$ 4,500,000	$ 9,700,000

Accrued Warranty Reserve (Details) - USD ($) $ in Thousands	12 Months Ended
Accrued Warranty Reserve (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 3,192	$ 3,049
Provision for warranties issued	5,289	1,064
Payments	(1,868)	(373)
Warranty expirations	(1,137)	(548)
Ending balance	$ 5,476	$ 3,192

Debt - Schedule of Senior Secured Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jan. 07, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt, balance	$ 789,426
Unamortized discount and issuance costs					$ (1,300)
Current portion of term loan facility	(38,691)	$ (47,686)	$ (51,494)	$ (48,180)		$ (4,300)
Senior secured credit facility, net of current portion and unamortized discount and issuance costs	720,352	$ 725,109	$ 793,557	$ 778,248		711,056
Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	312,475					326,775
Unamortized discount and issuance costs	(19,135)					(23,282)
Long-term portion, net of debt discount and issuance costs	293,340					303,493
Current portion of term loan facility	(4,300)					(4,300)
Term loan facility \| Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	312,475					326,775
Revolving credit facility \| Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	0					0
Senior secured credit facility, net of current portion and unamortized discount and issuance costs	$ 289,040					$ 299,193

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Debt - Senior Secured Credit Facility Narrative (Details) - USD ($)			12 Months Ended
	Feb. 23, 2021	Oct. 14, 2020	Dec. 31, 2022	Jan. 07, 2022	Dec. 31, 2021	Feb. 26, 2021
Debt Instrument [Line Items]
Long-term debt, balance			$ 789,426,000
Debt discount and issuance costs				$ 1,300,000
Term loan facility
Debt Instrument [Line Items]
Interest rate applicable margin			7.94%
Senior secured credit facility \| LIBOR \| Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Monthly basis spread on variable rate	0.50%	1.00%
Senior secured credit facility \| Base Rate \| Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Minimum annual variable rate	0.0325	0.0400
Term loan facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 575,000,000
Debt instrument term		7 years
Long-term debt, balance			$ 312,500,000		$ 326,800,000
Debt discount and issuance costs			19,100,000		23,300,000
Annual amortization rate		1.00%
Term loan facility \| LIBOR
Debt Instrument [Line Items]
Monthly basis spread on variable rate		1.00%
Term loan facility \| Base Rate
Debt Instrument [Line Items]
Minimum annual variable rate		0.0300
Minimum allowable variable rate		0.0150
Term loan facility \| Base Rate \| Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Minimum annual variable rate		0.0225
Term loan facility \| Fed Funds Effective Rate
Debt Instrument [Line Items]
Interest rate applicable margin		0.50%
Term loan facility \| Eurodollar
Debt Instrument [Line Items]
Minimum annual variable rate		0.0400
Minimum allowable variable rate		0.0100
Term loan facility \| Eurodollar \| Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Minimum annual variable rate		0.0325
Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 150,000,000
Debt instrument term		5 years
Long-term debt, balance			0		0
Available borrowing capacity			161,200,000		186,400,000
Prepayment premium		1.00%
Prepayment premium, period		12 months
Springing financial maintenance covenant		35.00%
Net leverage ratio		7.10
Revolving credit facility \| Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 150,000,000
Revolving credit facility \| Revolving Credit Facility, Second Amendment
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 200,000,000
Revolving credit facility \| LIBOR
Debt Instrument [Line Items]
Monthly basis spread on variable rate		1.00%
Revolving credit facility \| Base Rate
Debt Instrument [Line Items]
Minimum annual variable rate		0.0225
Minimum allowable variable rate		0.0150
Revolving credit facility \| Fed Funds Effective Rate
Debt Instrument [Line Items]
Interest rate applicable margin		0.50%
Revolving credit facility \| Eurodollar
Debt Instrument [Line Items]
Minimum annual variable rate		0.0325
Minimum allowable variable rate		0.0050
Standby Letters of Credit
Debt Instrument [Line Items]
Letters of credit outstanding			$ 38,800,000		$ 13,600,000

Debt - Summary of Convertible Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 07, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Unamortized discount and issuance costs		$ (1,300)
Effective interest rate	1.00%
Convertible Notes
Debt Instrument [Line Items]
1.00% Convertible Senior Notes	$ 425,000		$ 425,000
Unamortized discount and issuance costs	(11,248)		(13,137)
Long-term portion, net of debt discount and issuance costs	$ 413,752		$ 411,863

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Debt - Convertible Debt Narrative (Details)					3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
Debt - Convertible Debt Narrative (Details)	Jan. 07, 2022 USD ($)	Dec. 09, 2021 USD ($)	Dec. 09, 2021 USD ($)	Dec. 03, 2021 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) d $ / shares shares	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Debt Instrument [Line Items]
Effective interest rate										1.00%
Interest expense					$ 8,746,000	$ 8,021,000	$ 6,942,000	$ 14,963,000	$ 23,709,000	$ 33,513,000	$ 35,475,000	$ 15,129,000
Amortization of debt discount and issuance costs							$ 1,710,000	$ 3,286,000	$ 5,003,000	$ 6,857,000	15,036,000	$ 3,366,000
Common Stock
Debt Instrument [Line Items]
Fees paid on issuance of convertible notes	$ 15,900,000
Convertible Notes
Debt Instrument [Line Items]
Threshold percentage of stock price trigger										130.00%
Convertible Senior Notes due 2028
Debt Instrument [Line Items]
Senior secured promissory note										$ 1,000
Convertible Senior Notes due 2028 \| Convertible Notes
Debt Instrument [Line Items]
Senior secured promissory note		$ 425,000,000	$ 425,000,000							$ 100,000,000
Effective interest rate		1.00%	1.00%	1.00%						1.50%
Proceeds from convertible debt		$ 48,600,000	$ 413,300,000	$ 364,700,000
Convertible note, interest rate, effective percentage discount		2.75%	2.75%	2.75%
Interest expense										$ 6,100,000	400,000
Contractual interest expense										4,200,000	300,000
Amortization of debt discount and issuance costs										$ 1,900,000	$ 100,000
Convertible note, annual interest rate										1.00%
Convertible note, trading days (in days) \| d										20
Convertible note, consecutive trading days (in days) \| d										30
Threshold percentage of stock price trigger										98.00%
Conversion price percentage										100.00%
Conversion price percentage, fundamental change repurchase										100.00%
Convertible Senior Notes due 2028 \| Convertible Notes \| Common Stock
Debt Instrument [Line Items]
Conversion price percentage										32.50%
Conversion of stock, shares converted per dollar (in shares) \| shares										41.9054
Convertible notes payable										$ 1,000
Convertible note, conversion price (in dollar per share) \| $ / shares										$ 23.86
Debt conversion, converted Instrument, shares issued (in shares) \| shares										10,100,000
Convertible Senior Notes due 2028, $375 Million \| Convertible Notes
Debt Instrument [Line Items]
Senior secured promissory note				$ 375,000,000
Convertible Senior Notes due 2028, $50 Million \| Convertible Notes
Debt Instrument [Line Items]
Senior secured promissory note		$ 50,000,000	$ 50,000,000
Convertible Note Capped Call Transactions
Debt Instrument [Line Items]
Deferred tax assets										$ 10,800,000
Convertible Note Capped Call Transactions \| Convertible Notes
Debt Instrument [Line Items]
Fees paid on issuance of convertible notes										$ 52,900,000
Derivative, cap price (in dollars per share) \| $ / shares										$ 36.0200
Convertible Note Capped Call Transactions \| Convertible Notes \| Common Stock
Debt Instrument [Line Items]
Debt conversion, converted Instrument, shares issued (in shares) \| shares										17,800,000

Debt - Other Debt Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Proceeds from issuance of other debt	$ 20,188	$ 0	$ 0
STI
Debt Instrument [Line Items]
Other term borrowings	52,000
Interest expense, other	2,400
Fixed Interest \| STI
Debt Instrument [Line Items]
Debt Instrument, periodic payment, interest	$ 20,300
Fixed Interest \| STI \| Minimum
Debt Instrument [Line Items]
Stated interest rate	4.52%
Fixed Interest \| STI \| Maximum
Debt Instrument [Line Items]
Stated interest rate	0.55%
Variable Interest \| STI
Debt Instrument [Line Items]
Proceeds from issuance of other debt	$ 31,700
Variable Interest \| STI \| Minimum
Debt Instrument [Line Items]
Stated interest rate	1.99%
Variable Interest \| STI \| Maximum
Debt Instrument [Line Items]
Stated interest rate	3.96%

Debt - Summary of Aggregate Future Debt Maturities (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 38,691
2024	13,583
2025	8,257
2026	6,453
2027	297,442
Thereafter	425,000
Total carrying value of debt	$ 789,426

Redeemable Perpetual Preferred Stock (Details) $ / shares in Units, $ in Thousands				9 Months Ended	12 Months Ended
	Jan. 07, 2022 USD ($) $ / shares shares	Sep. 27, 2021 USD ($) shares	Aug. 11, 2021 USD ($) vote $ / shares shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Jun. 30, 2022 USD ($) shares	Mar. 31, 2022 USD ($) shares	Dec. 31, 2019 USD ($)
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares) \| shares				400,000	406,000	350,000		412,606	400,000
Stock issued (in shares) \| shares	1,125,000
Net proceeds from sale of series A perpetual preferred stock	$ 49,400
Repayment of long term line of credit					$ 14,300	$ 0	$ 57,702
Initial public offering of common stock, net of underwriting discounts and commissions (in shares) \| shares	50,000
Other offering costs					0	0	6,464
Temporary equity, carrying amount, attributable to parent				$ 287,561	299,570	237,462	0	$ 293,974	$ 281,792
Common stock, value, issued				150	150	135		150	150
Total stockholders’ equity (deficit)				111,453	124,281	(69,205)	(80,899)	$ 110,368	$ 170,218	$ 305,151
Debt discount and issuance costs	$ 1,300
Percentage of variable weighted average price of temporary equity	95.00%
Payments of dividends				$ 18,670	18,670	8,051	$ 0
Percentage of initial liquidation preference			130.00%
Temporary equity, redemption amount			$ 200,000
Anniversary Date One
Temporary Equity [Line Items]
Purchase commitment, percentage	0.00%
Purchase commitment, period	6 months
Anniversary Date Two
Temporary Equity [Line Items]
Purchase commitment, percentage	1.50%
Anniversary Date Two \| Minimum
Temporary Equity [Line Items]
Purchase commitment, period	6 months
Anniversary Date Two \| Maximum
Temporary Equity [Line Items]
Purchase commitment, period	12 months
Anniversary Date Three
Temporary Equity [Line Items]
Purchase commitment, percentage	3.00%
Purchase commitment, period	12 months
Securities Purchase Agreement
Temporary Equity [Line Items]
Net proceeds from sale of series A perpetual preferred stock			346,000
Repayment of long term line of credit		$ 100,000
Proceeds from Series A issuance	$ 334,600
Temporary equity, carrying amount, attributable to parent	229,800
Common stock, value, issued	105,400
Total stockholders’ equity (deficit)	12,400
Derivative instrument, prepaid forward contract	11,700
Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Net proceeds from sale of series A perpetual preferred stock			$ 148,000
Series A Redeemable Perpetual Preferred Shares
Temporary Equity [Line Items]
Other offering costs	11,100
Preferred stock discount	4,400
Fees paid on issuance of convertible notes	$ 33,100
Temporary equity, accretion of interest					23,200	$ 7,400
Initial liquidation preference (in dollars per share) \| $ / shares	$ 1,000		$ 1,000
Dividend rate, percentage				6.25%
Payments of dividends				$ 18,700
Accrued and unpaid dividends					$ 6,400
Temporary equity, amortization of discount, period	5 years
Number of votes per temporary equity share \| vote			1
Series A Redeemable Perpetual Preferred Shares \| Accrued Regular Dividend Rate
Temporary Equity [Line Items]
Dividend rate, percentage	6.25%
Series A Redeemable Perpetual Preferred Shares \| Cash Regular Dividend Rate
Temporary Equity [Line Items]
Dividend rate, percentage	5.75%
Temporary equity dividend rate spread	2.00%
Percent of the amount of default accrued dividends to be paid	100.00%
Series A Redeemable Perpetual Preferred Shares \| Cash Regular Dividend Rate \| Fifth, Sixth, and Seventh Anniversaries
Temporary Equity [Line Items]
Temporary equity dividend rate spread	0.50%
Series A Redeemable Perpetual Preferred Shares \| Cash Regular Dividend Rate \| Eighth, Ninth, and Tenth Anniversaries
Temporary Equity [Line Items]
Temporary equity dividend rate spread	1.00%
Series A Redeemable Perpetual Preferred Shares \| Securities Purchase Agreement
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares) \| shares			350,000
Repayment of long term line of credit		$ 102,000
Proceeds from Series A issuance	$ 334,600
Series A Redeemable Perpetual Preferred Shares \| Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Stock issued (in shares) \| shares			150,000
Common Stock
Temporary Equity [Line Items]
Fees paid on issuance of convertible notes	$ 15,900
Common Stock \| Securities Purchase Agreement
Temporary Equity [Line Items]
Stock issued (in shares) \| shares			7,098,765
Common Stock \| Securities Purchase Agreement, Expiry or Termination \| BCP Helios Aggregator L.P.
Temporary Equity [Line Items]
Stock issued (in shares) \| shares		776,235
Net proceeds from sale of series A perpetual preferred stock		$ 10
Common Stock \| Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Stock issued (in shares) \| shares			3,375,000
Common Stock \| Securities Purchase Agreement, Additional Closings, Certain Pricing Adjustments
Temporary Equity [Line Items]
Stock issued (in shares) \| shares			6,100,000

Common and Preferred Stock (Details)	Dec. 31, 2022 vote
Equity [Abstract]
Number of votes per common share	1

Revenue (Details) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
Revenue (Details) $ in Thousands	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) contract	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Disaggregation of Revenue [Line Items]
Revenue	$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475	$ 1,637,546	$ 853,318	$ 872,662
Unbilled receivables						101,513	111,224	18,073
Deferred revenue						178,922	99,575	149,821
Deferred revenue recognized						$ 84,700	$ 149,800
Percentage of deferred revenue recognized						85.00%	100.00%
Revenue, bill and hold performance obligation, number of contracts \| contract						1
Revenue, bill and hold performance obligation, amount						$ 13,700	$ 168,900
Remaining performance obligation						$ 719,300
Percentage of performance obligation to be recognized						100.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, period						12 months
Over-time revenue
Disaggregation of Revenue [Line Items]
Revenue						$ 1,155,848	519,003	503,238
Point in time revenue
Disaggregation of Revenue [Line Items]
Revenue						$ 481,698	$ 334,315	$ 369,424

Earnings per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 14, 2020	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Net income (loss)		$ 40,644	$ (5,024)	$ (25,937)	$ (30,961)	$ 9,683	$ 4,432	$ (50,403)	$ 59,073
Preferred dividends and accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)	(48,054)	(15,715)	0
Net income (loss) to common shareholders		$ 28,387	$ (17,206)	$ (37,543)	$ (54,749)	$ (26,362)	$ (43,622)	$ (66,118)	$ 59,073
Basic:
Weighted average common shares outstanding (in shares)	119,994,467	150,322,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,467,000
Earnings (loss) per share (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49
Diluted:
Effect of Restricted Stock and Performance Awards (in shares)							0	0	47,000
Weighted average dilutive shares (in shares)	119,994,467	151,382,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,514,000
Income (loss) per share (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49

Earnings per Share - Narrative (Details) - shares	12 Months Ended
Earnings per Share - Narrative (Details) - shares	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Equity compensation anti-dilutive securities (in shares)	2,165,217	1,078,096	500,006
Equity grants \| Class B units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares not included in the calculation of basic or diluted EPS (in shares)			26,671,594
Equity grants \| Class C Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares not included in the calculation of basic or diluted EPS (in shares)			1,000

Commitments and Contingencies - Narrative (Details) - USD ($)		12 Months Ended
	Jul. 15, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition, Contingent Consideration [Line Items]
Contingent consideration		$ 8,587,000	$ 14,577,000	$ 19,691,000
Surety Bond
Business Acquisition, Contingent Consideration [Line Items]
Contractual obligation		199,300,000
Array \| Tax Receivable Agreement
Business Acquisition, Contingent Consideration [Line Items]
Contingent consideration		$ 8,600,000	$ 14,600,000
Tax Receivable Agreement, payment term		125 days
Array \| Earn-Out Liability
Business Acquisition, Contingent Consideration [Line Items]
Maximum aggregate earn-out consideration		$ 25,000,000
Nextracker Litigation \| Settled Litigation
Business Acquisition, Contingent Consideration [Line Items]
Loss contingency, damages awarded, value	$ 42,800,000

Commitments and Contingencies - Summary of Liability Related to Estimated Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Combination, Contingent Consideration Arrangements, Change In Amount Of Contingent Consideration [Roll Forward]
Beginning balance			$ 14,577	$ 14,577	$ 14,577	$ 14,577	$ 19,691
IRS Settlement							2,696
Fair value adjustment							(7,810)
Fair value adjustment	$ (572)	$ (1,678)	(3,731)	(5,409)	(5,981)	(4,507)	2,696	$ 26,441
Payments			$ (1,483)	$ (1,483)	$ (1,483)	(1,483)	(7,810)	0
Ending balance						$ 8,587	$ 14,577	$ 19,691

Commitments and Contingencies - Undiscounted Future Expected Payments Under the TRA (Details) - Array - Tax Receivable Agreement $ in Thousands	Dec. 31, 2022 USD ($)
Other Commitments [Line Items]
2023	$ 1,806
2024	1,762
2025	1,615
2026	1,425
2027	1,232
Thereafter	2,516
Total	$ 10,356

Fair Value of Financial Instruments - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - Convertible Notes - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Convertible senior notes, carrying value	$ 413,752	$ 411,863
Convertible senior notes, fair value	$ 430,236	$ 410,771

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Fair Value of Financial Instruments - Narrative (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Other debt	$ 52,000
2023	38,691
2024	13,583
Variable Interest
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Other debt	31,700
Fixed Interest
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Other debt	20,300
2023	14,900
2024	$ 5,400

Equity-Based Compensation - Narrative (Details) - USD ($) $ in Millions					12 Months Ended
	Mar. 23, 2021	May 19, 2020	Mar. 28, 2020	Nov. 19, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Oct. 14, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined contribution plan, maximum annual contributions per employee, percent					75.00%
Defined contribution plan, employer matching contribution, percent of match					100.00%
Defined contribution plan, employer matching contribution, percent of employees' gross pay					3.00%
Defined contribution plan, employer matching contribution, percent of match, secondary					50.00%
Defined contribution plan, contributions					$ 1.5	$ 1.1	$ 0.8
Common Class B and Common Class C
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity based compensation	$ 8.9
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					3 years
Shares granted in period (in shares)					466,916	177,472
Unrecognized compensation costs, period of recognition					2 years 2 months 12 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)					1,484,782	661,924	500,006
Unrecognized compensation costs, period of recognition					1 year 10 months 24 days
Equity grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity based compensation					$ 14.8	$ 16.3	$ 4.8
Unrecognized compensation costs					17.9
Equity grants \| Class B units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)		4,344,941		22,326,653
Equity grants \| Class C Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)			1,000
Employee stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity based compensation					$ 0.1
Employee stock purchase plan, discount rate					15.00%
Purchase period					6 months
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized shares (in shares)								6,683,919

Equity-Based Compensation - Schedule of RSUs and PSUs Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
RSUs
Number of Shares
Outstanding non-vested, beginning balance (in shares)	930,409	500,006	0
Shares granted (in shares)	1,484,782	661,924	500,006
Shares vested (in shares)	(458,849)	(157,473)	0
Shares forfeited (in shares)	(255,518)	(74,048)	0
Outstanding non-vested, ending balance (in shares)	1,700,824	930,409	500,006
Weighted Average Grant Date Fair Value
Outstanding non-vested, weighted average grant date fair value, beginning balance (in dollars per share)	$ 22.39	$ 22.00	$ 0
Shares granted, weighted average grand date fair value (in dollars per share)	10.93	23.17	22.00
Shares vested, weighted average grand date fair value (in dollars per share)	20.00	22.00	0
Shares forfeited, weighted average grand date fair value (in dollars per share)	15.42	27.51	0
Outstanding non-vested, weighted average grant date fair value, ending balance (in dollars per share)	$ 13.81	$ 22.39	$ 22.00
PSUs
Number of Shares
Outstanding non-vested, beginning balance (in shares)	147,687	0
Shares granted (in shares)	466,916	177,472
Shares vested (in shares)	0	0
Shares forfeited (in shares)	(150,210)	(29,785)
Outstanding non-vested, ending balance (in shares)	464,393	147,687	0
Weighted Average Grant Date Fair Value
Outstanding non-vested, weighted average grant date fair value, beginning balance (in dollars per share)	$ 27.75	$ 0
Shares granted, weighted average grand date fair value (in dollars per share)	10.88	28.25
Shares vested, weighted average grand date fair value (in dollars per share)	0	0
Shares forfeited, weighted average grand date fair value (in dollars per share)	20.81	30.74
Outstanding non-vested, weighted average grant date fair value, ending balance (in dollars per share)	$ 11.96	$ 27.75	$ 0

Equity-Based Compensation - Schedule of Assumptions (Details) - PSUs	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	60.00%	66.00%
Risk-free interest rate	2.83%	0.28%
Dividend yield	0.00%	0.00%

Leases - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021
Leases [Abstract]
ROU assets	$ 17,770	$ 11,245	$ 13,200
Lease liabilities	$ 20,406	$ 11,268	$ 13,500

Leases - Summary of Right of Use Assets Lease Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
Leases [Abstract]
ROU Assets	$ 17,770	$ 11,245	$ 13,200
Operating lease, right-of-use asset, statement of financial position	Other assets	Other assets	Other assets	Other assets
Lease liabilities, current portion	$ 6,509	$ 5,909
Operating lease, liability, current, statement of financial position	Other current liabilities	Other current liabilities
Lease liabilities, long-term portion	$ 13,897	$ 5,359
Operating lease, liability, noncurrent, statement of financial position	Other long-term liabilities	Other long-term liabilities
Total lease liabilities	$ 20,406	$ 11,268	$ 13,500

Leases - Schedule of Components of Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease expense	$ 7,701	$ 6,635
Variable lease expense	1,089	106
Short-term lease expense	327	0
Total lease expense	$ 9,117	$ 6,741

Leases - Schedule of Future Minimum Operating Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021
Leases [Abstract]
2023	$ 6,966
2024	5,598
2025	4,399
2026	1,606
2027	1,453
Thereafter	2,908
Total lease payments	22,930
Less: Imputed lease interest	(2,524)
Total lease liabilities	$ 20,406	$ 11,268	$ 13,500

Leases - Schedule of Weighted-Average Remaining Lease-Term and Discount Rate (Details)	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Weighted average remaining lease-term	4 years 2 months 12 days	3 years 9 months 18 days
Weighted average discount rate	5.40%	5.00%

Leases - Supplemental Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating cash flows from operating leases	$ 5,380	$ 6,644
Non cash investing activities:
Lease liabilities arising from obtaining right-of-use assets	$ 12,558	$ 17,363

Related Party Transactions (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 14, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Related Party Transaction [Line Items]
Accounts payable - related party					$ 478	$ 478	$ 478
Special distribution	$ 589,000	$ 0	$ 0	$ 589,000
Former shareholder \| Consent Fees
Related Party Transaction [Line Items]
Consent fees incurred		2,200
Accounts payable - related party		$ 500

Segment and Geographic Information - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($) segment	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments \| segment	2	1
Number of reportable segments \| segment	2	1
Assets	$ 1,706,052	$ 1,142,979	$ 1,734,186	$ 1,818,631	$ 1,783,850
Array Legacy Operations
Segment Reporting Information [Line Items]
Assets	$ 843,000
Assets, consolidated	49.00%
STI Operations
Segment Reporting Information [Line Items]
Assets	$ 863,000
Assets, consolidated	51.00%

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Segment and Geographic Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475	$ 1,637,546	$ 853,318	$ 872,662
Gross Profit	$ 80,223	$ 39,946	$ 26,587	$ 66,533	$ 146,756	227,276	82,859	202,801
Array Legacy Operations
Segment Reporting Information [Line Items]
Revenue						1,267,883	853,318	872,662
Gross Profit						168,170	$ 82,859	$ 202,801
STI Operations
Segment Reporting Information [Line Items]
Revenue						369,663
Gross Profit						$ 59,106

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Segment and Geographic Information - Schedule of Revenue from External Customers by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475	$ 1,637,546	$ 853,318	$ 872,662
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue						1,286,064	826,639	805,070
Spain
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue						129,292	7,281	181
Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue						144,464	0	0
Australia
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue						9,429	5,509	45,216
Rest of the world
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue						$ 68,297	$ 13,889	$ 22,195

- Definition

+ References

+ Details

Segment and Geographic Information - Schedule of Property, Plant and Equipment, Net by Geographic Region (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 23,174	$ 20,024	$ 17,802	$ 16,878	$ 10,692
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	17,789				9,959
Spain
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	2,676				0
Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,676				0
Australia
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1				0
Rest of the world
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 1,032				$ 733

Restatement (Unaudited) - Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 133,901	$ 62,778	$ 51,046	$ 49,491	$ 367,670
Accounts receivable, net	421,183	485,174	452,836	390,921	236,009
Due from affiliates			0
Inventories, net	233,159	269,775	329,951	299,010	205,653
Income tax receivables	3,532	12,765	16,217	31,079	9,052
Prepaid expenses and other	39,434	40,484	52,006	45,670	33,649
Total current assets	831,209	870,976	902,056	816,171	852,033
Property, plant and equipment, net	23,174	20,024	17,802	16,878	10,692
Goodwill	416,184	401,373	417,694	442,222	69,727
Other intangible assets, net	386,364	399,883	436,549	482,035	174,753
Deferred tax assets	16,466	18,785	18,521	0	9,345
Other assets	32,655	23,145	26,009	26,544	26,429
Total assets	1,706,052	1,734,186	1,818,631	1,783,850	1,142,979
Current liabilities
Accounts payable	170,430	199,358	231,798	187,466	92,002
Accounts payable - related party		478	478	478
Accrued expenses and other	54,895	91,102	51,072	54,837	38,494
Accrued warranty reserve	3,690	4,237	2,911	3,201	3,192
Income tax payable	6,881	10,587	419	6,452	60
Deferred revenue	178,922	154,692	167,556	121,624	99,575
Current portion of contingent consideration	1,200	0		0	1,773
Current portion of debt	38,691	47,686	51,494	48,180	4,300
Other current liabilities	10,553	4,981	6,949	10,886	5,909
Total current liabilities	465,262	513,121	512,677	433,124	245,305
Long-term liabilities
Deferred tax liability	72,606	76,864	86,590	99,260	0
Contingent consideration, net of current portion	7,387	7,113	7,686	9,363	12,804
Other long-term liabilities	14,808	9,113	9,723	7,102	5,557
Long-term warranty	1,786	3,852	4,056	4,743	0
Long-term debt, net of current portion	720,352	725,109	793,557	778,248	711,056
Total long-term liabilities		822,051	901,612	898,716
Total liabilities	1,282,201	1,335,172	1,414,289	1,331,840	974,722
Commitments and contingencies
Series A Redeemable Perpetual Preferred Stock	299,570	287,561	293,974	281,792	237,462	$ 0
Stockholders’ equity (deficit)
Preferred stock	0	0	0	0	0
Common stock	150	150	150	150	135
Additional paid-in capital	383,176	392,862	401,614	411,232	202,562
Accumulated deficit	(267,470)	(262,219)	(302,863)	(297,839)	(271,902)
Accumulated other comprehensive (loss) income	8,425	(19,340)	11,467	56,675	0
Total stockholders’ equity (deficit)	124,281	111,453	110,368	170,218	(69,205)	$ (80,899)	$ 305,151
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity (deficit)	$ 1,706,052	1,734,186	1,818,631	1,783,850	1,142,979
As Previously Reported
Current assets
Cash and cash equivalents		62,778	51,046	49,491
Accounts receivable, net		485,174	452,836	390,921
Due from affiliates			0
Inventories, net		269,775	329,951	299,010
Income tax receivables		12,765	16,217	31,079
Prepaid expenses and other		41,309	52,831	46,495
Total current assets		871,801	902,881	816,996
Property, plant and equipment, net		20,024	17,802	16,878
Goodwill		359,629	378,706	379,840
Other intangible assets, net		384,084	421,862	470,690
Deferred tax assets		18,785	18,521	0
Other assets		27,502	30,573	31,314
Total assets		1,681,825	1,770,345	1,715,718
Current liabilities
Accounts payable		199,358	231,798	187,466
Accounts payable - related party		478	478	478
Accrued expenses and other		91,102	51,072	54,837
Accrued warranty reserve		4,237	2,911	3,201
Income tax payable		10,587	419	6,452
Deferred revenue		154,692	167,556	121,624
Current portion of contingent consideration		0		0
Current portion of debt		47,686	51,494	48,180
Other current liabilities		4,981	6,949	10,886
Total current liabilities		513,121	512,677	433,124
Long-term liabilities
Deferred tax liability		74,139	84,819	92,931
Contingent consideration, net of current portion		7,113	7,686	9,363
Other long-term liabilities		9,113	9,723	7,102
Long-term warranty		3,852	4,056	4,743
Long-term debt, net of current portion		725,109	793,557	778,248
Total long-term liabilities		819,326	899,841	892,387
Total liabilities		1,332,447	1,412,518	1,325,511
Commitments and contingencies
Series A Redeemable Perpetual Preferred Stock		287,561	293,974	281,792	237,462
Stockholders’ equity (deficit)
Preferred stock		0	0	0
Common stock		150	150	150
Additional paid-in capital		392,862	401,614	411,232
Accumulated deficit		(258,360)	(299,182)	(293,956)
Accumulated other comprehensive (loss) income		(72,835)	(38,729)	(9,011)
Total stockholders’ equity (deficit)		61,817	63,853	108,415	(69,205)
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity (deficit)		1,681,825	1,770,345	1,715,718
Restatement Adjustments
Current assets
Cash and cash equivalents		0	0	0
Accounts receivable, net		0	0	0
Due from affiliates			0
Inventories, net		0	0	0
Income tax receivables		0	0	0
Prepaid expenses and other		(825)	(825)	(825)
Total current assets		(825)	(825)	(825)
Property, plant and equipment, net		0	0	0
Goodwill		41,744	38,988	62,382
Other intangible assets, net		15,799	14,687	11,345
Deferred tax assets		0	0	0
Other assets		(4,357)	(4,564)	(4,770)
Total assets		52,361	48,286	68,132
Current liabilities
Accounts payable		0	0	0
Accounts payable - related party		0	0	0
Accrued expenses and other		0	0	0
Accrued warranty reserve		0	0	0
Income tax payable
Deferred revenue		0	0	0
Current portion of contingent consideration		0		0
Current portion of debt		0	0	0
Other current liabilities		0	0	0
Total current liabilities		0	0	0
Long-term liabilities
Deferred tax liability		2,725	1,771	6,329
Contingent consideration, net of current portion		0	0	0
Other long-term liabilities		0	0	0
Long-term warranty		0	0	0
Long-term debt, net of current portion		0	0	0
Total long-term liabilities		2,725	1,771	6,329
Total liabilities		2,725	1,771	6,329
Commitments and contingencies
Series A Redeemable Perpetual Preferred Stock		0	0	0	0
Stockholders’ equity (deficit)
Preferred stock		0	0	0
Common stock		0	0	0
Additional paid-in capital		0	0	0
Accumulated deficit		(3,859)	(3,681)	(3,883)
Accumulated other comprehensive (loss) income		53,495	50,196	65,686
Total stockholders’ equity (deficit)		49,636	46,515	61,803	$ 0
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity (deficit)		$ 52,361	$ 48,286	$ 68,132

Restatement (Unaudited) - Consolidated Balance Sheets - Additional Information (Details) - USD ($)	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract]
Temporary equity, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Temporary equity, shares authorized (in shares)	500,000	500,000	500,000	500,000	500,000
Temporary equity, shares issued (in shares)	406,000	400,000	412,606	400,000	350,000
Temporary equity, liquidation preference	$ 400,000,000	$ 400,000,000	$ 413,000,000	$ 400,000,000	$ 350,000,000.0
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000
Preferred stock, shares issued (in shares)	0	0	0	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	150,513,104	150,334,261	150,279,160	150,173,507	135,026,940

Restatement (Unaudited) - Consolidated Statements of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 14, 2020	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue		$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475	$ 1,637,546	$ 853,318	$ 872,662
Cost of revenue		434,801	379,919	273,999	653,918	1,088,719	1,410,270	770,459	669,861
Gross profit		80,223	39,946	26,587	66,533	146,756	227,276	82,859	202,801
Operating expenses
General and administrative		38,703	28,936	45,425	74,361	113,064	150,777	80,974	55,634
Contingent consideration		(572)	(1,678)	(3,731)	(5,409)	(5,981)	(4,507)	2,696	26,441
Depreciation and amortization		24,898	26,020	23,237	49,257	74,155	99,139	23,930	25,514
Total operating expenses		63,029	53,278	64,931	118,209	181,238	245,409	107,600	107,589
Income (loss) from operations		17,194	(13,332)	(38,344)	(51,676)	(34,482)	(18,133)	(24,741)	95,212
Other expense
Other income (expense), net		(399)	(371)	743	372	(27)	2,789	(905)	(2,305)
Legal settlement		42,750				42,750	42,750	0	0
Foreign currency gain (loss)		(159)	(1,736)	3,863	2,127	1,968	1,155	0	0
Interest expense		(8,746)	(8,021)	(6,942)	(14,963)	(23,709)	(33,513)	(35,475)	(15,129)
Total other income (expense)		33,446	(10,128)	(2,336)	(12,464)	20,982	13,181	(36,380)	(17,434)
Income (loss) before income tax benefit		50,640	(23,460)	(40,680)	(64,140)	(13,500)	(4,952)	(61,121)	77,778
Income tax expense (benefit)		9,996	(18,436)	(14,743)	(33,179)	(23,183)	(9,384)	(10,718)	18,705
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	59,073
Preferred dividends and accretion		12,257	12,182	11,606	23,788	36,045	48,054	15,715	0
Net income (loss) to common shareholders		$ 28,387	$ (17,206)	$ (37,543)	$ (54,749)	$ (26,362)	$ (43,622)	$ (66,118)	$ 59,073
Income (loss) per common share
Basic (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49
Diluted (in dollars per share)		$ 0.19	$ (0.11)	$ (0.25)	$ (0.37)	$ (0.18)	$ (0.29)	$ (0.51)	$ 0.49
Weighted average common shares outstanding
Basic (in shares)	119,994,467	150,322,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,467,000
Diluted (in shares)	119,994,467	151,382,000	150,203,000	148,288,000	149,246,000	149,604,000	149,819,000	129,984,000	121,514,000
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue		$ 515,024	$ 419,865	$ 300,586	$ 720,451	$ 1,235,475
Cost of revenue		434,801	379,919	273,999	653,918	1,088,719
Gross profit		80,223	39,946	26,587	66,533	146,756
Operating expenses
General and administrative		38,911	29,143	39,827	68,970	107,881
Contingent consideration		(572)	(1,678)	(3,731)	(5,409)	(5,981)
Depreciation and amortization		23,364	24,389	22,652	47,041	70,405
Total operating expenses		61,703	51,854	58,748	110,602	172,305
Income (loss) from operations		18,520	(11,908)	(32,161)	(44,069)	(25,549)
Other expense
Other income (expense), net		(399)	(371)	743	372	(27)
Legal settlement		42,750				42,750
Foreign currency gain (loss)		(159)	(1,736)	3,863	2,127	1,968
Interest expense		(8,746)	(8,021)	(6,942)	(14,963)	(23,709)
Total other income (expense)		33,446	(10,128)	(2,336)	(12,464)	20,982
Income (loss) before income tax benefit		51,966	(22,036)	(34,497)	(56,533)	(4,567)
Income tax expense (benefit)		11,144	(16,810)	(12,443)	(29,253)	(18,109)
Net income (loss)		40,822	(5,226)	(22,054)	(27,280)	13,542
Preferred dividends and accretion		12,257	12,182	11,606	23,788	36,045
Net income (loss) to common shareholders		$ 28,565	$ (17,408)	$ (33,660)	$ (51,068)	$ (22,503)
Income (loss) per common share
Basic (in dollars per share)		$ 0.19	$ (0.12)	$ (0.23)	$ (0.34)	$ (0.15)
Diluted (in dollars per share)		$ 0.19	$ (0.12)	$ (0.23)	$ (0.34)	$ (0.15)
Weighted average common shares outstanding
Basic (in shares)		150,322,000	150,203,000	148,288,000	149,246,000	149,604,000
Diluted (in shares)		151,382,000	150,203,000	148,288,000	149,246,000	149,604,000
Restatement Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue		$ 0	$ 0	$ 0	$ 0	$ 0
Cost of revenue		0	0	0	0	0
Gross profit		0	0	0	0	0
Operating expenses
General and administrative		(208)	(207)	5,598	5,391	5,183
Contingent consideration		0	0	0	0	0
Depreciation and amortization		1,534	1,631	585	2,216	3,750
Total operating expenses		1,326	1,424	6,183	7,607	8,933
Income (loss) from operations		(1,326)	(1,424)	(6,183)	(7,607)	(8,933)
Other expense
Other income (expense), net		0	0	0	0	0
Legal settlement		0				0
Foreign currency gain (loss)		0	0	0	0	0
Interest expense		0	0	0	0	0
Total other income (expense)		0	0	0	0	0
Income (loss) before income tax benefit		(1,326)	(1,424)	(6,183)	(7,607)	(8,933)
Income tax expense (benefit)		(1,148)	(1,626)	(2,300)	(3,926)	(5,074)
Net income (loss)		(178)	202	(3,883)	(3,681)	(3,859)
Preferred dividends and accretion		0	0	0	0	0
Net income (loss) to common shareholders		$ (178)	$ 202	$ (3,883)	$ (3,681)	$ (3,859)
Income (loss) per common share
Basic (in dollars per share)		$ 0	$ 0	$ (0.03)	$ (0.02)	$ (0.03)
Diluted (in dollars per share)		$ 0	$ 0	$ (0.03)	$ (0.02)	$ (0.03)
Weighted average common shares outstanding
Basic (in shares)		0	0	0	0	0
Diluted (in shares)		0	0	0	0	0

Restatement (Unaudited) - Consolidated Statements of Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ 40,644	$ (5,024)	$ (25,937)	$ (30,961)	$ 9,683	$ 4,432	$ (50,403)	$ 59,073
Change in foreign currency translation adjustments	(30,807)	(45,208)	56,675	11,467	(19,340)	8,425	0	0
Comprehensive income (loss)	9,837	(50,232)	30,738	(19,494)	(9,657)	$ 12,857	$ (50,403)	$ 59,073
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	40,822	(5,226)	(22,054)	(27,280)	13,542
Change in foreign currency translation adjustments	(34,106)	(29,718)	(9,011)	(38,729)	(72,835)
Comprehensive income (loss)	6,716	(34,944)	(31,065)	(66,009)	(59,293)
Restatement Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	(178)	202	(3,883)	(3,681)	(3,859)
Change in foreign currency translation adjustments	3,299	(15,490)	65,686	50,196	53,495
Comprehensive income (loss)	$ 3,121	$ (15,288)	$ 61,803	$ 46,515	$ 49,636

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Restatement (Unaudited) - Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) (Details) - USD ($) $ in Thousands		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Jan. 07, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 110,368	$ 170,218	$ (69,205)	$ (69,205)	$ (69,205)	$ (69,205)	$ (80,899)	$ 305,151
Equity-based compensation		4,097	2,944	4,413	7,357	11,454	14,543	13,562	4,809
Issuance of stock, net (in shares)	50,000
Issuance of stock, net							216,078	104,764	145,532
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)	(48,054)	(8,226)
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	59,073
Other comprehensive income (loss)		(30,807)	(45,208)	56,675	11,467	(19,340)	8,425
Ending balance		$ 111,453	$ 110,368	$ 170,218	$ 110,368	$ 111,453	$ 124,281	$ (69,205)	$ (80,899)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		413,000	400,000	350,000	350,000	350,000	350,000	0
Beginning balance		$ 293,974	$ 281,792	$ 237,462	$ 237,462	$ 237,462	$ 237,462	$ 0
Issuance of Series A Preferred, net of fees (in shares)				50,000	50,000	50,000	50,000	350,000
Issuance of Series A Preferred, net of fees				$ 32,724	$ 32,724	$ 32,724	$ 32,724	$ 229,799
Preferred cumulative dividends plus accretion (in shares)			13,000		13,000	13,000	19,000
Preferred cumulative dividends plus accretion		$ 12,257	$ 12,182	$ 11,606	$ 23,788	$ 36,045	$ 48,054	$ 8,226
Dividends paid (in shares)		(13,000)				(13,000)	(13,000)
Dividends paid		$ (18,670)				$ (18,670)	$ (18,670)
Ending balance (in shares)		400,000	413,000	400,000	413,000	400,000	406,000	350,000	0
Ending balance		$ 287,561	$ 293,974	$ 281,792	$ 293,974	$ 287,561	$ 299,570	$ 237,462	$ 0
Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		$ (592)	$ (380)	$ 215,878	$ 215,498	$ 214,906	$ (1,938)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		150,279,000	150,174,000	135,027,000	135,027,000	135,027,000	135,027,000	126,994,000	0
Beginning balance		$ 150	$ 150	$ 135	$ 135	$ 135	$ 135	$ 127	$ 0
Equity-based compensation (in shares)		55,000	105,000			161,000	339,000	158,000
Issuance of stock, net (in shares)				15,147,000			15,147,000	7,875,000	7,000,000
Issuance of stock, net							$ 15	$ 8	$ 7
Ending balance (in shares)		150,334,000	150,279,000	150,174,000	150,279,000	150,334,000	150,513,000	135,027,000	126,994,000
Ending balance		$ 150	$ 150	$ 150	$ 150	$ 150	$ 150	$ 135	$ 127
Common Stock \| Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net (in shares)					15,252,000	15,146,000
Issuance of stock, net				15	$ 15	$ 15
Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		401,614	411,232	202,562	202,562	202,562	202,562	140,473	0
Equity-based compensation		4,097	2,944	4,413	7,357	11,454	14,543	13,562	1,412
Issuance of stock, net							216,063	104,756	145,525
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)	(48,054)	(8,226)
Ending balance		392,862	401,614	411,232	401,614	392,862	383,176	202,562	140,473
Additional Paid-In Capital \| Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		(592)	(380)	215,863	215,483	214,891	(1,938)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(302,863)	(297,839)	(271,902)	(271,902)	(271,902)	(271,902)	(221,499)	0
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	(12,321)
Ending balance		(262,219)	(302,863)	(297,839)	(302,863)	(262,219)	(267,470)	(271,902)	(221,499)
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		11,467	56,675	0	0	0	0	0
Other comprehensive income (loss)		(30,807)	(45,208)	56,675	11,467	(19,340)	8,425
Ending balance		(19,340)	11,467	56,675	11,467	(19,340)	8,425	0	$ 0
As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		63,853	108,415	(69,205)	(69,205)	(69,205)	$ (69,205)
Equity-based compensation		4,097	2,944	4,413	7,357	11,454
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)
Net income (loss)		40,822	(5,226)	(22,054)	(27,280)	13,542
Other comprehensive income (loss)		(34,106)	(29,718)	(9,011)	(38,729)	(72,835)
Ending balance		$ 61,817	$ 63,853	$ 108,415	$ 63,853	$ 61,817		$ (69,205)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		413,000	400,000	350,000	350,000	350,000	350,000
Beginning balance		$ 293,974	$ 281,792	$ 237,462	$ 237,462	$ 237,462	$ 237,462
Issuance of Series A Preferred, net of fees (in shares)				50,000	50,000	50,000
Issuance of Series A Preferred, net of fees				$ 32,724	$ 32,724	$ 32,724
Preferred cumulative dividends plus accretion (in shares)			13,000		13,000	13,000
Preferred cumulative dividends plus accretion		$ 12,257	$ 12,182	$ 11,606	$ 23,788	$ 36,045
Dividends paid (in shares)		(13,000)				(13,000)
Dividends paid		$ (18,670)				$ (18,670)
Ending balance (in shares)		400,000	413,000	400,000	413,000	400,000		350,000
Ending balance		$ 287,561	$ 293,974	$ 281,792	$ 293,974	$ 287,561		$ 237,462
As Previously Reported \| Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		$ (592)	$ (380)	$ 215,878	$ 215,498	$ 214,906
As Previously Reported \| Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		150,279,000	150,174,000	135,027,000	135,027,000	135,027,000	135,027,000
Beginning balance		$ 150	$ 150	$ 135	$ 135	$ 135	$ 135
Equity-based compensation (in shares)		55,000	105,000			161,000
Issuance of stock, net (in shares)				15,147,000
Ending balance (in shares)		150,334,000	150,279,000	150,174,000	150,279,000	150,334,000		135,027,000
Ending balance		$ 150	$ 150	$ 150	$ 150	$ 150		$ 135
As Previously Reported \| Common Stock \| Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net (in shares)					15,252,000	15,146,000
Issuance of stock, net				15	$ 15	$ 15
As Previously Reported \| Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		401,614	411,232	202,562	202,562	202,562	202,562
Equity-based compensation		4,097	2,944	4,413	7,357	11,454
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)
Ending balance		392,862	401,614	411,232	401,614	392,862		202,562
As Previously Reported \| Additional Paid-In Capital \| Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		(592)	(380)	215,863	215,483	214,891
As Previously Reported \| Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(299,182)	(293,956)	(271,902)	(271,902)	(271,902)	(271,902)
Net income (loss)		40,822	(5,226)	(22,054)	(27,280)	13,542
Ending balance		(258,360)	(299,182)	(293,956)	(299,182)	(258,360)		(271,902)
As Previously Reported \| Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(38,729)	(9,011)	0	0	0	0
Other comprehensive income (loss)		(34,106)	(29,718)	(9,011)	(38,729)	(72,835)
Ending balance		(72,835)	(38,729)	(9,011)	(38,729)	(72,835)		0
Restatement Adjustments
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		46,515	61,803	0	0	0	$ 0
Net income (loss)		(178)	202	(3,883)	(3,681)	(3,859)
Other comprehensive income (loss)		3,299	(15,490)	65,686	50,196	53,495
Ending balance		$ 49,636	$ 46,515	$ 61,803	$ 46,515	$ 49,636		$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		0	0	0	0	0	0
Beginning balance		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)		0	0	0	0	0		0
Ending balance		$ 0	$ 0	$ 0	$ 0	$ 0		$ 0
Restatement Adjustments \| Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		0	0	0	0	0	0
Beginning balance		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)		0	0	0	0	0		0
Ending balance		$ 0	$ 0	$ 0	$ 0	$ 0		$ 0
Restatement Adjustments \| Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		0	0	0	0	0	0
Ending balance		0	0	0	0	0		0
Restatement Adjustments \| Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(3,681)	(3,883)	0	0	0	0
Net income (loss)		(178)	202	(3,883)	(3,681)	(3,859)
Ending balance		(3,859)	(3,681)	(3,883)	(3,681)	(3,859)		0
Restatement Adjustments \| Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		50,196	65,686	0	0	0	$ 0
Other comprehensive income (loss)		3,299	(15,490)	65,686	50,196	53,495
Ending balance		$ 53,495	$ 50,196	$ 65,686	$ 50,196	$ 53,495		$ 0

Restatement (Unaudited) - Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income (loss)	$ 40,644	$ (5,024)	$ (25,937)	$ (30,961)	$ 9,683	$ 4,432	$ (50,403)	$ 59,073
Adjustments to net income (loss):
Provision for (recovery of) bad debts			145	510	660	2,599	(467)	595
Deferred tax expense (benefit)			4,349	(23,910)	(36,002)	(31,565)	(10,102)	(2,739)
Depreciation and amortization			23,608	49,795	74,957	101,059	25,946	27,474
Amortization of debt discount and issuance costs			1,710	3,286	5,003	6,857	15,036	3,366
Equity-based compensation			4,508	7,472	11,677	14,982	13,757	4,809
Contingent consideration	(572)	(1,678)	(3,731)	(5,409)	(5,981)	(4,507)	2,696	26,441
Warranty provision			594	1,215	4,341	4,152	516	953
Provision for inventory obsolescence			409	409	(2,333)	(859)	990	1,225
Changes in operating assets and liabilities, net of acquisition
Accounts receivable			(44,268)	(106,548)	(139,036)	(76,984)	(116,848)	(23,038)
Inventories			(46,250)	(77,191)	(14,273)	20,870	(88,184)	28,340
Income tax receivables			(21,924)	(7,062)	(3,610)	5,611	8,106	(16,530)
Prepaid expenses and other			11,558	5,015	16,329	19,124	(21,226)	1,101
Accounts payable			59,551	74,645	42,205	12,667	7,015	(50,519)
Accounts payable - related party			(132)	(132)	(132)
Accrued expenses and other			7,027	3,356	41,271	1,024	9,133	10,913
Warranty payments					(373)
Income tax payable			(8,760)	(7,217)	2,951	(755)	(8,754)	6,870
Lease liabilities			6,085	4,700	1,914	3,784	221	0
Deferred revenue			(18,639)	47,263	34,772	59,002	(50,619)	(178,960)
Net cash provided by (used in) operating activities			(50,097)	(60,764)	44,023	141,493	(263,187)	(122,205)
Investing activities:
Purchase of property, plant and equipment			(2,357)	(3,895)	(6,690)	(10,619)	(3,357)	(1,338)
Acquisition of STI, net of cash acquired			(373,816)	(373,818)	(373,816)	(373,818)	0	0
Investment in equity security			0	0	0	0	(11,975)	0
Net cash used in investing activities			(376,173)	(377,713)	(380,506)	(384,437)	(15,332)	(1,338)
Financing activities:
Proceeds from Series A issuance			33,098	33,098	33,098	33,098	224,987	0
Proceeds from common stock issuance			15,885	15,885	15,885	15,885	120,645	145,532
Series A equity issuance costs			(175)	(575)	(1,167)	(1,893)	(7,195)	0
Common stock issuance costs			(450)	(450)	(450)	(450)	(3,873)	0
Dividends paid on Series A Preferred					(18,670)	(18,670)	(8,051)	0
Proceeds from revolving credit facility			52,000	101,000	116,000	116,000	126,033	0
Payments on revolving credit facility			0	(33,000)	(116,000)	(116,000)	(126,033)	(70)
Proceeds from issuance of other debt			6,229	30,599	39,219
Principal payments on other debt			(4,368)	(22,377)	(33,286)
Contingent consideration			(1,483)	(1,483)	(1,483)	(1,483)	(7,810)	0
Debt issuance costs			0	0		0	(6,590)	(36,011)
Net cash provided by (used in) financing activities			100,736	122,697	33,146	8,440	537,748	(129,273)
Effect of exchange rate changes on cash and cash equivalent balances			7,355	(844)	(1,555)	735	0	0
Net change in cash and cash equivalents			(318,179)	(316,624)	(304,892)	(233,769)	259,229	(252,816)
Cash and cash equivalents, beginning of period	51,046	49,491	367,670	367,670	367,670	367,670	108,441	361,257
Cash and cash equivalents, end of period	62,778	51,046	49,491	51,046	62,778	133,901	367,670	108,441
Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI			200,224	200,224	200,224	200,224	0	$ 0
As Previously Reported
Operating activities:
Net income (loss)	40,822	(5,226)	(22,054)	(27,280)	13,542
Adjustments to net income (loss):
Provision for (recovery of) bad debts			145	510	660
Deferred tax expense (benefit)			6,649	(19,984)	(30,928)
Depreciation and amortization			23,023	47,579	71,207
Amortization of debt discount and issuance costs			1,710	3,286	5,003
Equity-based compensation			4,508	7,472	11,677
Contingent consideration	(572)	(1,678)	(3,731)	(5,409)	(5,981)
Warranty provision			594	1,215	4,341
Provision for inventory obsolescence			409	409	(2,333)
Changes in operating assets and liabilities, net of acquisition
Accounts receivable			(44,268)	(106,548)	(139,036)
Inventories			(46,250)	(77,191)	(14,273)
Income tax receivables			(21,924)	(7,062)	(3,610)
Prepaid expenses and other			5,960	(376)	11,146
Accounts payable			59,551	74,645	42,205
Accounts payable - related party			(132)	(132)	(132)
Accrued expenses and other			7,027	3,356	41,271
Warranty payments					(373)
Income tax payable			(8,760)	(7,217)	2,951
Lease liabilities			6,085	4,700	1,914
Deferred revenue			(18,639)	47,263	34,772
Net cash provided by (used in) operating activities			(50,097)	(60,764)	44,023
Investing activities:
Purchase of property, plant and equipment			(2,357)	(3,895)	(6,690)
Acquisition of STI, net of cash acquired			(373,816)	(373,818)	(373,816)
Investment in equity security			0	0	0
Net cash used in investing activities			(376,173)	(377,713)	(380,506)
Financing activities:
Proceeds from Series A issuance			33,098	33,098	33,098
Proceeds from common stock issuance			15,885	15,885	15,885
Series A equity issuance costs			(175)	(575)	(1,167)
Common stock issuance costs			(450)	(450)	(450)
Dividends paid on Series A Preferred					(18,670)
Proceeds from revolving credit facility			52,000	101,000	116,000
Payments on revolving credit facility			0	(33,000)	(116,000)
Proceeds from issuance of other debt			6,229	30,599	39,219
Principal payments on other debt			(4,368)	(22,377)	(33,286)
Contingent consideration			(1,483)	(1,483)	(1,483)
Debt issuance costs			0	0
Net cash provided by (used in) financing activities			100,736	122,697	33,146
Effect of exchange rate changes on cash and cash equivalent balances			7,355	(844)	(1,555)
Net change in cash and cash equivalents			(318,179)	(316,624)	(304,892)
Cash and cash equivalents, beginning of period	51,046	49,491	367,670	367,670	367,670	367,670
Cash and cash equivalents, end of period	62,778	51,046	49,491	51,046	62,778		367,670
Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI			200,224	200,224	200,224
Restatement Adjustments
Operating activities:
Net income (loss)	(178)	202	(3,883)	(3,681)	(3,859)
Adjustments to net income (loss):
Provision for (recovery of) bad debts			0	0	0
Deferred tax expense (benefit)			(2,300)	(3,926)	(5,074)
Depreciation and amortization			585	2,216	3,750
Amortization of debt discount and issuance costs			0	0	0
Equity-based compensation			0	0	0
Contingent consideration	0	0	0	0	0
Warranty provision			0	0	0
Provision for inventory obsolescence			0	0	0
Changes in operating assets and liabilities, net of acquisition
Accounts receivable			0	0	0
Inventories			0	0	0
Income tax receivables			0	0	0
Prepaid expenses and other			5,598	5,391	5,183
Accounts payable			0	0	0
Accounts payable - related party			0	0	0
Accrued expenses and other			0	0	0
Warranty payments					0
Income tax payable			0	0	0
Lease liabilities			0	0	0
Deferred revenue			0	0	0
Net cash provided by (used in) operating activities			0	0	0
Investing activities:
Purchase of property, plant and equipment			0	0	0
Acquisition of STI, net of cash acquired			0	0	0
Investment in equity security			0	0	0
Net cash used in investing activities			0	0	0
Financing activities:
Proceeds from Series A issuance			0	0	0
Proceeds from common stock issuance			0	0	0
Series A equity issuance costs			0	0	0
Common stock issuance costs			0	0	0
Dividends paid on Series A Preferred					0
Proceeds from revolving credit facility			0	0	0
Payments on revolving credit facility			0	0	0
Proceeds from issuance of other debt			0	0	0
Principal payments on other debt			0	0	0
Contingent consideration			0	0	0
Debt issuance costs			0	0
Net cash provided by (used in) financing activities			0	0	0
Effect of exchange rate changes on cash and cash equivalent balances			0	0	0
Net change in cash and cash equivalents			0	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0	0	0	0
Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI			$ 0	$ 0	$ 0